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BO01-01
WHAT IS THE IMPACT OF MARGINAL
GRAFTS ON THE POSTOPERATIVE
OUTCOME IN CIRRHOTIC LIVER
TRANSPLANT RECIPIENTS WITH A
MELD SCORE >30?
Francois Cauchy, David Fuks, Federica Dondero, Safi
Dokmak, Sebastien Gaujoux, Francois Durand, Claire
Francoz, Catherine Paugam and Jacques Belghiti
Beaujon Hospital, France
Introduction: While the indications for liver transplan-
tation keep on increasing, the existence of an ongoing
graft shortage has led to the development of several
alternative strategies including use of marginal grafts.
However, the exact influence of such policy on both
operative results and long-term outcomes in cirrhotic
patients with high MELD scores still remains unclear.
Method: Between 2007–2012, 61 cirrhotic patients with
a MELD score ≥30 underwent liver transplantation at
a single center. The preoperative characteristics, opera-
tive results and long-term outcomes of 33 (54%)
patients receiving high (≥1.65) donor risk index (DRI)
grafts were compared to those of 28 (46%) patient
receiving low (<1.65) DRI grafts.
Results: The two groups were similar in terms of
demography, comorbidities, underlying liver disease,
liver function tests and operative characteristics. Dura-
tion on the waiting list with a MELD score ≥30 was
significantly lower for patients receiving high DRI
grafts (6 vs. 14 days, p = 0.03). Compared to patients
receiving low DRI grafts, patients receiving high DRI
grafts had significantly higher AST (p < 0.001), ALT
(p = 0.03) and bilirubin levels (p = 0.001) on postoper-
ative days 1, 3 and 5. Mortality rate (36% vs. 14%,
p = 0.05), median number of complications per patient
(4 vs. 3, p = 0.05) and rate of infectious complications
(91% vs. 71%, p = 0.048) were significantly higher in
patients recieving high DRI grafts. On multivariate
analysis, a high DRI graft was the only risk factor sig-
nificantly associated with increased mortality (HR 4.16,
95%CI 1.05–16.1, p = 0.04). Overall survivals at 1 and
3 years were significantly lower in patients receiving
high DRI grafts than in patients receiving low DRI
grafts (80 vs. 65%, 80 vs. 55%, p = 0.04).
Conclusions: The use of high DRI grafts is associated
with prohibitive postoperative mortality and poorer
long-term survival in cirrhotic recipients with MELD
scores ≥30 and should therefore be avoided.
BO01-02
VALIDATION OF A DROPOUT
ASSESSMENT MODEL OF
CANDIDATES WITH/WITHOUT
HEPATOCELLULAR CARCINOMA ON A
COMMON LIVER TRANSPLANT
WAITING LIST
Christian Toso, Pietro Majno, Thierry Berney, Philippe
Morel, Gilles Mentha and Christophe Combescure
Geneva University Hospitals, Switzerland
Introduction: In many countries, liver graft allocation
is based on the model of end-stage liver disease
(MELD) score, with the use of exception points (22 in
the US) for patients with hepatocellular carcinoma
(HCC). A better model is desirable for HCC patients
as they tend to have a provileged access to transplanta-
tion, without any modulation according to the HCC
aggressiveness.
Method: A simple model designed from a training set
of the US patients (n = 49,026) was tested on two vali-
dation sets (US and UK patient cohorts with respec-
tively n = 20,475 and n = 1781). A multivariate
proportional hazard competitive risk model was used.
Results: The risk of drop-out at three months in HCC
patients was captured into a score, including HCC size,
HCC number, AFP and MELD. This new model could
be validated on external US and UK liver candidate
cohorts. It provided a dynamic and more accurate
assessment of drop-out than the use of exception
MELD (C index: 0.731 vs. 0.544). In addition, the
model showed a similar distribution and accuracy as
MELD for non-HCC patients (C-index: 0.767).
Conclusions: The proposed score allows to estimate the
risk of drop-out in HCC candidates according to HCC
characteristics and MELD. It could be used in combi-
nation to MELD for non-HCC patients, for the man-
agement of patients with and without HCC on a
common waiting list.
BO01-03
MANAGEMENT OF EXTENSIVE
NON- TUMOROUS PORTAL VEIN
THROMBOSIS IN ADULT LIVING
DONOR LIVER TRANSPLANTATION
Deok-Bog Moon, Sung-Gyu Lee, Shin Hwang, Chul-
Soo Ahn, Ki-Hun Kim, Tae-Yong Ha, Dong-Hwan
Jung, Gi-Won Song, Gil-Chun Park and Bo-Hyun
Jung
Asan Medical Center, Ulsan University, Korea
Introduction: Patent portal vein (PV) and adequate
portal inflow is essential for successful living donor
liver transplantation (LDLT). In extensive portal vein
thrombosis (PVT) patients, however, complete PV thromb-
ectomy is not feasible particularly at intrapancreatic
portion, and subsequently portal flow steal through
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preexisting sizable collaterals or rethrombosis can
occur. To overcome those problems, we introduced
interruption of sizable collaterals and intraoperative
cine-portogram (IOP), which is useful for diagnosis
and treatment of residual PVT and sizable collaterals.
Method: Fourteen percent of adult LDLT (188/1399)
had PVT from February 2008 to December 2012 and
were subdivided into Yerdel’s grade 1, 2, 3 and 4 based
on preoperative imaging and operative findings. Con-
sidering the severity of PVT and presence of sizable
collaterals, the managements were followings: thromb-
ectomy alone, additional PV plasty, PV stenting, inter-
position graft, or additional interruption of collaterals.
Results: The Yerdel’s grade of PVT patients were 1
(42%), 2 (54%), 3 (3%) and 4 (1%). One hundred one
(77%) patients underwent interruption of sizable collat-
erals. The most common management for PVT was
thrombectomy alone in grade 1 and 2, thrombectomy
plus PV stenting and/or ballooning in grade 3, and
interposition graft in grade 4. In LDLT for PVT
patients, one-year mortality was 9% and PV related
complication occurred in 5%. The severity of PVT
made no difference in the outcome.
Conclusions: Multi-disciplinary approaches including
surgical correction of PVT, IOP, and interruption of
sizable collaterals resulted in excellent outcome, and it
was not affected by the severity of PVT.
BO01-04
NOT ISCHEMIA/REPERFUSION
INJURY BUT SUPPRESSION OF
REGENERATION CAUSES SMALL FOR
SIZE SYNDROME AFTER SMALL-
FOR-SIZE LIVER TRANSPLANTATION
IN MICE
Qinlong LIU and Liming Wang
the second affiliated hospital of Dalian medical
university, China
Introduction: Mechanisms of small-for-size syndrome
after partial liver transplantation remain unclear. Ische-
mia/reperfusion injury (IRI) is commonly considered to
play a crucial role in the pathogenesis of small-for-size
syndrome (SFSS) after liver transplantation, and rapid
regeneration is essential for the survival of SFS grafts.
Accordingly, This study investigated whether ischemia/
reperfusion injury or suppression of regeneration is the
primary cause of small-for-size syndrome, thus causing
tissue injury and graft failure after transplantation in
mouse.
Method: Mouse models of full-size orthotopic liver
transplantation, 50% partial liver transplantation and
30% partial liver transplantation were established. We
observed survival rate, serum alanine aminotransferase,
total bilirubin and albumin. IRI was assessed through
hepatic pathologic alterations, apoptosis and necrosis
responses. Regeneration responses were detected by
mitotic index, BrdU incorporation, and expression of
PCNA, Cyclin D1 and Cyclin E.
Results: The 30% partial liver graft resulted to signifi-
cantly low 7-day survival rate (p = 0.002) and marked
tissue injury. Serum alanine aminotransferase (ALT)
levels showed no differences between partial transplan-
tation and full-size transplantation. Western blotting of
caspase-3 and Tunnel staining also indicated no signifi-
cant differences of apoptosis response between 30%
partial transplantation and half-size or full-size trans-
plantation(p = 0.436, p = 0.113). Nevertheless, responses
of liver regeneration were markedly lower in 30% LTx
compared with 50% LTx: Mitotic index (p < 0.0001),
BrdU (p = 0.0022). Suppressed expressions of PCNA,
cyclin D1 and cyclin E by western blotting were
detected as well.
Conclusions: Liver regeneration is markedly suppressed
in SFSS, and is probably the primary cause of SFSS,
not the ischemia/reperfusion injury. Therapy of recov-
ering graft regeneration could be a potentially impor-
tant strategy to reduce the incidence of SFSS.
BO01-05
LIVER TRANSPLANTATION IN
CHILDREN UNDER 10 KILOGRAMS OF
WEIGHT, EXPERIENCE OF A SINGLE
SURGICAL TEAM
Carlos Derosas, Jorge Godoy, Gloria Gonzalez, Bessie
Hunter, Silvia Alegrıa, Mario Uribe, Mario Ferrario
and Erwin Buckel
Clinica Las Condes, Chile
Introduction: Pediatric liver transplantation in small
recipients is a surgical challenge, mostly due to small
recipient and graft size and the need for complex vascu-
lar reconstructions. The aim of this study is to show
our experience with recipients under 10 kilograms (kg)
of weight.
Method: Retrospective observational study of all
patients transplanted by the same surgical team for the
past 20 years (from 1993 to present date), we identified
the group of patients under 10 kg of weight and ana-
lyzed multiple variables. Statistical analysis was per-
formed with SPSS 20.0.
Results: Our surgical team has performed 432 liver
transplants; of which 231 were pediatric (53,4%) of
these 23,8% (55 transplants in 50 patients) were under
10 kg of weight. The median of age was
14,6  7 months and the mean weight 8.2  1.5 kg.
Main indication was Biliary Atresia (63.6%), and ful-
minant hepatitis (5.5%). In 60% Living Donors were
used. In one case of a very small recipient a monoseg-
mental graft was used. The most common vascular
complication was hepatic artery thrombosis (11%).
52.7% required a reoperation. 7 patients required re-
trasplantation of which 2 required second retransplan-
tation. The mean operative time was
372  108 minutes. The actuarial survival was 78.1%
and 70.9% at 1 and 5 years respectively.
Conclusions: This report shows the results of the larg-
est experience in our country in very small pediatric
liver transplantation. Despite the complexity of this
group of recipients and significant morbidity, we were
able to obtain excellent 5-year survival.
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BO01-06
A MATCHED PAIR ANALYSIS OF
MULTICENTER LONG-TERM FOLLOW-
UP AFTER SPLIT LIVER
TRANSPLANTATION WITH EXTENDED
RIGHT GRAFTS
Mitchell Ross2, Marco Spada, Duilio Pagano, Matteo
Cescon3, Enzo Andorno4, Giorgio Rossi5, Antonio
Pinna3, Luciano De Carlis6, Umberto Baccarani7 and
Umberto Cillo8
Mediterranean Institute for Transplantation and
Advanced Specialized Therapies ISMETT, University of
Pittsburgh Medical Center UPMC in Italy, Italy;
2Pittsburgh, PA, USA., U.S.A.; 3Alma Mater
Studiorum-University of Bologna, Bologna, Italy; 4San
Martino Hospital, University of Genoa, Genoa, Italy;
5Fondazione IRCCS Ospedale Maggiore Policlinico
Mangiagalli e Regina Elena, Milan, Italy; 6Niguarda
Hospital, Milan, Italy; 7University Hospital of Udine,
Udine, Italy; 8Policlinic of Padua, University of Padua,
Padua, Italy
Introduction: Split liver transplantation(SLT) has been
proposed as an alternative to whole liver transplanta-
tion(WLT) in an attempt to expand the donor pool.
However, studies comparing adult outcomes between
the two methods are conflicting, and data beyond five
years is limited. We aimed to argue that SLT should
have comparable long-term outcomes to WLT when
particular known liver transplantation risk factors are
minimized.
Method: 119 matched-pair recipients of whole and
extended right grafts (ERGs) were retrospectively ana-
lyzed for one, five and ten year patient and graft sur-
vival outcomes. An exclusively long-term cohort of 81
matched-pairs that survived the first post-transplant
year was also analyzed. Survivals between different
transplant centers were compared, and a number of
clinical variables were subject to Cox regression analy-
sis to identify risk factors for undergoing SLT.
Results: In the entire study population, one, five and
ten-year patient and graft survivals were 74%, 64% and
60%, and 68%, 57% and 52%, for ERG patients, and
90%, 83% and 79%, and 85%, 75% and 72%, for WLT
patients, respectively(p < 0.001). SLT and WLT recipi-
ents in the long-term cohort had 5- and 10-year patient
survivals of 89% and 81%, and 93% and 89%, respec-
tively (p = 0.408). 5 and 10-year graft survivals were also
comparable: 83% and 75% for SLT patients, and 89%
and 79% for WLT patients (p = 0.397). Risk factors for
patient survival when undergoing SLT included re-trans-
plantation and UNOS I-IIA status in the overall cohort
and donor age over 50 in the long-term study group.
Transplantation centers exhibited highly variable ten-
year patient survivals, but center level of experience with
SLT was not always associated with better performance.
Conclusions: In the first multicenter report of long-term
outcomes with Italian donors, we demonstrate that
ERG transplantation can achieve long-term success
equal to that of WLT in appropriate patients at high-
performing centers, but should be selectively used in
cases of re-transplantation, UNOS I-IIA status or
advanced donor age.
BO02-01
ACCURATE COMPUTED
TOMOGRAPHY-BASED PORTAL
PRESSURE ASSESSMENT IN PATIENTS
WITH HEPATOCELLULAR
CARCINOMA
Pouya Iranmanesh, Oscar Vazquez, Sylvain Terraz,
Pietro Majno, Laurent Spahr, Antoine Poncet, Philippe
Morel, Gilles Mentha and Christian Toso
University Hospitals of Geneva
Introduction: Liver resection is restricted to patients
with low hepatic venous pressure gradient (HVPG ≤
10 mmHg) and many teams perform transjugular
HVPG measurements as part of the pre-operative
work-up. The present study investigates whether a non-
invasive Computed Tomography (CT)-based assessment
could be as accurate as the invasive transjugular mea-
surement.
Method: Patients with hepatocellular carcinoma (HCC)
treated by resection (n = 36) or transplantation
(n = 39) were included (mean age: 61  9.2 years,
male/female ratio: 4/1). Pre-operative CT was read by
two independent investigators, and potential CT-based
HVPG predictors were compared to the transjugular
HVPG assessment.
Results: The invasive HVPG levels were significantly
correlated to liver/spleen volume ratio, spleen volume,
platelet count, and peri-hepatic ascites (p < 0.001),
which all showed high inter-observer agreements (intra-
class correlation coefficients ≥0.927, Kappa ≥0.945).
The presence of an HVPG > 10 mmHg was best pre-
dicted by the liver/spleen volume ratio [AUC: 0.883
(0.805–0.960)] and the peri-hepatic ascites (p < 0.001).
These two variables were combined into an accurate
model for predicting HVPG > 10 mmHg [AUC: 0.911
(0.847–0.975)], with sensitivity, specificity, and positive
and negative predictive values of 92%, 79%, 91% and
81%.
Conclusions: The proposed CT-based model showed a
high accuracy in the prediction of HVPG and could
replace the invasive transjugular assessment in patients
not requiring a biopsy of the non-tumoral liver, pend-
ing external validation.
BO02-02
ACCURACY AND RELIABILITY OF THE
CLINICAL MEASUREMENTS OF THE
PORTAL PRESSURE
Taegyu Kim, Bong-Wan Kim, Hee Jung Wang, Yong
Keun Park and Weiguang Xu
Ajou University School of Medicine, Korea
Introduction: The direct or indirect measurement of
portal pressure is important to predict complications
for the patients with liver cirrhosis or to determine the
treatment modalities for liver cancer. The hepatic vein
pressure gradient (HVPG) is known as the most precise
method to measure the portal pressure, and the HVPG
> 6 mmHg is regarded as portal hypertension (pHTN)
and >10 mmHg as decompensated pHTN. Indocyanin
green 15 min. retention rate (ICG-R15) is also widely
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performing to measure portal pressure indirectly in the
Eastern, and the ICG R-15 > 20% is believed decom-
pensated pHTN, however, there is no study suggesting
precise value to compensated and/or decompensated
pHTN. In this study, we evaluated the accuracy and
reliability of various parameters which reflecting portal
pressure by comparing with HVPG.
Method: Between December 2005 and January 2007,
164 consecutive patients who received liver surgery
were included. All of them performed direct and indi-
rect measurement of portal pressure including HVPG,
ICG R15, complete blood count, liver function test.
We compared the values with HVPG to find out accu-
racy and reliability of the indirect portal pressure mea-
surements of ICG-R15, platelete count, serum
bilirubin, serum albumin, and prothrombin time.
Results: ICG R15 showed the most reliable correlation
with HVPG according to R-squared value (0.653) of
the equation. HVPG(mmHg) = 0.530*ICG-R15
(%)-3.751 (R2 = 0.653), HVPG(mmHg) = 0.038*
Platelet counts(*103) + 14.529 (R2 = 0.418). Serum bili-
rubin, albumin and prothrombin time were not able to
discriminate compensated and decompensated pHTN
due to low R-squared value. According to the equation,
ICG-R15 = 25% regards as HVPG 9.49 mmHg and
platelet 100,000 means HVPG 10.72 mmHg (ICG-
R15 = 20% correspond to HVPG = 6.84, ICG R15
30% to HVPG = 12.14 mmHg).
Conclusions: The correlation between HVPG and ICG-
R15 is significantly valid and good fitted on R-squared.
But according to equation, ICG R15 = 20% is not sui-
ted for the value of the decompensated pHTN. The
value of ICG-R15 should be reappraised by corre-
sponding to HVPG.
BO02-03
COMPUTED TOMOGRAPHIC
PERFUSION (CTP) OF THE LIVER: A
NEW NON-INVASIVE LIVER FUNCTION
TEST?
Andrea Ruzzenente1, Calogero Iacono1, Simone
Conci1, Fabio Bagante1, Elisabetta Dolci1, Alessandro
Valdegamberi1, Adriano Dorna1, Guido Mantovani1,
Mirko D’Onofrio2 and Alfredo Guglielmi1
1Unit of HPB surgery, Division of General Surgery A,
University of Verona Medical School, Italy; 2University
Hospital G.B. Rossi, University of Verona, 37134
Verona, Italy
Introduction: The aim of this study was to investigate
the role of the computed tomographic perfusion (CTP)
as a liver function test and its correlation with post-
hepatectomy liver failure (PHLF) in patients undergo-
ing liver resection.
Method: Between November 2011 and March 2013
dynamic contrast-enhanced CTP scans of the liver were
performed in 28 patients (22 patients without cirrhosis
and six patients with cirrhosis). The perfusion parame-
ters obtained by CTP include total perfusion flow
(TPF), hepatic perfusion index (HPI), arterial and por-
tal perfusion flow (aPF and pPF), arterial and portal
blood volume (aBV and pBV), arterial and portal Time
to Peak (aTTP and pTTP). Hepatic perfusion parame-
ters were compared with preoperative biochemical
blood liver function tests, indocyanin green retention
rate at 15 minutes (ICGR15) and with CT measured
future remnant liver volume (FRLV).
Results: aPF, pPF, aTTP and pTTP are strongly
related with ICGR15 test with a linear statistic correla-
tion (p values 0.004, 0.024, <0.001 and <0.001, respec-
tively). In cirrhotic patients aTTP, ICGR15 and
Prothrombin Time (PT) are significantly higher com-
pare with no-cirrhotic patients (p value 0.048). In
patients underwent liver resection higher levels of
aTTP, ICGR15 and PT are significantly related with
signs of PHLF (p values 0.004, 0.004 and 0.001, respec-
tively). At multivariate analysis aTTP, ICGR15 and
FRLV are significantly related with incidence of signs
of PHLF (HR 2.886, p value 0.024 and HR 0.034, p
value 0.023, respectively).
Conclusions: arterial Time to Peak (aTTP) measured
by CTP may represent a new non-invasive method for
the study of liver function and it could be useful, in
addition to current liver function tests, in the preopera-
tive evaluation of patients undergoing liver resection.
BO02-04
HYPOTHERMIC PERFUSION DURING
TOTAL VASCULAR EXCLUSION
IMPROVES POSTOPERATIVE LIVER
AND RENAL FUNCTION
Safi Dokmak, Fadhel Samir Fteriche, Beatrice
Aussilhou, Olivier Farges, Alain Sauvanet and Jacques
Belghiti
Beaujon hospital, France
Introduction: Evaluate the outcome of patients who
underwent liver resection under total vascular exclusion
(TVE) >60 mn with or without in situ hypothermic per-
fusion (ISHP).
Method: From 2000 to 2012, among 2535 liver resec-
tions, 34 patients underwent liver resection under TVE
> 60 minutes, with ISHP (n = 16) or without (control
group: n = 18). There was no significant difference
regarding demographic data, malignancy (75% vs.
83%), vascular reconstruction (44% vs. 50%), extent of
resection (100% vs. 94%), abnormal liver (24% vs.
18%) and TVE duration (81 vs. 96) minutes. Liver
injury was assessed by transaminases level on POD1
and liver and renal tolerance were assessed on POD 5
for bilirubin (lmol/L) and PT and on POD1 for creati-
nine (lmol/l). (ISHP vs. no ISHP) were compared. The
preservation solution was HTK (custodiol).
Results: No difference regarding blood loss (2041 ml
vs. 3269 ml), transfusion rate (66% vs. 58%) and
operation duration (376 vs. 439). Mortality was higher
in the control group (12% vs. 28%, p = 0.27).
Although major morbidity was similar (75% vs. 78%,
p = 0.84), ISHP was associated with less liver injury
[ASAT (267 vs. 808, p = 0,039), ALAT (469 vs. 728,
p = 0.046)] and better liver and renal tolerance [biliru-
bin (14 vs. 131, p = 0.047), PT (74% vs. 56%,
p = 0.039) and creatinine lmol/l (75 vs. 120,
p = 0.021)]. No significant difference regarding bleed-
ing (18% vs. 6%), re-intervention (50% vs. 33%) and
hospital stay (19 vs. 17).
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Conclusions: IHSP improves dramatically the tolerance
of total vascular clamping and questioning its use in
patients requiring complex liver procedures regularly
performed under intermittent vascular clamping.
BO02-05
THE ADVERSE EFFECT OF
PREOPERATIVE CHOLANGITIS ON
THE OUTCOME OF PORTAL VEIN
EMBOLIZATION AND SUBSEQUENT
MAJOR HEPATECTOMY
Yukihiro Yokoyama, Tomoki Ebata, Tsuyoshi Igami,
Gen Sugawara, Takashi Mizuno and Masato Nagino
Nagoya University Graduate School of Medicine, Japan
Introduction: We previously established rat segmental
cholangitis model and showed that the presence of cho-
langitis impairs liver regeneration capacity after major
hepatectomy. In this study, the effects of preoperative
cholangitis on hepatic regeneration rate following pre-
operative portal vein embolization (PVE) and subse-
quent postoperative course after major hepatectomy
were determined in human cases.
Method: From 1991 to 2012, 449 patients underwent
preoperative PVE and subsequent major hepatectomies.
Among them, 72 patients (16%) had preoperative cho-
langitis. The volume change of non-embolized lobe
after PVE and postoperative outcome after major hepa-
tectomy were compared between the cholangitis group
and non-cholangitis group.
Results: The average volume increase in the non-em-
bolized lobe following PVE was almost identical in
both cholangitis group (9.5%) and non-cholangitis
group (9.6%). However, the average term that required
for the regeneration was significantly greater in the
cholangitis group (24.0 days) compared to the non-
cholangitis group (18.5 days) (p = 0.01). Postoperative
maximum serum total bilirubin levels (5.7 mg/dl vs.
8.1 mg/dl, p = 0.012), morbidity rate (56% vs. 78%,
p = 0.001), and postoperative hospital stay (43.8 days
vs. 53.4 days, p = 0.022) were all significantly greater in
the cholangitis group compared to the non-cholangitis
group.
Conclusions: These results indicate that the patients
who developed preoperative cholangitis should be care-
fully managed during the perioperative period of PVE
and subsequent major hepatectomy.
BO02-06
SURGICAL ANATOMY OF HEPATIC
ARTERY: A NEW CLASSIFICATION
Shallu Garg, Hemanth Kumar, Daisy Sahni and
Thakur deen Yadav
Post graduate institute of medical education and
research, chandigarh, India
Introduction: Knowledge of vascular pattern of hepatic
artery (HA) is essential for successful and uncompli-
cated surgical and interventional radiological proce-
dures in hepato-biliary pancreatic areas, The aim of the
present study was to find out the variations of hepatic
artery (HA) at its origin and its extrahepatic branching
at the hilum.
Method: The study was conducted in 100 enbloc liver
specimens. Origin of HA was recorded according to the
Michels description and hilar anatomy was classified
according to the number of right and left hepatic
arterial pedicles entering their respective hemilivers.
Single right and left arterial pedicle entering their
respective hemilivers was considered normal. An alter-
nate classification was constituted by forming four
possible combinations of normal (N) or variable (V)
origin / branching of HA. Each type was further cate-
gorized into three subtypes.
Results: Normal origin and branching of HA (Type
1 N/N) was observed in 51% of specimens. In 17% of
livers, origin of HA was normal but branching was var-
iant resulting in multiple arterial pedicles entering right
or left hemiliver (Type 2 N/V). A marked variety of
branching pattern of HA was observed after its normal
origin from CT leading to multiple arterial pedicles
entering right or left hemiliver. In 14% of livers, origin
of one of the arteries supplying the liver was variable
but single right and left hepatic arterial pedicles entered
into their respective hemilivers (Type 3 V/N). In
another 14% livers, both origin as well as branching
pattern of HA was variable (Type 4 V/V).
Conclusions: The new nomenclature system enabled us
to describe the detailed anatomy of all observed varia-
tions of the present study including the non reported
ones. The present classification would make this anat-
omy more accessible for clinical use, allowing better
guidance to the surgeon conducting LDLT/SLT.
BO03-01
EARLY ORGAN DYSFUNCTION
AFFECTS LONG-TERM SURVIVAL OF
ACUTE PANCREATITIS PATIENTS
Christos Skouras, Alastair J. Hayes2, Linda Williams,
James O. Garden, Rowan W. Parks and Damian
J. Mole
The University of Edinburgh, United Kingdom; 2Royal
Infirmary of Edinburgh, N.H.S. Lothian, United
Kingdom
Introduction: The effect of early organ dysfunction on
long-term outcome and survival of patients after acute
pancreatitis (AP) is unknown. The aim of this study
was to ascertain whether early organ dysfunction
impacts on long-term survival after an episode of AP.
Method: Data were collected on consecutive patients
with AP admitted to a single centre during the 5-year
period commencing January 2000. A multiple organ
dysfunction syndrome (MODS) score ≥2 during the
first week of admission was used to define early organ
dysfunction. After accounting for in-hospital deaths,
long-term survival probabilities were estimated using
Kaplan–Meier and Log Rank tests. The prognostic sig-
nificance of patient characteristics was assessed by uni-
variate and multivariate analysis using Cox’s
proportional hazards methods.
Results: 694 patients were studied. Median follow-up
was 8.8 years. After the exclusion of in-hospital deaths,
we found that patients with early organ dysfunction
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died prematurely (mean survival: 10.0 years; 95% C.I.:
9.4–10.6 years), compared to those who did not
develop organ dysfunction (mean survival: 11.6 years;
95% C.I.: 11.2–11.9 years, Wilcoxon p = 0.002, Log
Rank p = 0.001). Importantly, this effect was indepen-
dent of age. Multivariate analysis confirmed MODS as
an independent negative predictor of long-term survival
(Cox’s Hazard Ratio: 1.528, 95% C.I.: 1.72–2.176,
p = 0.019) along with age (HR: 1.062, p < 0.001), alco-
hol aetiology (HR: 2.027, p = 0.001) and idiopathic
aetiology (HR: 1.548, p = 0.048).
Conclusions: Early organ dysfunction in AP is an inde-
pendent negative predictor of long-term survival even
when in-hospital deaths are accounted for. Negative
predictors also include age, idiopathic and alcohol aeti-
ology. This paper demonstrates that the damaging
effects of critical illness persist even after the initial
organ dysfunction has resolved. This adds a new
dimension to the importance of predicting and prevent-
ing organ dysfunction in AP patients in order to
improve long-term outcome.
BO03-02
PROGNOSTIC INDICATORS IN
OBJECTIVE EARLY IDENTIFICATION
OF SEVERE ACUTE PANCREATITIS. AN
INSTITUTES EXPERIENCE OVER
5 YEARS
Sivaraj Gunasekaran, Jee Keem Low, Winston Woon
and Junnarkar Sameer
Tan Tock Seng Hospital, Singapore, Singapore
Introduction: Severe pancreatitis has been associated
with significant morbidity and mortality. Several clini-
cal predictors have been used classically to prognosti-
cate the severity of pancreatitis. The aim of our study
is to review factors relevant to the early identification
and prognostication of severe acute pancreatitis within
our own institution and population of patients.
Method: A retrospective review of all patients who
were admitted for acute pancreatitis from November
2008 to July 2013. The Atlanta classification was used
for diagnosis and evaluation of severity of pancreatits.
Data was collected on pre-existing demographics and
co-morbidities of the subjects including age, ethnicity,
gender, smoking, alcohol intake, ischemic heart disease,
diabetes mellitus, cerebrovascular disease, hyperlipid-
emia, hypertension, chronic obstructive lung disease,
asthma, immunosuppression, anticoagulation, chronic
steroid usage, renal impairment and previous history of
episodes of acute pancreatitis. Common clinical and
laboratory data on admission was also obtained. This
data was then correlated with their final severity out-
come upon discharge.
Results: A total of 501 patients were included, out of
which 51 patients had eventual severe pancreatitis. In
terms of demographics and comorbidities, a patients of
age >55 and chinese and malay ethnicity showed posi-
tive correlation with severe pancreatitis. Smoking, alco-
hol intake and indian ethnicity intake were the only
factors that showed negative correlation. Similarly
TWC > 15, Albumin <32, LDH levels >600, serum glu-
cose >10, serum calcium <2, CRP > 150, base excess
<4, an increase in blood urea nitrogen >1.8 and fluid
intake of >6 l over the first 48 hrs of admission were
all statistically significant predictors of severity.
Conclusions: In our patient population the above iden-
tified demographics and clinical factors can be used as
objective clinical predictors of severe outcome in acute
pancreatitis either as part of an established scoring sys-
tem or individually.
BO03-03
PROPHYLAXIS OF ERCP-RELATED
PANCREATITIS BY AN ENDOSCOPIC
PANCREATIC SPONTANEOUS
DISLODGEMENT STENT: THE
USEFULNESS OF THE PROPENSITY
SCORE ANALYSIS
Mamoru Takenaka, Hideyuki Shiomi, Atsuhiro
Masuda, Maki Sugimoto, Yoshifumi Arisaka, Hiromu
Kutsumi and Takeshi Azuma
Kobe University Graduate School of Medicine, Japan
Introduction: The prophylaxis of post-endoscopic retro-
grade cholangiopancreatography (ERCP) pancreatitis
(PEP) by pancreatic spontaneous dislodgement stent
(PSDS) has been demonstrated in randomized con-
trolled trials and meta-analyses. However, recently it
was reported that there was obvious discrepancy
between the scientific evidence and the routine use. We
aimed to assess the use of PSDS in the current ERCP
practice, and to elucidate the usefulness of PSDS.
Method: We reviewed the medical records of the
patients of 1131 ERCPs performed at Kobe University
Hospital from April 2006 to February 2009, and inves-
tigated their clinical characteristics, including the risk
factors of PEP, the use of PSDS and complications of
ERCP. The difference of incidence of PEP between the
patients with PSDS (S group) and the patients without
PSDS (NS group), were compared using the propensity
score matching analysis.
Results: Of the 1131 ERCPs, PSDS placements were
performed in the 105 (9.0%)ERCPs. The risk factor for
which PSDS was attempted in the highest frequency,
was pre-cut sphincterotomy (47.4%). In 210 ERCPs
which were matched by using propensity scores, the fre-
quency of PEP in the matched-S group were signifi-
cantly lower than that in the matched-NS group (6%
vs. 18%, Odds ratio 0.32, 95% CI 0.12–0.77, p = 0.02).
Furthermore, efficacy of PSDS for PEP was confirmed
by multiple logistic regression analysis (Odds ratio 0.21,
95% CI 0.06–0.56, p < 0.01).
Conclusions: The frequency of the use of PSDS varied
according to the risk factors. Usefulness of PSDS in
prophylaxis of PEP was proved by using the propensity
score analysis. The propensity score analysis can be
adapted to the ERCP-related analysis with many
unpredictable procedure-related factors that are unsuit-
able for RCT by volume and ethical issue.
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BO03-04
TIMING OF SURGICAL INTERVENTION
AFTER PERCUTANEOUS CATHETER
DRAINAGE (PCD) IN STEP UP
APPROACH OF SEVERE ACUTE
PANCREATITIS
Sunil Shenvi, Rajesh Gupta, Rajinder Singh, Madhu
Khullar, Mandeep Kang and Deepak Bhasin
Postgraduate Institute of Medical Education and
Research, India
Introduction: A study was conducted to determine
appropriate timing of surgical intervention after PCD
in infected pancreatic necrosis (IPN), as a part of STEP
UP approach and to see change in morbidity and mor-
tality after changing the interval of surgery after PCD.
Method: Randomized controlled trial was tried to find
out the optimal timings of surgery following PCD in a
patients with IPN who are not improving significantly
within one week of PCD. The trial has to be stopped
prematurely because of difficulty in recruitment of
patients and apparent increase in the mortality in
patients undergoing surgery early following PCD com-
pared to patients who were managed with continued
treatment of PCD. Following this rest 32 patients were
managed by extended treatment with PCD in prospec-
tive manner and weekly inflammatory and nutritional
markers were monitored in these patients. Surgery was
performed in these patients when required. Out of 40
patients managed prospectively, 36 patients who under-
went continued treatment with PCD were analyzed.
Results: Duration between first PCD and surgery ran-
ged from 10 to 58 days with a mean of
41  16.15 days and median of 43 days. The efficacy
of Extended treatment PCD alone in achieving com-
plete recovery in patients with infected pancreatic
necrosis was 68.5%.Overall mortality in the present
study was 15.1%.Disease specific morality in PCD
alone group was 5.5%. Disease specific mortality in
surgery group was 42.8%.ICU stay and Extrapancreat-
ic necrosis in posterior pararenal space were predicting
need of surgery on univariate and multivariate analysis.
Serial estimation of inflammatory and nutritional
markers does not help in predicting the timing of sur-
gery.
Conclusions: Timing of surgeryin patients of severe
acute pancreatitis managed by STEP UP approach can-
not be fixed and needs to be tailored depending on
patient’s response to extended treatment of PCD.
BO03-05
DYNAMIC CHANGE OF SERUM
CYTOKINE EXPRESSION AND EFFECT
OF BETA-CATENIN IN SAP RATS
Wangjun Bu1, Shu Zhang2, Jun Li2, Jian Zhang1, Ren
Li2, Hang Li2, Zhengan Yang1 and Zongfang LI1
1the Second Affiliated Hospital, School of Medicine,
Xi’an Jiaotong University, China; 2National-local Joint
Engineering Research Center of Biodiagnostics and
Biotherapy, China
Introduction: To study the change of serum cytokine
expression profile and the effect of beta-catenin in rats
with severe acute pancreatitis (SAP).
Method: Our experiment was composed of two sec-
tions. The first section was a profile analysis of the
dynamic change of serum cytokine expression. It
involved 24 SD rats which were divided into sham
operation group 1 (SO1) and SAP group 1 (SAP1). In
the second section, the study of the effect of beta-cate-
nin protein in SAP, 18 SD rats were divided into 3
groups: sham operation 2 (SO2), SAP group 2 (SAP2)
and SAP rats treated with sulindac (ST). Serum cyto-
kine expression levels in all the groups were deter-
mined. Expressions of beta-catenin, NF-jB, TNF-a
and IL-6 were observed using immunohistochemistry
and western blotting. The pancreatic tissues were exam-
ined using HE.
Results: In both sections, obvious difference was identi-
fied between the serum cytokine expression in SAP rats
and that in normal rats. The expressions of beta-cate-
nin, NF-jB, TNF-a and IL-6 were found higher in
SAP2 group than in SO2 group (p < 0.05). While, the
activity of beta-catenin was inhibited by sulindac in ST
group, and the expressions of NF-jB, TNF-a and IL-6
were higher in ST group than in SAP2 group
(p < 0.05).
Conclusions: Beta-catenin is involved in relieving pan-
creas injury. The protective effect of beta-catenin might
be associated with the down-regulation of NF-jB and
subsequently the down-regulation of TNF-a and IL-6.
Acknowledgements: The work was supported by the
National Natural Science Foundation of China
(30901945).
BO03-06
SYNBIOTICS IN SURGERY FOR
CHRONIC PANCREATITIS: ARE THEY
TRULY EFFECTIVE? A SINGLE BLIND
PROSPECTIVE RANDOMIZED
CONTROL TRIAL [CTRI/2013/06/003737]
Ashwin Rammohan, Jeswanth Sathyanesan,
Kamalakannan Rajendran, Anbalagan Pitchaimuthu,
Senthil Kumar Perumal, Kesavan B, Ravi Ramasamy,
Ravichandran Palaniappan and Manoharan Govindan
Govt. Stanley Medical College Hospital, India
Introduction: Prebiotics and probiotics influence all
pathogenic mechanisms of bacterial translocation. Used
in combination, they are called synbiotics. Postopera-
tive infective complications in patients undergoing pan-
creatic surgery lead to a significant prolongation of
hospital stay and increased costs. While synbiotics are
considered to have beneficial effects on human health,
their clinical value in surgical patients, especially in
South Asia remains unclear given a paucity of applica-
ble clinical studies.In this study we aimed to determine
the impact of perioperative synbiotic therapy on post-
operative infectious complications, morbidity and mor-
tality in patients undergoing pancreatic surgery for
chronic pancreatitis.
Method: A prospective monocentric randomized single
blind controlled trial was conducted in patients with
chronic calcific pancreatitis undergoing Frey’s proce-
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dure.Group A received a specific synbiotic composition,
5 days prior and 10 days after the surgery.Group B
received a placebo. Primary study endpoint was the
occurrence of postoperative infection during the first
30 days. Secondary outcome measures were mortality,
length of hospital stay, days in intensive care unit and
duration of antibiotic therapy.From previous studies,
perioperative synbiotics reduce the proportion of
patients with infectious complications from 50% to
12%. Using this data, with alpha of 0.05 and power
80%, the calculated sample size was calculated as 35
patients for each group with a dropout rate of 10%.
Results: Of the 79 patients enrolled, 75 completed the
trial [Group A (n = 39) and Group B (n = 36)]. The
incidence of postoperative infective complications
(12.5% vs. 40% p < 0.05), duration of antibiotics ther-
apy (p < 0.05), and length of hospital stay(p < 0.05)
were significantly lower in the synbiotic group.
Conclusions: This study shows synbiotics to be a prom-
ising therapy in significantly reducing septic complica-
tions, hospital stay and antibiotic requirement in
patients undergoing pancreatic surgery for chronic pan-
creatitis. Further basic and clinical research would clar-
ify the underlying mechanisms of their therapeutic
effect and define the appropriate conditions for use.
[CTRI/2013/06/003737]
BO04-01
INDEPENDENT PROGNOSTIC
FACTORS AFTER RESECTION OF
HILAR CHOLANGIOCARCINOMA:
ANALYSIS OF 307 PATIENTS FROM
TWO HPB CENTERS
Jimme Wiggers1, Bas Groot Koerkamp2, Peter Allen2,
Olivier Busch, Michael D’Angelica2, Ronald
DeMatteo2, Yuman Fong, Dirk Gouma1, William
Jarnagin2 and ThomasVan Gulik1
1Acadamic Medical Centre, Netherlands; 2Memorial
Sloan–Kettering Cancer Center, U.S.A.
Introduction: The purpose of this study was to deter-
mine survival and independent prognostic factors after
resection of hilar cholangiocarcinoma (HCCA).
Method: Patients with HCCA resected between 1991
and 2012 were identified from prospectively maintained
databases from two institutions (in Europe and USA).
Patients with final pathology other than HCCA or in-
hospital mortality were excluded. Prognostic factors
were evaluated using univariate Kaplan-Meier survival
analysis with log-rank test and multivariable cox-
proportional hazards modelling using backward selection
with likelihood ratio test.
Results: 307 patients underwent resection for HCCA.
The median overall survival was 38 months, and 5-year
survival 37%. In multivariable analysis four factors
were independently associated with a poor prognosis: a
positive resection margin, HR 1.69 (95% CI: 1.25–
2.28), p = 0.001, one or more positive lymph nodes,
HR 2.31 (1.66–3.23), p < 0.001, perineural invasion,
HR 1.59 (1.13–2.23), p = 0.008, and moderate or poor
differentiation, HR 1.64 (1.15–2.33), p = 0.006. Other
traditional factors were associated with a poor progno-
sis only in univariate analysis, including lymphovascu-
lar invasion, non-papillary tumor, T-stage (7th edition),
and AJCC stage (7th edition). Patients with at least
three out of four poor prognostic factors (n = 90) had
a median survival of 19 months [95% CI: 16–22] vs.
52 months [95% CI: 40–64]. Analyzing R0 patients sep-
arately resulted in the same independent prognostic fac-
tors.
Conclusions: A positive resection margin, one or more
positive lymph nodes, perineural invasion and moderate
or poor differentiation are independent prognostic
factors after resection of HCCA. Based on these
poor prognostic factors we will derive and validate a
prognostic nomogram for resected hilar cholangiocarci-
noma.
BO04-02
ANALYSIS OF MICROSCOPIC TUMOR
SPREAD PATTERNS ACCORDING TO
GROSS MORPHOLOGIES AND
SUGGESTIONS FOR OPTIMAL
RESECTION MARGINS IN BILE DUCT
CANCER
Ye Rim Chang, Kyoung Bun Lee, Jin-Young Jang,
Chang-Sup Lim, Mee Joo Kang, Wooil Kwon, Woo
Hyun Jung and Sun-Whe Kim
Seoul National University College of Medicine, Korea
Introduction: Surgical resection is the only curative
treatment for extrahepatic bile duct (EHBD) cancer but
guidelines for optimal resection margins have not yet
been established. Therefore, the purpose of this study is
to analyze the patterns of microscopic tumor spreads
and their lengths according to gross morphology and
to suggest optimal resection margins for EHBD cancer.
Method: A total of 79 patients with EHBD cancers
who underwent curative resection at Seoul National
University Hospital between 2007 and 2010 were
reviewed. Pathologic findings, including spread patterns
and the length of tumor spread, were reviewed by a sin-
gle specialized pathologist.
Results: Mucosal and mural/perimural spreads were
seen in 37.3% and 62.3%, respectively. Gross morpho-
logies were classified as papillary (n = 13), nodular/
nodular infiltrative (n = 43), and sclerosing (n = 23)
types. Spread patterns correlated with gross morpho-
logies (p < 0.001). Of the papillary cases, 80.8%
showed mucosal spreads while, of the sclerosing cases,
16.9% did. The mean length of tumor spreads in the
papillary, nodular/nodular infiltrative, and sclerosing
types were 4.5  6.3 mm, 1.8  6.4 mm, and
6.4  6.7 mm (p = 0.004), respectively, and the lengths
of tumor spreads at the 90th percentile were 15.6 mm,
10.0 mm, and 15.6 mm, respectively.
Conclusions: The patterns of tumor spreads correlated
with gross morphologies and the sclerosing type
showed the longest tumor spread. Optimal resection
margins in EHBD cancers should be 16 mm in the pap-
illary and sclerosing types and 10 mm in the nodular/
nodular infiltrative type.
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BO04-03
COMPARATIVE ANALYSIS OF LEFT
VERSUS RIGHT SIDED RESECTION IN
PATIENTS UNDERGOING LIVER
SURGERY FOR KLATSKIN TUMOR:
CAN LESION SIDE BE CONSIDERED A
PROGNOSTIC FACTOR?
Francesca Ratti, Federica Cipriani, Marco Catena,
Annalisa Gagliano, Michele Paganelli and Luca
Aldrighetti
San Raffaele Hospital, Italy
Introduction: Achievement of negative margins in Klat-
skin tumor surgery has been advocated as a main goal
of curative intent treatment: a treatment including hilar
and liver parenchyma resection, allows to obtain a bet-
ter long term outcome. Considering the anatomical
relationships between the vascular hilar structures and
bile duct, this study aims to compare short and long
term outcome of left and right sided resections.
Method: From January 2004 to July 2013, 104 patients
with preoperative diagnosis of Klatskin tumor were
candidated to surgery: of these, 85 underwent major
liver resection. The data of all patients were prospec-
tively collected and are retrospectively reviewed. 51
patients underwent right sided resections (Right
Group), while the remaining 34 left sided resections
(Left Group). The two groups were compared in terms
of perioperative morbidity and mortality and overall
and disease free survival.
Results: The two groups were comparable in terms of
patient and disease characteristics. Patients in Right
Group needed more frequently preoperative PVE. The
postoperative morbidity and mortality was greater in
Right Group (56.6% and 8.7% respectively) than in
the Left Group (34.5% and 3.4% respectively)
(p < 0.005). The most frequent cause of death was
postoperative liver failure (more frequent in the Right
Group). R1 resections were 26.1% in the Right Group
and 31.5 % in the Left Group (p not significant). 5-
years survival rate was 32% in the Right Group and
25% in the Left Group, with no significant differences.
Recurrent disease was found in 70.6% of patients,
without statistically significant.
Conclusions: Right sided resections for Klatskin tumors
are associated with a significantly higher postoperative
morbidity compared with left sided, probably related to
a greater parenchymal sacrifice. Despite this, they seem
to be associated with better long-term survival, since
resection of the right hepatic pedicle may allow a full
radicality in right sided lesions
BO04-04
PROGNOSTIC IMPACT OF THE
NUMBER OF INVOLVED LYMPH
NODES IN DISTAL
CHOLANGIOCARCINOMA
Muneyasu Kiriyama, Tomoki Ebata, Yukihiro
Yokoyama, Tsuyoshi Igami, Gen Sugawara, Takashi
Mizuno and Masato Nagino
Nagoya University Graduate School of Medicine, Japan
Introduction: The nodal status has not been fully
addressed in distal cholangiocarcinoma, because previ-
ous studies have involved a limited number of patients
(<100). We conducted a multi-institutional study to ver-
ify the prognostic impact of the number of involved
lymph nodes in distal tumor.
Method: A total of 188 patients with distal cholangio-
carcinoma (middle tumor, n = 74; lower tumor,
n = 114) who underwent surgical resection between
2001 and 2010 was the reviewed. Pancreatoduodectomy
and bile duct resection were performed in 171 and 17
patients, respectively. The nodal metastasis was histo-
logically defined according to the AJCC cancer staging
manual. The number of lymph nodes examined histo-
logically was 17 in median (range, 1–51).
Results: Nodal metastasis was found in 90 (48%)
patients. The number of involved node ranged from 1
to 13; single metastasis was the most common (n = 38),
followed by two (n = 22), and three (n = 15). Survival
rate for the 90 patients with nodal metastasis was 28%
at 3-years and 24% at 5-years; that for the 98 patients
without nodal metastasis was 71% and 63%, respec-
tively (p < 0.001). Because the survival rates of the
patients groups with 1, 2, or 3 involved nodes largely
overlapped, the patients were stratified according to the
number of involved nodes (1–3 vs. 4 or more). The for-
mer group showed a better survival than the latter with
3-year survival rates of 34% vs. 0, respectively
(p < 0.001), and a worse survival rate than node-negative
group (p < 0.001). Cox regression analysis identified
there independent predictors: the number of involved
node (p < 0.001), pancreatic invasion (p = 0.009), and
major vascular invasion (p = 0.012).
Conclusions: The increased number of involved nodes
correlated with poor survival in distal cholangiocarci-
noma. The patients with 4 or more involved nodes
should be categorized as an independent stage from
those with 3 or less involved nodes.
BO04-05
A FOUR MICRORNA SIGNATURE
CORRELATES WITH IMPROVED
SURVIVAL IN
CHOLANGIOCARCINOMA
Siobhan Mckay, Kristian Unger2, Stephanos
Pericleous, Gordon Stamp3, Jo-Anne Chin Aleong5,
Robert Hutchins4, Geraldine Thomas2 and Duncan
Spalding
Imperial College London, United Kingdom; 2Imperial
College London, United Kingdom; 3The Royal Marden
Hospital, London, United Kingdom; 4Barts and The
london NHS Trust, London, United Kingdom; 5Barts
and The london NHS Trust, London, United Kingdom
Introduction: Cholangiocarcinoma (CC) is increasing
in incidence and has a dismal prognosis. Complete
surgical resection offers the only chance of cure. Even
with complete resection there remains a disparity in
survival, with recurrence and death at an early stage
in some patients. MicroRNAs (miRNAs) are small
non-coding RNAs that are involved in gene regula-
tion. Several miRNAs have been linked to cancer pro-
gression and prognosis. We employed miRNA
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microarray technology to identify miRNAs that can
predict survival.
Method: MiRNA was extracted from 30 archival for-
malin-fixed paraffin-embedded CC samples. Samples
were labeled with Cy3 and hybridised to Agilent
Human miRNA slides, each microarray contained
probes for 866 human miRNAs. Slides were scanned at
5 micron, raw intensities were extracted using Feature
Extraction software (Agilent). Data was analysed
within the R statistical environment.
Results: The 30 cases included: 10 perihilar CC; 19
extrahepatic CC; and 1 gallbladder carcinoma. All
cases were operatively treated with macroscopically
complete resections. Data analysis of miRNA expres-
sion revealed that a miRNA expression signature con-
sisting of 4 miRNAs (hsa-miR-765, hsa-miR-1471,
hsa-miR-345, and hsa-miR-663) that correlated with
overall survival. The 4 miRNAs were ”protective” i.e.
higher expression lowered the risk and improved sur-
vival and lower expression increased the risk and led to
poorer survival. The expression data for all 4 miRNAs
were used to calculate a risk factor for each patient
that allowed to assign the patients to a low-risk (high
expression of the signature) and a high-risk (low
expression of the signature) group, respectively. The
two groups showed a median survival of 15.7 months
vs. 35.6 months: p = 0.00016, hazard ratio 1.71 (95%
confidence interval 1.26–2.34).
Conclusions: Despite complete surgical resection, some
patients still exhibit poor survival with CC. We have
identified a miRNA signature comprising of four miR-
NAs that is predictive of survival in CC following com-
plete surgical resection.
BO04-06
SURGICAL TECHNIQUE OF
HEPATODUODENAL LIGAMENT
RESECTION FOR ADVANCED BILIARY
MALIGNANCY
Yuji Kaneoka, Atsuyuki Maeda and Masatoshi Isogai
Ogaki Municipal Hospital, Japan
Introduction: From 1996, en bloc resection of hepa-
toduodenal ligament (HDL) with hepatectomy and/or
pancreatoduodenectomy for advanced biliary malig-
nancy underwent to eradicate the microscopic cancer
cells around the vasculatures. The operative indication
was both hepatic arterial invasion and portal trunk
involvement concomitant with the biliay infiltration by
the preoperative imaging. We report the operative tech-
nique and surgical outcome of this surgery.
Method: Subjects were 14 patients with 9 cholangiocar-
cinomas and 5 gallbladder carcinomas, who received 7
hepato-ligamento-pancreatoduodenectomies (HLPD), 5
hepato-ligamentectomies (HL), and 2 ligamento-pancre-
atoduodenectomies (LPD). Mean age was 63 years (43–
71) and male/female ratio was 6/8.
En bloc resection of HDL compelled the graft usage
for the portal vein reconstruction (PVR) and the hepa-
tic artery was anastomosed to the heterogeneous artery
(middle colic or gastroduodenal artery) because of the
shortening of the vessels. The PVR using the right
external iliac vein (2 to 4 cm in length) was carried out
before the extirpation of the specimen in the right hep-
atectomy, however, in the other cases, PVR was carried
out after the extirpation and the hepatic artery recon-
struction (HAR) was followed. Both vascular recon-
structions were performed by continuous suturing
method under loupe.
Results: The mean operating time and blood loss were
539 min (386–1025) and 1227 ml (550–2900). Patency
was 100% in PVR and 80% in HAR. Morbidity (Cla-
vien-Dindo ≥ Grade III) was 50% and mortality within
30-days was nil, but in-hospital mortality was 14% due
to septicemia and liver abscess secondary to the hepatic
arterial ischemia. Histologically, R0 was achieved in
71%. Median and 5-year survivals were 24 months and
34%, respectively, and two patients (HL and HLPD)
survive over 5 years without recurrence.
Conclusions: En bloc resection of HDL could be car-
ried out safely and brought the favorable long-term
results. To overcome the postoperative complication a
sound HAR is mandatory.
BO05-01
A NOVEL ONCOLYTIC ADENOVIRUS
TARGETING C-MET RECEPTOR
INCREASES INFECTIVITY EFFICIENCY
AND ONCOLYTIC ACTIVITY IN
HUMAN PANCREATIC
ADENOCARCINOMA CELL LINES
Quyen Chu, Guang Sun, Lei Liu, Benjamin Li, Roger
Kim and J. Michael Mathis
Louisiana State University Health Sciences Center-
Shreveport, U.S.A.
Introduction: Virotherapy using oncolytic adenoviruses
(Ads) is an innovative approach to cancer therapy. The
c-Met receptor and its ligand, hepatocyte growth factor
(HGF), are involved in a wide array of neoplastic dis-
eases, including pancreatic cancer. We created a novel
oncolytic adenovirus by incorporating NK2, a competi-
tive antagonist of the HGF/c-Met association, into the
Ad serotype 5 knob fiber. We hypothesized that this
new oncolytic Ad will result in efficient viral transduc-
tion and cell killing in an array of human pancreatic
cancer cell lines.
Method: Human pancreatic cancer lines CFPAC-1,
AsPC-1, and BxPC-3 were obtained from the American
Type Culture Collection. Efficiency of Ad infection in
the cells was determined using an vector construct
expressing the green fluorescence protein (GFP) marker
in place of the E1A gene (Ad5-RFP-FF-NK2) and
quantified by flow cytometry. Oncolytic activity in the
pancreatic cancer cells was determined using the onco-
lytic Ad5-NK2-E1A by a crystal violet staining
method.
Results: C-Met was overexpressed in all three pancre-
atic cancer cell lines. The oncolytic Ad5-NK2 was more
efficient in transducing pancreatic cancer cell lines as
well as cell killing than wild type adenoviruses
Conclusions: The novel recombinant oncolytic Ad5-
NK2 efficiently transduced and killed human pancreatic
cancer cells. This novel construct represents a potential
new therapy against pancreatic cancer.
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BO05-02
INHIBITION OF NUCLEAR FACTOR
KAPPA-B ENHANCES THE
ANTITUMOR EFFECT OF
COMBINATION TREATMENT WITH
GEMCITABINE AND S1 FOR
PANCREATIC CANCER CELLS
Yoshihiro Shirai, Tadashi Uwagawa, Hiroaki Shiba,
Ryota Iwase, Koichiro Haruki, Yuki Fujiwara, Kenei
Furukawa, Yasuro Futagawa, Toya Ohashi and
Katsuhiko Yanaga
Tokyo Jikei University School of Medicine, Japan
Introduction: Nuclear factor jB(NF-jB) plays an
important role in promoting growth, angiogenesis, and
metastasis in pancreatic cancer and serves as a mecha-
nism underlying therapeutic resistance. Pomalidomide
is investigational immunomodulating drug (IMiDs) of
thalidomide under development that also inhibits
angiogenesis and induces apotosis. We hypothesized
that pomalidomide inhibits the anticancer agent-
induced NF-jB activity and enhances the antitumor
effect of combination treatment with gemcitabine and
S1 for pancreatic cancer cells.
Method: We assessed NF-jB activity and cell viability
of human pancreatic cancer cell lines (PANC-1, MIA
PaCa 2) treated with gemcitabine alone, S1 alone, both
gemcitabine and S1, triple combination of gemcitabine,
S1, and pomalidomide, or vehicle as control. NF-jB
activation was evaluated by measuring nuclear localiza-
tion of p65 protein.
Results: NF-jB activity in anticancer agent groups
were higher than that in control group (p < 0.05,
respectively). Pomalidomide significantly inhibited anti-
cancer agent-induced NF-jB activation (p < 0.05,
respectively). Cell viability in triple combination group
was lower than that in gemcitabine alone, and combi-
nation of gemcitabine and S1 groups (p < 0.05, respec-
tively).
Conclusions: Inhibition of NF-jB by pomalidomide
enhances the antitumor effect of combined gemcitabine
and S1 for pancreatic cancer cells.
BO05-03
NEW THERAPEUTIC TARGETS IN
PANCREATIC CANCER:
POSTRANSCRIPTIONAL REGULATION
OF HO-1 AND COX-2 EXPRESSION
Zilvinas Dambrauskas, Antanas Gulbinas, Aldona
Jakstaite, Giedrius Barauskas and Juozas Pundzius
Lithuanian University of Health Sciences, Lithuania
Introduction: Pancreatic cancer is a rapidly invasive,
metastatic tumor, which is resistant to standard thera-
pies, thus only 10–15% of patients are candidates for
potentially curative surgery. None of the currently
available chemotherapeutic agents have an objective
response rate of over 10%. Recent studies show that
RNA binding proteins regulate posttranscriptional gene
expression and play a critical role in RNA stability and
translation, thus they potentially could become an
important group of new therapeutic targets.
Method: We examined the association of this postran-
scriptional regulation pathway (CUGBP2 and HuR)
and the expression of COX-2 and HO-1, which are
known to be associated with inhibition of apoptosis,
increased tumor invasiveness and resistance to oxida-
tive stress and/or chemotherapy, and promotion of
angiogenesis. Western blot analysis, immunohiosto-
chemistry and quantitative RT-PCR were employed to
show the expression of mRNA and protein in normal
pancreas (from organ donors), cancer tissue (surgical
specimens).
Results: RT-PCR analysis showed 10.3 and 14 fold
lower HuR and CUGBP2 mRNA levels in pancreatic
cancer compared to normal tissue (p < 0.05), COX-2
levels were 1.5 times higher and HO-1 expression on
average was upregualted 6-fold in the pancreatic cancer
samples, compared to the normal pancreatic tissue
(p < 0.05). Western blot analysis showed very low lev-
els of HuR and CUGBP2 in pancreatic cancer com-
pared with the normal tissue (p < 0.05). Expression of
COX-2 protein levels was 2-fold higher in pancreatic
cancer. Western blot analysis revealed 3.5 times higher
(p < 0.017) expression of HO-1 in pancreatic cancer.
Conclusions: The decreased or altered activity of CU-
GBP2 and HuR could be associated with high chemo-
resistance and early dissemination of pancreatic cancer
though the HO-1 and COX-2 mediated cytoprotective
and carcinogenesis pathways. These results mandate
further functional studies and evaluation of postran-
scriptional regulation as a new potential therapeutic
target.
BO05-04
THE IMPACT OF EPITHELIAL
MESENCHYMAL TRANSITION
MEDIATED BY HIF-1a/NOTCH ON
PANCREATIC CANCER STEM CELL
Kun Xie, Zhigong Zhang, Fubao Liu, Hongchuan
Zhao and Xiaoping Geng
first hospital of Anhui medical University, China
Introduction: To clarify the impact and the mechanism
of EMT mediated by HIF-1a/Notch signal pathway in
the maintaining the properties of pancreatic cancer
stem cell.
Method: RNAi vector was designed according to HIF-
1a gene sequence. The expressions of HIF-1a, notch1,
E-Cad, N-Cad and snail were detected by Real time
RT-PCR and Western blot among vector transfected
cells, hypoxia induced cells and normal cells. Prolifera-
tive activity was detected by MTT and the pancreatic
cancer stem cell ratios were detected by flow cytometry.
Results: HIF-1a vector was successfully constructed
and the best transfection rate was 86.5%. The expres-
sions of notch1 (19.3  0.6 vs. 66.7  0.6, p < 0.001),
N-Cad (0.5  0.2 vs. 15.10  0.7, p < 0.001), snail
(2.9  0.5 vs. 4.4  0.2, p = 0.021) significantly
decreased and E-cadherin (2.6  0.9 vs. 0.6  0.27,
p < 0.001) expression significantly increased. In hypoxia
induced group, the results showed that the expressions
of notch1 (16.5  0.8 vs. 53.4  0.6, p < 0.001), N-
Cad (20.3  1.1 vs. 27.4  1.6, p < 0.001), snail
(2.4  0.0 vs. 3.9  0.9, p = 0.038) significantly
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increased and E-cadherin expression significantly
decreased (2.9  0.16 vs. 0.7  0.2, p < 0.001). Flow
cytometry results showed that CD44 + expression rate
was 91.72%  2.26% and CD24 + expression rate was
5.53% in the normal MIA-PaCa2 cell lines. In vector
tranfected group, CD44 + expression rate significantly
decreased (83.08  3.43%, p < 0.05) and CD24 +
expression rate significantly increased (14.41% 
5.28%, p < 0.01). In hypoxia induced group, CD44 +
expression rate significantly increased (95.54% 
2.37%, p < 0.05), CD24 + expression rate significantly
decreased (3.21%  0.78%, p < 0.05).
Conclusions: The inhibition of HIF-1a could reduce
EMT and the prolifteration of pancreatic cancer MIA-
PaCa2 cell line, showing that the regulation of HIF-1a/
Notch pathway could affect EMT of pancreatic cancer
MIA-PaCa2 cell by changing the expressions of notch1,
N-Cad, snail and E-cadherin gene. Some cells of MIA-
PaCa2 could convert to cancer stem cells after obtain-
ing EMT ability, and the inhibition of EMT could
reduce the ratios of pancreatic cancer stem cell, show-
ing that EMT was a necessary process for MIA-PaCa2
cell to transform to cancer stem cell.
BO05-05
MULTI-MARKER PREDICTION
MODELS FOR PANCREATIC DUCTAL
ADENOCARCINOMA USING MRNA
AND MIRNA EXPRESSION
Min-Seok Kwon, Yong-gang Kim, Seungyeoun Lee3,
Junghyun Namkung3, Taegyun Yun3, Sung Gon Yi3,
Meejoo Kang4, Sun Whe Kim4, Jin-Young Jang4 and
Taesung Park
Seoul National University, Korea; 2Sejong University,
Korea; 3SK telecom, Korea; 4Seoul National University
Hospital, Korea
Introduction: Pancreatic ductal adenocarcinoma
(PDAC) is the most common type of pancreatic cancer,
which has dismal prognosis because of its silent early
symptoms, high metastatic potential and resistance to
conventional therapies. Although PDAC patient who is
diagnosed at an early stage has a chance to improve his
survival rates greatly, the survival rate is poor because
there is no efficient non-invasive diagnostic test in the
early stage.
Method: In this study, we developed an efficient multi-
marker prediction models to detect PDAC in its early
stages. Our prediction models use both mRNA and
miRNA expression data from 105 PDAC tissues and
17 normal pancreatic tissues using microarray technol-
ogy. After quality control, we built prediction models
based on the exhaustive search for multi-markers from
mRNA and miRNA expressions. The prediction mod-
els implements support vector machine (SVM) and ran-
dom forest (RF) for detecting early PDAC. In this
step, to prevent over-fitting effect, we conducted leave-
one-out cross validation (LOOCV) and 5-fold cross val-
idation (CV) in our dataset.
Results: After cross-validation, we identified 104
multi-markers with powerful prediction performance.
For independent validation of prediction models, we
performed statistical evaluation on independent data-
sets from Gene Expression Omnibus (GEO). In addi-
tion, the multi-marker candidates are annotated with
cancer pathways using pathway and gene ontology
analysis.
Conclusions: We developed multi-marker prediction
models in PDAC and they may have potential in being
used for early diagnosis of PDAC.
BO05-06
BIOCHEMICAL MARKERS FOR
PANCREATIC NEUROENDOCRINE
TUMORS (PNET)
Anneke Jilesen, Olivier Busch, ThomasVan Gulik, Dirk
Gouma and Els Nieveenvan Dijkum
Academic Medical Center, Netherlands
Introduction: Different biochemical markers, such as
chromogranin A, are used for diagnosis and staging
patients with functional and non functional pancreatic
neuroendocrine tumors (NF-pNET). Up till now, the
ideal biochemical marker hasn’t been found. This study
gives the contributing values of 3 biochemical markers
for diagnosis and detecting metastases in patients with
pNET.
Method: All patients with pNET operated between
1992 and July 2013 were included. Calcitonin, chro-
mogranin A and gastrin were routinely determined at
time of diagnosis and during follow-up according to
standardized method with monitoring for false-positive
elevation due to other reasons.
Results: A total of 132 patients were included. Calcito-
nin was used at time of diagnosis in 38 patients and
elevated in 8 patients (21%), including 1 glucagonoma
and 7 NF-pNET. Chromogranin A was used in 42
patients and elevated in 13 patients (31%), including 1
gastrinoma and 12 NF-pNET. Calcitonin was elevated
in 6 patients (14%) while chromogranin A was negative
in these patients. Gastrin was used in 50 patients and
elevated in 10 patients (20%) including 6 gastrinomas
and 4 NF-pNET.
In the detection of metastases during follow-up in
patients with NF-pNET, the positive predictive value
(PPV) for calcitonin was 100% and negative predictive
value (NPV) was 43%. In the detection of metastases
during follow-up in patients with NF-PNET, the PPV
for chromogranin A was 45% and NPV was 81%. In
gastrinomas, the PPV for gastrin in the detection for
metastases during follow up was 67% and NPV was
100%.
Conclusions: In NF-pNET, calcitonin can contribute to
the diagnosis or detection of metastases besides chro-
mogranin A. In patients with gastrinomas, gastrin
seems a sufficient biochemical marker.
BO06-01
SURVEY OF GENERAL SURGERY
PROGRAM DIRECTORS FOR
HEPATOPANCREATOBILIARY
TRAINING
Vijay MITTAL and Neelima Rehil
Providence Hospital and Medical Centers, U.S.A.
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Introduction: To better understand the perceptions gen-
eral surgery program directors (PDs) have regarding
HPB training in furthering the education of graduating
residents.
Method: A 22-question electronic survey was sent to
210 general surgery PDs across the United States
regarding the experience and competency of their grad-
uating residents.
Results: Of the 81 PDs who responded (39% rate),
56% were from academic programs and 26% were
from community programs. Almost 80% were not affil-
iated with an HPB fellowship, while 64% had no HPB
service on which residents rotated. Most programs
(81%) had 1–2 HPB-trained teaching faculty. Less than
5% of residents showed interest in applying to (67% of
programs) or matched into (72% of programs) HPB
fellowships. However, approximately 40% of PDs felt
graduating residents performed 11–25 complex hepatic,
pancreatic and biliary cases each. Moreover, 5–10 PDs
said graduating residents were performing >40 complex
hepatic, pancreatic and biliary cases each. Approxi-
mately two-thirds of PDs were confident graduating
residents could perform Whipples and liver resections,
and virtually all were confident the residents could per-
form distal pancreatectomies and liver biopsies. Conse-
quently, some PDs feel residents meeting certain HPB
numbers should automatically be certified to perform
HPB surgery with (26%) or without (33%) passing a
certification examination.
Conclusions: General surgery residents are getting more
than the required number of cases in HPB categories.
If residents perform >25 cases in each category, they
should be certified to perform HPB surgery as fellow-
ship-trained HPB surgeons. Only residents who plan on
practicing HPB surgery at high-volume HPB centers
should be required to complete a formal HPB fellow-
ship.
BO06-02
HEPATIC VEIN EMBOLISATION IN
PATIENTS WITH INSUFFICIENT LIVER
REGENERATION AFTER PORTAL VEIN
EMBOLISATION
Hugo Rio Tinto, Elia Coimbra, Tomas Figueira, Luıs
Rosa and Eduardo Barroso
Hospital Curry Cabral, Portugal
Introduction: To assess the technical and clinical out-
comes of hepatic vein embolisation (HVE) in patients
with insufficient liver regeneration after portal vein em-
bolisation (PVE). To describe this singular procedure
performed in our liver centre using coils and Amplatzer
Plug as embolisation agents.
Method: We retrospectively review from August 2009
to December 2012 our cases of HVE after limited liver
regeneration four weeks after portal vein embolisation
and candidates for major hepatic resection. Thirteen
procedures were performed in twelve patients. Five
males and 7 females were treated in our institution
using the same approach and using coils and Amplatzer
Plug as the embolic agent. Ten patients had liver
metastases from colorectal carcinoma. One had a Klat-
skin tumor and the other had liver metastases from a
primary small bowel angiosarcoma. A jugular approach
under US guidance was used and a 9F sheath was
introduced. A hydrophilic shapeable guidewire and a
multipurpose diagnostic catheter were used to catheter-
ize the hepatic vein to embolize. We used coils and
Amplatzer Plug as embolisation materials. Measure-
ments of the supra hepatic vein with previous CT, US
and DSA were crucial to estimate coils and plug diame-
ters. Liver volumetry were performed after portal vein
embolisation and after HVE with a radiologist with
more than 10 years of experience in abdominal imag-
ing.
Results: All the patients were not considered candi-
dates for major hepatic resection after PVE due to lim-
ited liver regeneration. We had a 100% technical
success of HVE and 10 patients underwent major hepa-
tectomy (86%) with a future liver remnant considered
enough to avoid risk of postoperative liver failure.
Conclusions: HVE is a very uncommon procedure that
should be performed in an experienced liver centre. It
is a safe and effective to induce liver regeneration in
candidates to major hepatectomy and insufficient future
liver remnant after portal vein embolisation.
BO06-03
COMPARISON OF ISCHEMIC
PRECONDITIONING WITH
CONTINUOUS CLAMPING VERSUS
INTERMITTENT CLAMPING IN LIVER
RESECTION: A PROSPECTIVE
RANDOMIZED CONTROLLED STUDY
Prithiviraj Nabi, Amritanshu Sharma, Lileswar Kaman,
Arunanshu Behera, Divya Dahiya, Dinesh Bagaria and
Rajinder Singh
PGIMER, chandigarh, India
Introduction: Resection is the most curative treatment
for various liver diseases. The prime concern in Liver
surgeries is to minimize blood loss and avoid transfu-
sions during surgery. Ischemic preconditioning and
intermittent clamping of portal triad are the clinically
established protective strategies against prolonged
ischemic injury. This study was done to compare their
effectiveness in term of blood loss, transfusion require-
ment and post operative outcome.
Method: A total 20 patients scheduled for liver resec-
tion (≥2 segments) were enrolled in the study. Patients
underwent randomization and resection was done using
either of one techniques. Intra operative and postopera-
tive variables were compared.
Results: Blood loss in Group A (Ischemic Precondi-
tioning) was 605 ml with a standard deviation of
528.33 ml and in Group- B (Intermittent Clamping)
group was 485 ml with a standard deviation of
604.63 ml. The difference between two groups was not
significant(p = .251). Intermittent Clamping resulted in
lower peak SGOT than Ischemic Preconditioning (103
vs 208) but the difference was not statistically signifi-
cant (p = .134) and the levels were comparable on
post-operative day 10. Similar results were seen in
SGPT (97 vs. 286). Post-operative serum bilirubin and
albumin levels were found not to be statistically differ-
ent in both the groups. Prothrombin time value was
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significantly different on POD 10 with the mean value
higher in IC group (p = .021).
Conclusions: Study found both these clamping tech-
niques to be equally effective, so the ultimate decision
vests with the operating surgeon.
BO06-04
SYNCHRONOUS PRIMARY
COLORECTAL CANCER AND LIVER
METASTASIS: IMPACT OF OPERATIVE
APPROACH ON CLINICAL OUTCOMES
AND HOSPITAL COSTS
Gaya Spolverato, Aslam Ejaz, Eugene Semenov, Dylan
Tanner, John Hundt and Timothy Pawlik
Johns Hopkins University, U.S.A.
Introduction: Management of patients with colorectal
cancer (CRC) and synchronous colorectal liver metas-
tasis (sCRLM) remains controversial. The current
study sought to assess the clinical and economic impact
of managing sCRLM with a staged versus simultaneous
approach.
Method: We identified 229 patients treated for sCRLM
between 1990–2012 from the Johns Hopkins Hospital
liver database. Data on clinicopathologic features, peri-
operative outcomes, and total hospital costs (inflation-
adjusted) were collected and analyzed.
Results: 118 (52%) patients underwent a staged
approach while 111 (48%) had a simultaneous CRC
and liver operation. Overall intra-hepatic tumor burden
was similar among patients treated with staged versus
simultaneous approach (largest metastasis: 3.2 cm vs.
1.9 cm; number of metastasis: 2 vs. 2; both p > 0.05).
At surgery, liver-directed therapy included hepatectomy
(73%), ablation alone (3%) or combined resec-
tion+ablation (24%). A major hepatectomy (>3 seg-
ments) was more common with a staged approach
(54% vs. 31%; p < 0.001); 43% of patients underwent
an extended hepatic resection (staged, n = 64 vs. simul-
taneous, n = 35). There were 68 (30%) patients who
had a post-operative complication with no difference in
the staged (38%) vs. simultaneous (27%) groups
(p > 0.05). 90-day mortality was 1.7% (staged, 1.7%
vs. simultaneous, 1.8%; p = 0.94). Median total length
of hospitalization was longer in the staged (12.5 days)
versus simultaneous (7.0 days) group (p < 0.001). Med-
ian total hospital costs were also higher among patients
undergoing a staged approach ($57,821) compared with
a simultaneous operation ($27,401) (p < 0.01). Long-
term outcomes were similar (5-year disease-free sur-
vival: staged, 39.8% vs. simultaneous, 48.6%;
p = 0.61).
Conclusions: Patients with sCRLM managed with
either a staged or simultaneous approach had compara-
ble peri-operative and long-term outcomes. However,
patients treated with a simultaneous approach spent
significantly fewer days in the hospital and had a med-
ian cost savings of $30,420. As such, when appropriate,
the simultaneous approach for sCRLM should be pre-
ferred.
BO06-05
LAPAROSCOPY-ASSISTED
TRANSGASTRIC ERCP IN PATIENTS
WITH ROUX-EN-Y GASTRIC BYPASS
PRESENTING WITH BILIARY DISEASE
Jean-Philippe Magema1, Christophe Snauwaert2,
Giovanni DAPRI3, Bruno Dillemans5, Michel Buset3,
Jacques Himpens4 and Abdenor Badaoui1
1Mont-Godinne-Dinant University Hospital, Belgium;
2Ghent University Hospital, Belgium; 3St-Pierre Brussels
University Hospital, Belgium; 4St-Blasius Hospital,
Belgium; 5St-Jan Brugge-Oostende Hospital, Belgium
Introduction: Preexisting biliary disease in morbidly
obese patients can lead to biliary complications because
of rapid weight loss after Roux-en-Y gastric bypass
(RYGBP). The conventional endoscopic access to the
biliary tract is limited principally for anatomic reasons.
Balloon enteroscopy-assisted ERCP has been reported
to be feasible but has several limitations as a time-
consuming procedure, with failures to identify the anas-
tomosis site and the lack of adapted accessories. ERCP
by laparoscopic transgastric access (ERCP-LTA) repre-
sents an alternative.
Method: We report all patients with RYGBP who
experienced biliary complications (mainly choledoco-
lithiasis) and were managed by ERCP-LTA. After cre-
ating a laparoscopic pneumoperitoneum, an incision
was made in the anterior and distal part of the
bypassed stomach close to the pylorus. A side-viewing
endoscope was introduced through a 15 or 18-mm tro-
car after creating a purse-string suture on the greater
curvature of the gastric remnant. ERCP with sphincter-
otomy and gallstones extraction was performed under
fluoroscopic guidance. Carbon dioxide gas was used for
endoscopic insufflation. After removal of the scope,
gastrostomy incision was closed. If necessary, laparo-
scopic cholecystectomy was performed.
Results: Twenty-one patients underwent ERCP-LTA
between May 2008 and April 2013 (18 women, 3 men,
mean age of 53 years, range 26–80). Biliary stones or
sludge extraction after sphincterotomy could be
achieved in 20 patients. In the 21th patient sphincterot-
omy was performed for papillary stenosis. A concomi-
tant laparoscopic cholecystectomy was performed in 15
patients. The mean endoscopic procedure duration was
53 min (range 15–120). No complications occurred.
The mean hospital stay was 3.3 days (range 2–5). Lapa-
roscopic access was converted to a minilaparotomy in 1
patient with multiple previous surgeries due to bypass
complications.
Conclusions: ERCP-LTA is a feasible approach for the
management of common bile duct stones in post-RY-
GBP patients and allows ERCP and cholecystectomy
to be performed consecutively in a single procedure.
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BO06-06
OUTCOMES OF EUS-GUIDED
TRANSMURAL GALLBLADDER
DRAINAGE WITH SINGLE-STEP
PLACEMENT OF A SELF-EXPANDABLE
METAL STENT IN PATIENTS WITH
ACUTE CHOLECYSTITIS UNSUITABLE
FOR CHOLECYSTECTOMY
Jun Ho Choi, Sang Soo Lee, Do Hyun Park, Dong
Wan Seo, Sung Koo Lee and Myung-Hwan Kim
Asan Medical Center, Ulsan University, Korea
Introduction: Recently, EUS-guided transmural gall-
bladder drainage (EUS-GBD) has been reported as an
alternative method for managing acute cholecystitis in
high risk patients, but little is known about the long-
term outcomes in terms of stent patency, and clinical
progress. This study was aimed to investigate the long-
term safety and efficacy after EUS-guided transmural
gallbladder drainage (EUS-GBD) in patients with acute
cholecystitis.
Method: A total of 63 patients with acute cholecystitis
who were unsuitable for cholecystectomy were under-
went EUS-GBD using a self-expandable metal stent
(SEMS). The procedural outcomes, recurrence of acute
cholecystitis, and clinical progress were recorded pro-
spectively in single tertiary referral center.
Results: Successful gallbladder puncture was achieved
in all 63 patients (100%), with the successful comple-
tion of metal stent placement in 62 patients (98.4%, as
an intention-to-treat analysis). The clinical success rate
of EUS-GBD was 98.4% (61 of 62, as a per-protocol
analysis). Post-procedure adverse events included duo-
denal perforation (n = 1, 1.6%), bile peritonitis (n = 1,
1.6%), and self-limited pneumoperitoneum (n = 2,
3.2%), all of which resolved with conservative treat-
ment. During follow-up after stent placement (median
262 days, range 70–1130 days), 56 patients were evalu-
ated as per protocol. Late adverse events developed in
four patients [7.1% (4/56) as per protocol], including
spontaneous distal migration (n = 2), and stent occlu-
sion (n = 2). Fifty-four patients (96.4%) had no recur-
rence of acute cholecystitis. The rate of re-intervention
was 3.5% (2/56). The median period of stent patency
and survival time (range) were 244 days (70–1130) and
262 days (70–1130), respectively.
Conclusions: Given the low recurrence rate of cholecys-
titis and long-term safety in high surgical risk patients
with acute cholecystitis, EUS-GBD with single-step
placement of a SEMS may provide a definitive treat-
ment in a select group of patients.
BO07-01
GADOXETIC ACID-ENHANCED MRI
VERSUS CONVENTIONAL MRI OR
MDCT FOR STAGING OF LIVER
METASTASIS - RESULTS OF A
RANDOMIZED MULTICENTER TRIAL
Jin-Young Choi1, C.J. Zech2, P. Korpraphong3,
A. Huppertz4, Myeong-Jin Kim1, W. Tanomkiat5,
S. Gschwend6 and E. Jonas7
1Severance Hospital, Yonsei University, Korea;
2University Hospital Munich – Grosshadern, Munich,
Germany; 3Siriraj Hospital, Bangkok, Thailand;
4Charite University Hospital, Berlin, Germany; 5Prince
of Songkla University, Songkhla, Thailand; 6Bayer
Pharma AG, Berlin, Germany; 7Karolinska University
Hospital, Stockholm, Sweden
Introduction: To analyse and compare the impact of
imaging strategy using gadoxetic acid-enhanced MRI
(Gd-EOB-DTPA-MRI), MRI with extracellular con-
trast media (ECCM-MRI) or contrast-enhanced multi-
detector computed tomography (CE-MDCT) as first-line
imaging method in patients with suspected colorectal
cancer liver metastases (CRCLM) in terms of sensitivity
and accuracy of the treatment surgical plan.
Method: Between October 2008 and September 2010
360 patients with suspected CRCLM were randomised in
a multi-national prospective trial to one of the three
imaging modalities. The primary variable was the pro-
portion of patients for whom further imaging after initial
imaging was required for a confident diagnosis. Second-
ary variables included confidence in the therapeutic deci-
sion, deviations from the imaging-based surgical plan
during operation due to additional operative findings,
and diagnostic efficacy (sensitivity and specificity) of the
imaging modalities with the extent of the disease as
determined by intra-operative findings (including intra-
operative contrast-enhanced ultrasound) and pathologi-
cal examination of resected specimens as endpoint.
Results: After exclusion of screening failures, prema-
ture study terminations and major protocol violations,
342 patients (efficacy population) were analyzed, 118,
112 and 112 with Gd-EOB-DTPA-MRI, ECCM-MRI
or CE-MDCT as initial imaging procedure respectively.
Further imaging was required in 0/118 (0%), 19/112
(17%) and 44/112 (39%) patients, respectively
(p < 0.0001). Diagnostic confidence was high or very
high in 98.3% of cases for Gd-EOB-DTPA-MRI,
85.7% for ECCM-MRI and 65.2% for CE-MDCT.
Surgical plans were changed intraoperatively in 12.8%,
16.0% and 29.4% of patients in the respective groups.
In patients who underwent surgery (n = 112), sensitiv-
ity for detection of metastases was 93.8%, 89.4% and
84.1%, respectively.
Conclusions: Diagnostic performance of Gd-EOB-
DTPA-MRI is better than CE-MDCT and ECCM-
MRI as initial imaging modality. No further imaging
to assess hepatic resectability was needed in the Gd-
EOB-DTPA-MRI group, with implications for work-
flow, costs and treatment planning. Comparison of
diagnostic efficacy parameters for the three modalities
demonstrates the diagnostic superiority of Gd-EOB-
DTPA-MRI.
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BO07-02
ONCOSURGICAL APPROACH OF
UNRESECTABLE COLORECTAL LIVER
METASTASES: TIME FOR SURGICAL
DE-ESCALATION?
Serge Evrard1, Abou Diallo1, Veronique Brouste2,
Graemen Poston5, Stefan Staettner5, Peter Kissmeyer-
Nielsen4, Frank Mortensen4, Ioannis Konstantidinis3
and Yuman Fong3
1Instiut Bergonie/universite de Bordeaux, France;
2Institut Bergonie, France; 3Memorial Sloan-Kettering
Cancer Center, U.S.A.; 4Aarhus University Hospital,
Denmark; 5Aintree University Hospitals, United
Kingdom
Introduction: To promote an oncosurgical approach of
initially unresectable colorectal liver metastases (CLM)
including downsizing chemotherapy, resection and
intra-operative ablation (IA). Objectives were to evalu-
ate overall survival (OS), local recurrence-free (LRFS),
hepatic recurrence-free (HRFS) and progression-free
(PFS) survivals over three years in a multicenter study,
identify factors associated with survivals and to report
complications.
Method: Four centers combined their clinical databases
regarding unresectable CLM treated by concomitant
resection and ablation. Demographics, treatments,
CLM characteristics, complications (Clavien-Dindo),
and survivals were analyzed.
Results: From 2001 to 2011, 288 patients (38% female,
median age 61 years) underwent surgical resection of
CLM combined with IA. 232 patient (81%) received
preoperative chemotherapy, 210 had synchronous CLM
(73.4%) and 255 bilateral (88.5%). Median number of
tumors resected was 2 (range 1–19) and ablated 2
(1–12). Mean size (mm) of largest and smallest CLM
ablated per patient were 15 mm and 11 mm respec-
tively. 100 patients experienced complications: 29 G1,
19 G2, 38 G3, 11 G4 and 3 deaths. Median follow-up
was 3.17 years [95%CI (2.83–4.08)]. Median OS was
3.33 years [95%CI (3.08–4.17)]. 1-, 2- and 3-year LRFS
rate was 89.4% [95%CI (85.0–92.5)], 85.5% [95%CI
(80.4–89.3)], and 81.2% [95%CI (74.9–86.1)] respec-
tively. Median HRFS was 14 months [95%CI (11–18)].
Median PFS was 9 months [95%CI (8–11)]. In the mul-
tivariate models adjusted for center, the occurrence of
complications was confirmed as a strong independent
factor associated with lower 3 years OS (HR 1.93, 95%
CI 1.27–2.92, p = 0.002), lower 3 year HRFS (HR
1.396, 95%CI 1.03–1.90, p = 0.035) and lower 3 year
PFS (HR 1.399, 95%CI 1.05–1.86, p = 0.022).
Conclusions: Initially unresectable CLM remain a diffi-
cult therapeutic challenge. In this difficult-to-treat
group, morbi-mortality seems to be the most prognostic
factor of survival. Combining IA to resection allows
treating patients with a low complication rate and
should be prefer to extensive hepatectomies which is
not compatible with the extensive use of peri-operative
chemotherapy.
BO07-03
TIMING OF FDG-PET SCAN IN
PATIENTS WITH COLORECTAL LIVER
METASTASES (CRLM)
Nagappan kumar1, Harsheet Sethi1, Amarjot Chander2,
Sudar Jayaprakasam2 and John Rees2
1University Hospital of Wales, United Kingdom;
2Cardiff University, United Kingdom
Introduction: PET scan is increasingly used to choose
patients for liver resection in CRLM. The best time to
do PET scan in CRLM patients has not been studied
well. We report on a consecutive series of patients who
had PET scan for CRLM.
Method: We perform FDG-PET scan on all patients
with CRLM. We analysed data on patients from 1
October 2010 to 31 December 2012. Minimum follow
up was 6 months. We recorded the demographics, tim-
ing of PET scan in relation to chemotherapy and liver
resection. PET scan was considered falsely negative if
inoperable disease was found at the time of laparotomy
or recurrence detected in 6 months following liver
resection.
Results: One hundred and forty two patients had PET
scans for CRLM. The male female ratio was 104:38.
Median age was 69 years (38–86). There were 35 and
107 patients with synchronous and metachronous liver
metastases respectively. PET scan was 87% accurate in
detecting liver and extrahepatic metastases. It avoided
liver resection in 28% of patients by detecting extrahe-
patic disease. Only 10% of patients with synchronous
disease proceeded to liver resection and PET scan alone
avoided liver resection in 39% of these patients. Che-
motherapy within the previous year was given to 35
patients at a median interval before PET of 16 weeks
(4–47). Sixty six patients were explored and 60 patients
(42%) had liver resection at a median interval of
72 days (20–387).
Conclusions: We conclude that PET scan should be
performed before any treatment (chemotherapy or sur-
gery for primary or liver metastases) in patients with
synchronous liver metastases. Accuracy of PET seems
satisfactory if done before or 4 weeks after completion
of chemotherapy in patients with metachronous liver
metastases. Further studies are needed to predict better
timing of PET scan after chemotherapy.
BO07-04
APRI SCORE IS PREDICTIVE OF LIVER
FAILURE AFTER MAJOR
HEPATECTOMY ON LIVER WITH SOS
Jeremy Vara, Francois Faitot2, Eric Vibert2, Rene
Adam2, Denis Castaing2, Olivier Soubrane and Olivier
Scatton
Hopital Saint Antoine AP-HP Paris, France; 2Hopital
Paul Brousse AP-HP Villejuif, France
Introduction: Oxaliplatin can cause severe sinusoidal
obstruction syndrome (SOS) after six cycles. SOS is
associated with intra-hepatic portal hypertension
increasing morbidity after major hepatectomy.
APRI > 0.36(aspartate aminotransferase to platelet
ratio index) is predictive of SOS severity. We aimed to
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evaluate the accuracy of APRI to predict liver failure
after major hepatectomy for colorectal liver metastases
(CLMs).
Method: 105 patients were operated for CLMs after at
least six cycles Oxaliplatin. Analysis of preoperative
data and APRI score were performed to predict post
hepatectomy liver failure (PHLF), defined as pro-
thrombin time <50% and/or serum bilirubin >50 lmol/
l on postoperative day 5. Body mass index (BMI),
extended hepatectomy (eHx) and APRI were evaluated
to predict PHLF using a receiving operative curve
analysis. Morbidity, correlation with splenic volume,
biologic parameters of liver regeneration were studied
according to APRI.
Results: 105 patients underwent right hepatectomy (26
had eHx and 40 had a preoperative portal vein emboli-
zation). 44 patients (56%) had severe SOS. Median
number of Oxaliplatin courses was 9(6–31). 33 patients
had PHLF (31%) including 12 severe PHLF (11%)
leading to 3 deaths (4%). PHLF occurred in 37%
patients with APRI > 0.36 vs. 15% when APRI < 0.36
(p = 0.039). 92% severe PHLF occurred in high
APRI group affecting 15% patients inside this group
(ns). The 3 deaths had APRI > 0.36 (ns). Univariate
and multivariate analysis showed that BMI > 25, eHx,
APRI > 0.36 were associated with PHLF. Receiving
operative curve analysis revealed that the association
of APRI, BMI, eHx was the best model predicting
PHLF (AUC = 0.70; 0.59–0.81). In multivariate analy-
sis APRI > 0.36 was associated with jaundice
(p = 0.04), ascite (p = 0.036) but not with morbidity
Clavien ≥ 3 (p = 0.13). There was no strong correla-
tion between APRI and splenomegaly (r2 = 0.065).
Biologically, liver regeneration was influenced by ante-
rior embolization and APRI score. Regeneration pro-
file when APRI > 0.36 tended to be closer to the
PHLF profil.
Conclusions: APRI > 0.36 is associated with PHLF
after major hepatectomy among patients treated with
preoperative oxaliplatin-based chemotherapy.
BO07-05
NODULAR REGENERATIVE
HYPERPLASIA IN PATIENTS
UNDERGOING LIVER RESECTION FOR
COLORECTAL METASTASES AFTER
CHEMOTHERAPY. RISK FACTORS,
PREOPERATIVE ASSESSMENT AND
CLINICAL IMPACT
Luca Vigano1, Laura Rubbia-Brandt2, GiovanniDe
Rosa1, Pietro Majno3, Alessandro Ferrero1, Christian
Toso3, Gilles Mentha3 and Lorenzo Capussotti1
1Ospedale Mauriziano Umberto I, Torino, Italy;
2University Hospitals, Geneva, Switzerland; 3University
Hospitals, Geneva, Switzerland
Introduction: Chemotherapy-related liver injuries
(CALI) worsen short-term outcome of resection of
colorectal metastases (CRLM). Nodular regenerative
hyperplasia (NRH) has been recently reported, but
poorly analyzed. To clarify NRH incidence, risk fac-
tors, preoperative assessment and clinical impact.
Method: 406 patients undergoing 478 resections for
CRLM between 2000 and 2012 after oxaliplatin- and/
or irinotecan-based chemotherapy were included. All
specimens were reviewed to assess CALI. After Gomori
staining, NRH was graded according to the Wanless
scoring system.
Results: Preoperative chemotherapy included oxalipla-
tin in 243 (50.8%) patients, irinotecan in 119 (24.9%)
and both in 116 (24.3%); bevacizumab was associated
in 167 (34.9%). The median number of cycles was 6
(2-31). 63 (13.2%) patients had >1 chemotherapy line.
NRH was diagnosed in 87 (18.2%) patients, grade 2–3
in 14 (2.9%). NRH was associated with grade 2–3 sinu-
soidal dilatation (p < 0.0001) and perisinusoidal fibrosis
(p = 0.001).
At multivariate analysis, NRH was increased after oxa-
liplatin administration (21.4% vs. 8.4%, OR = 3.117,
p = 0.002), but attenuated by the addition of bev-
acizumab (11.7% vs. 19.8%, OR = 0.402, p = 0.013).
Chemotherapy duration had no influence. NRH was
increased in patients with arterial hypertension (25.5%
vs. 15.2%, OR = 2.171, p = 0.003). APRI score (AST
to platelet ratio index) predicted NRH (25.3% if APRI
>0.36 vs. 9.7% if ≤0.36, OR = 3.367, p < 0.0001). No
further test predicted NRH.
90-day mortality was 0.6% (n = 3). 139 (29.1%)
patients had complications; 17 (3.6%) had liver dys-
function. NRH was associated with higher liver dys-
function rate (9.2% vs. 2.3%, p = 0.005). In patients
with grade 2–3 NRH liver dysfunction rate was 14.3%,
25.0% after major hepatectomy. NRH was an indepen-
dent predictor of postoperative liver dysfunction (OR =
4.008, p = 0.006) together with major hepatectomy
(OR = 3.451, p = 0.018). No further CALI correlated
with short-term outcomes.
Conclusions: NRH is the most clinically relevant CALI,
increasing the postoperative liver dysfunction risk. Oxa-
liplatin increases NRH incidence, while bevacizumab
attenuates it. The APRI score is a useful tool to predict
NRH.
BO07-06
A SPLENIC VOLUME INCREASE DUE
TO PREOPERATIVE CHEMOTHERAPY
MAY IMPAIR THE LONG-TERM
OUTCOME AFTER HEPATECTOMY IN
PATIENTS WITH INITIALLY
NON-OPTIMALLY RESECTABLE
COLORECTAL CANCER LIVER
METASTASES
Hiroshi Nakano1, Masafumi Katayama1, Shinya
Kishi1, Shinjiro Kobayashi1, Satoshi Koizumi1,
Kazuyoshi Ishibashi2, Tetsu Fukunaga1 and Takehito
Otsubo1
1St. Marianna University Hospital, Japan; 2St.
Marianna University Yokohama-City-Western Hospital,
Japan
Introduction: Preoperative chemotherapy has been con-
sidered an indispensable therapeutic option for patients
with initially non-optimally resectable colorectal cancer
liver metastases (CRCLM) in order to convert into
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resectable disease and to obtain sufficient long-term
outcome. However, chemotherapy can induce adverse
changes in the non-tumoral hepatic parenchyma, lead-
ing to increased morbidity and mortality after a subse-
quent major hepatectomy (Nakano, et al. Ann Surg
2008). Interestingly, a recent report showed that che-
motherapy-associated hepatotoxicity (CAH) might
impair the long-term survival after surgical resection of
CRCLM (Tamandl, et al. Ann Surg Oncol 2011). On
the other hand, CAH has been shown to be associated
with splenomegaly. The aim of the present study was
to investigate whether a higher splenic volume increase
(SVI) after preoperative chemotherapy was associated
with a worse long-term outcome after hepatectomy in
patients with initially non-optimally resectable
CRCLM.
Method: Between 2007 and 2012, there were 36
patients who received preoperative chemotherapy based
on a diagnosis of initially non-optimally resectable syn-
chronous CRCLM. The splenic volume was measured
by CT-volumetry before preoperative chemotherapy
and 12 weeks after the start of the chemotherapy.
Long-term outcome was analyzed in these patients.
Results: The overall survival was significantly shorter
in the SVI ≥ 30% group than in the SVI < 30% group
(3-year survival = 52% vs. 28%, p < 0.05). The disease-
free survival was also significantly shorter in the SVI ≥
30% group than in the SVI < 30% group (Median = 11
vs. 6 months, p < 0.05). The survival after recurrence
was significantly shorter in the SVI ≥ 30% group than
in the SVI < 30% group (Median = 12.0 vs. 18 months,
p < 0.05).
Conclusions: In patients with non-optimally resectable
CRCLM, the SVI during the first 12 weeks of preoper-
ative chemotherapy may be a significant predictor of
the long-term survival after hepatectomy.
BO08-01
ROLE OF HUMAN LEUKOCYTE
ANTIGEN COMPATIBILITY IN GRAFT
OUTCOMES FOLLOWING LIVING
DONOR LIVER TRANSPLANTATION
Milljae Shin, Jong Man Kim, Choon Hyuck Kwon,
Sung-Joo Kim and Jae-Won Joh
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: The importance of human leukocyte anti-
gen (HLA) matching in liver transplantation has been
widely studied, but is still controversial. HLA matching
is taken no account of liver graft allocation. The aim
of this study is to analyze the influence of HLA com-
patibility between donor and recipient on the trans-
plant outcomes of living donor liver transplantation
(LDLT) in a large single-center.
Method: A total of 925 consecutive recipients under-
went LDLT between March 2000 and April 2011 were
retrospectively analyzed. HLA typing was formerly per-
formed by standard complement dependent cytotoxicity
technique. The type and degree of HLA-A,B,DR mis-
matching were assessed. We also investigated the post-
transplant level of liver function tests, development of
rejection, and graft survival as outcome parameters.
Results: Mean number of HLA mismatching was
3.2  1.3 and mean follow-up period was
61.3  38.4 months. Each type and degree of HLA-A,
B, DR mismatching had no effect on graft rejection,
whereas the effect on graft survival was significant.
Except for HLA-A, HLA-B and -DR mismatching was
notably associated with graft survival. Recipients with
1 HLA-B or 0-1 HLA-DR mismatched had superior
graft survival in contrast to recipients with 2 HLA-B or
2 HLA-DR mismatched, respectively. In addition, post-
transplant serum bilirubin level and graft survival have
been improved by the lower quantity of HLA mis-
matching, comparing 0–3 vs. 4–6 MM and comparing
0–4 vs. 5–6 MM.
Conclusions: This study confirmed the critical relation
between HLA-B,DR mismatching and graft survival,
but not rejection incidence. In addition, the degree of
HLA mismatching play a great role in graft outcomes.
To obtain a prolonged graft survival, the type as well
as degree of HLA compatibility should be considered
in the setting of LDLT providing enough time to select
a favorable combination of donor and recipient.
BO08-02
RAPID FIBROSIS AND SIGNIFICANT
HISTOLOGIC RECURRENCE OF
HEPATITIS POST LIVER TRANSPLANT
IS ASSOCIATED WITH HIGHER
TUMOR RECURRENCE RATES POST
LIVER TRANSPLANT IN HCC WITH
HCV.
Bhavin Vasavada1, Karan Julka1 and Chao long Chan2
1Fellow liver surgery and transplant, India; 2Professor
and superintendent, Taiwan
Introduction: HCV recurrence after transplant is uni-
versal. Histologic recurrence is seen in more than 50%
of HCV-infected grafts within the first year. Many
studies are there on evaluating prognostic factors for
HCC recurrence and mortality however very few stud-
ies evaluated histologic markers of HCV recurrence as
prognostic factors post liver transplant. Primary aim of
our study was to evaluate factors associated with HCC
recurrence and mortality including hepatitis c recur-
rence severity.
Method: All the patients who have undergone trans-
plant for HCC associated with HCV between 2002 and
2012 were evaluated retrospectively. We defined post
transplant Ishak’s score greater than 6 as significant
HCV recurrence and fibrosis stage 2 or greater one year
after transplant at rapid fibrosers. Statistical analysis
was done using SPSS version 21. (IBM).
Results: One hundred and nine patients with HCC
associated with HCV underwent living donor liver
transplant from July 2002 to June 2012. Median follow
up time was 31 months. Total 14 patients had HCC
recurrence 4 intrahepatic and 10 metastatic. On univar-
iate analysis pre operative MELD score (p = 0.026),
AFP levels (0.020) and Rapid fibrosis (0.008), HAI
greater than 6 (p = 0.008) were associated with recur-
rence. However on multivariate cox regression analysis
MELD (p < 0.0001, HR = 1.236,95% confidence
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interval 1.119–1.364) score and Rapid fibrosis
(p = 0.015, HR = 0.235, 95% confidence interval 0.074
and 0.752) independently predicted HCC recurrence.
On univariate analysis preoperative and postoperative
interferon therapy was associated with significantly bet-
ter survival rates (p = 0.009) and (p = 0.043)and tumor
beyond Milan criteria had worst survival (p = 0.016).
However on multivariate cox regression analysis no
factor independently predicted overall survival.
Conclusions: Significant HCV recurrence on biopsy is
poor prognostic factor and is associated with higher
chance of HCC recurrence post liver transplant. Rapid
fibrosis post liver transplant independently predicts
HCC recurrence.
BO08-03
IMPACT OF SARCOPENIA AND
PERIOPERATIVE NUTRITIONAL
THERAPY ON SURVIVAL IN PATIENTS
UNDERGOING LIVING DONOR LIVER
TRANSPLANTATION
Toshimi Kaido, Kohei Ogawa, Akira Mori, Yasuhiro
Fujimoto, Koji Tomiyama, Koichiro Hata, Tadahiro
Uemura, Hideaki Okajima, Etsuro Hatano and Shinji
Uemoto
Kyoto University, Japan
Introduction: Skeletal muscle depletion, referred to as
sarcopenia, predicts morbidity and mortality in patients
undergoing digestive surgery. However, the impact on
liver transplantation is unclear. The present study
investigated the impact of sarcopenia and perioperative
nutritional therapy on patients undergoing living donor
liver transplantation (LDLT).
Method: Sarcopenia was assessed by a body composi-
tion analyzer in 124 adult patients undergoing LDLT
between February 2008 and April 2012. The correlation
of sarcopenia with other patient factors including nutri-
tional factors and the impact of sarcopenia as well as
perioperative nutritional therapy on survival after
LDLT were analyzed.
Results: The median ratio of preoperative skeletal mus-
cle mass was 92% (range 67%–130%) of the standard
mass. Preoperative skeletal muscle mass was signifi-
cantly correlated with the branched-chain amino acids
to tyrosine ratio (r = 0.254, p = 0.005) and body cell
mass (r = 0.636, p < 0.001). The overall survival rate in
patients with low skeletal muscle mass was significantly
lower than in patients with normal/high skeletal muscle
mass (p < 0.001). Perioperative nutritional therapy sig-
nificantly increased overall survival in patients with low
skeletal muscle mass (p = 0.009). Multivariate analysis
showed that low skeletal muscle mass and lack of peri-
operative nutritional therapy were independent risk fac-
tors for death after transplantation.
Conclusions: Sarcopenia was closely involved with
post-transplant mortality in patients undergoing LDLT.
Perioperative nutritional therapy significantly improved
overall survival in patients with sarcopenia.
BO08-04
THE NEGLIGIBLE AGING OF HUMAN
LIVER: A STUDY ON PROTEASOMES
Gian Luca Grazi1, Elena Bellavista2, Morena
Martucci2, Francesco Vasuri2, Aurelia Santoro2 and
Michele Mishto3
1Regina Elena National Cancer Institute, Italy;
2University of Bologna, Italy; 3Charite
Universitaetsmedizin Berlin, Germany
Introduction: Proteasomes represent the most impor-
tant intracellular protein degradation machineries and
they play an important role in the maintenance of cel-
lular homeostasis. We previously reported a changes of
proteasomes composition in human hepatocytes after
the birth, but no data are available on further modifi-
cations during liver aging. In the context of the proto-
col donor-recipient allogenic graft we tested whether
aging impinges upon proteasomes and whether these
might contribute to the sustained functionality of trans-
planted organs from elderly and very old subjects.
Method: Liver biopsies were obtained from 56 explant-
ed organs of heart-beating donors of different age
(range 16–87 years) and gender before engraftment.
Western blotting, 2D PAGE electrophoresis and immu-
noistochemistry (IHC) staining have been use to assess
proteasomes composition and distribution. Proteasome
activity has been assessed directly by short fluorogenic
peptides assay and indirectly by measuring the content
of oxidized and poly-ubiquitinilated proteins.
Results: No age-related modifications in the content of
oxidized and poly-ubiquitinated proteins, as well as
proteasomes activity were observed in human liver,
even if the latter parameter seems to be differently
affected by donor gender. Minor changes of total pro-
teasomes content were observed, i.e an increase of pro-
teasomes containing b5 inducible catalytic subunits and
a decrease of PA28ab regulatory complex. IHC showed
a decreased staining of PA28a subunit in hepatocytes
at cytosolic level.
Conclusions: Proteasomes functionality and composi-
tion is mainly preserved in human liver, suggesting that
the biological age of the organ does not correspond to
its chronological age. This fact may in part explain
why liver graft from aged subjects has, in specific con-
ditions, function and duration comparable to those
achievable with liver grafts from young donors. The
impact of changes in inducible components on specific
cellular processes deserve further investigations.
BO08-05
LIVER TRANSPLANTATION IS A
HIGHLY EFFECTIVE TREATMENT FOR
MANAGEMENT OF HEPATOCELLULAR
CARCINOMA, EVEN FOR HIGHLY
SELECTED ADVANCED STAGE
PATIENTS
William Chapman, Neeta Vachharajani, Katherine
Fowler, Nael Saad and Majella Doyle
Washington University in St Louis, U.S.A.
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Introduction: Optimal management of hepatocellular
carcinoma (HCC) remains controversial, with a high
recurrence rate in patients undergoing standard hepatic
resection. While results for orthotopic liver transplanta-
tion (OLT) have been favorable for patients with HCC
within Milan criteria, concerns about recurrence have
limited use of this therapy in patients beyond Milan at
many centers. Since 2000, we have used a strategy of
tumor downstaging with a minimum 6-month period of
observation prior to OLT.
Method: We retrospectively reviewed our single-center
experience from 1/1/2000 to 12/31/2012 from a pro-
spective database, during which time 937 cadaveric
adult liver transplants were performed. Patient demo-
graphics, recurrence, and survival results were reviewed.
Kaplan-Meier survival plots were generated with statis-
tical comparison made using Log-Rank test.
Results: During the 13 year period, 300 (32%) trans-
planted patients had HCC. 243 (81%) of HCC cases
were diagnosed in the pre-transplant work-up and 210
underwent liver directed therapy prior to OLT. 45
(22.3%) of patients were outside of Milan criteria
before initiation of downstaging (ALTSG stage III –
27; stage IVA1 – 13; Stage IVA- 5). No patient beyond
Milan who failed to downstage underwent OLT. One-,
3-, 5-year overall patient survival in 45 down-staged
cases was 91%, 82.4%, 78.9%, comparable to within-
Milan TACE’d cases (92.9%, 80.8% and 69.3%).One-,
3-, 5-year recurrence-free patient survival in 45 down-
staged cases was 86.5%, 80.4%, 72.6%, also compara-
ble to within-Milan TACEd cases (88.4%, 77.7% and
64.2%). Recurrence rates were 19/249 (7.6%) for
patients undergoing OLT within Milan and 3/45
(6.7%) initially beyond Milan but downstaged.
Conclusions: Liver transplantation remains a highly
effective therapy for patients with HCC, with excellent
long-term survival and low recurrence risk. We believe
patients with HCC beyond Milan criteria should be
required to undergo tumor downstaging with a period
of observation prior to undergoing OLT.
BO08-06
RECENT ADVANCEMENTS AND
PERSPECTIVES OF DONOR
OPERATION IN LIVING DONOR LIVER
TRANSPLANTATION: SINGLE-CENTER
EXPERIENCE OF 886 CASES IN
13 YEARS
Suk-won Suh, Jeong-Moo Lee, Tae Yoo, Youngrok
Choi, Nam-Joon Yi, Kwang-Woong Lee and Kyung-
Suk Suh
Seoul National University Hospital, Korea
Introduction: With the recent increased application of
living donor liver transplantation (LDLT), donor safety
remains an inevitable concern. We sought to address
this issue by investigating recent changes in donor char-
acteristics and clinical outcomes over time in our expe-
rience.
Method: A total of 886 living donors who underwent
donor hepatectomy during 13 years between January
1999 and December 2012 at single center were investi-
gated using our prospectively collected database. Three
groups were divided; group A, initial period (1999–
2004, n = 239), group B, main usage of right-hemi graft
(2005–2010, n = 422), and group C, standardized pro-
tocol including without systemic heparinization and
central catheterization (2011–2012, n = 225). Donor
characteristics and clinical outcomes were compared
and risk factors for donor morbidity were investigated.
Results: Over the three time periods, age over 50 years
(2.5% vs. 4.7% vs. 8.9%, p = 0.007) and right- hemi
graft (51.9% vs. 87.0% vs. 95.1%, p = 0.000) were
increased and operative time (292.7 vs. 290.0 vs.
272.8 min, p = 0.006), hospital stay (12.4 vs. 11.2 vs.
8.5 day, p = 0.000), and overall morbidity rate (26.4%
vs. 13.3% vs. 5.8%, p = 0.000) were reduced. In recent
period, residual liver volume less than 30% (6.5 vs.
13.9 vs. 6.3, p = 0.005) and macrosteatosis (7.9% vs.
11.1% vs. 4.4%, p = 0.014) were reduced. None had
transfused intraoperatively. Most complications were
grade I or II, conservatively resolved and 14 (5.9%)
patients of grade III had treated by intervention or re-
operation without any other complication. There was
no case of irreversible disability or mortality and no
significant risk factors for donor morbidity were identi-
fied.
Conclusions: Donor selection became more lenient and
expanded without any contribution to its morbidity,
while clinical outcomes were imroved. Donor operation
has been standardized with a large volume of experi-
ence and it has a minimal risk. However, morbidity
and mortality maybe inevitable events as long as we
have LDLT programs and constant evaluation of our
experience is key to preparedness for any crisis.
BO09-01
CIRCULATING ENDOTHELIAL
PROGENITOR CELLS AND SOLUBLE
ANGIOGENIC FACTORS
CORRELATION WITH
ARCHITECTURAL GROWTH PATTERN
OF HCC IN SURGICAL PATIENTS
Włodzimierz Otto, Maria Krol, Ewa Wilkowojska,
Ewa Wilczek, Wacaw Hoowko, Janusz Sierdzinski and
Marek Krawczyl
The Medical University of Warsaw, Poland
Introduction: Treatment options of HCC and prognosis
are dependent on tumor staging and condition of the
liver. Tumour grading and architectural growth pattern
are also important but such informations are unavail-
able or are obtained behind the time of decision.
Though, could not help in patients selection for surgery
and palliation. The study evaluated the correlation
between circulating endothelial progenitor cells, soluble
angiogenic factors and architectural growth patterns of
HCC in surgical patients.
Method: The study were carried out on 132 patients
with hepatocellular carcinoma treated in 2009/2012; 46
were suitable for surgery, 45 for liver transplantation
and 41 for non-surgical palliative treatment. The rate
of circulating EPCs defined as CD45dim, 34 + , 133 + ,
309 + was assessed by phenotypic analysis of 2 ml
fresh blood in flow cytometer. Serum VEGF concentra-
tion was measured by enzyme-linked immunoassay
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(ELISA). Tissue samples were obtained from all under-
going surgery, but only from 27 undergoing palliation
(8 deceased, 19 biopsied). The tissue were examined for
architectural growth patterns of HCC, as well as, for
expression of VGEF and VEGFR-2 by immunohisto-
chemical staining with proper monoclonal antibodies
next to the procedure. The data were analyzed by sta-
tistical tests.
Results: There were 47 trabecular (A), 31 tubular (B),
and 40 solid (C) tumors of HCC. There were significant
differences in the rate of circulating EPCs in the blood
of their possessors (ANOVA test, Chisq = 10.07,
p < 0.005). The rate of circulating EPCs correlated with
concentration of VEGF and VEGFR-2 within the
tumor according to growth patterns of HCC (Spear-
man’s rank test: for A r = 0.36, p < 0.001, for B
r = 0.46, p < 0.005, for C r = 0.46, p < 0.001).
Conclusions: Angiogenic capability of the tumor corre-
sponds to architectural growth patterns of HCC. The
results indicate a benefit from evaluation of angiogenic
factors in the course of patients selection to the treat-
ment options.
BO09-02
PROGNOSTIC GENE SIGNATURE OF
HCC PATIENTS FULFILLING MILAN
CRITERIA
Hee-Jung Wang
Ajou University School of Medicine, Korea
Introduction: Because there is a high recurrence risk
after hepatectomy with no effective anticancer regimen,
accurate prognosis prediction in patients with hepato-
cellular carcinoma (HCC) is critical for planning thera-
peutic strategies and achieving better clinical outcome.
To improve patient survival, the best candidates for
each treatment modality must be selected with the aid
of novel prognostic biomarkers. As a first step, we
undertook subclassification of hepatectomized patients
with HCC within Milan criteria using prognostic gene
signature.
Method: We aimed to demonstrate the feasibility of
predicting survival for HCC patients fulfilling the
Milan criteria. A series of 294 HCC tissues from four
institutions were retrospectively analyzed. To discover a
gene-expression signature associated with survival, real-
time PCR analysis was performed with a panel of can-
didate genes.
Results: Starting from 778 archived HCC tissues, high
quality mRNA was acquired from 569 patients, among
which 294 cases were from patients fulfilling the Milan
criteria. Starting from 272 candidate genes from our
earlier proteomic and genomic profiling results and
published literature, the panel of 40 genes was selected
and the expression profiles were analyzed on the train-
ing cohort of 97 patients. The seven most informative
genes for patient prognosis were selected to construct a
risk score for patient survival. When applied to the val-
idation cohorts of 197 patients from four medical insti-
tutions, the risk score was an independent prognostic
factor both as a categorical variable (p = 7.411x104)
and as a continuous variable (p = 7.790 9 105).
Conclusions: We have demonstrated the feasibility of
classifying prognosis for HCC patients fulfilling the
Milan criteria. The challenge for the future is to pre-
cisely determine the specific influence of risk scores in
patient prognosis and to further validate clinical appli-
cability of risk scores including clinical decisions on
liver transplantation.
BO09-03
HIGH LEVEL OF DRG FAMILY
REGULATORY PROTEIN 1 (DFRP1)
SERVES AS A SIGNIFICANT
PROGNOSIS MARKER IN HCC
PATIENTS AFTER SURGERY
RESECTION
Bei-ge JIANG, Li-wei Dong and Wei-ping Zhou
Eastern Hepatobiliary Surgery Hospital, Second
Military Medical University, China
Introduction: DRG family regulatory protein 1
(DFRP1) is highly conserved in eukaryotes and associ-
ated to the active translation machinery. The objective
of the current study was to investigate the clinical sig-
nificance of DFRP1 in HCC and its prognostic values
in predicting survival and tumor recurrence.
Method: We constructed a cohort with 261 HCC
tumor tissues and matched normal tissues from HCC
patients. All of the patients included had defined clini-
copathologic and follow-up data. DFRP1 level was
determined by immunohistochemistry, western blot
analysis, and quantitative polymerase chain reaction.
Association of DFRP1 with HCC-specific disease-free
survival and overall survival was analyzed by Kaplan-
Meier curves, log-rank test and Multivariate Cox
regression analyses.
Results: DFRP1 was expressed in the majority of HCC
cases. High DFRP1 level in HCC was significantly
associated with high serum a-fetoprotein (AFP) level
(>20 ng/ml; p = 0.0064) and vascular invasion
(p = 0.0049). Kaplan-Meier and Cox regression data
indicated that DFRP1 was an independent predictor
for HCC-specific disease-free survival [hazards ratio
(HR), 1.789; 95% confidence interval (95% CI), 1.298–
2.466 (p = 0.0004)] and overall survival [HR, 1.613;
95% CI, 1.120–2.322 (p = 0.0101)]. Cellular experi-
ments validated the interaction of DFRP1 with DRG1,
and further demonstrated that DFRP1 could regulate
tumor cells proliferation in vitro and in vivo.
Conclusions: DFRP1 is an independent prognostic
marker for overall survival and disease-free survival
rates of HCC patients and clinicopathologically associ-
ated with tumor invasion and serum AFP level.
DFRP1 may be a potential therapeutic target for this
aggressive malignancy.
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BO09-04
NOVEL FLUORESCENCE-NAVIGATION
LIVER SURGERY USING ICG-PDE
SYSTEM:TUMOR DIAGNOSIS AND
ANATOMICAL MARKING
Takafumi Abo, Atsushi Nanashima, Junichi Arai,
Katsunori Takagi and Takeshi Nagayasu
Nagasaki University School of Biomedical Sciences,
Japan
Introduction: To improve of diagnosis for occult tumor
localization and define the accurate anatomical area for
resection in the liver, we have applied the novel fluores-
cent diagnosis using the indocyanine green dye-photo-
dynamic eye (ICG-PDE) system during hepatectomy in
108 patients with hepatic tumors accompanied with the
enhanced ultrasonography since 2009.
Method: For tumor detection, 0.5 mg/kg-weight of
ICG was intravenously administrated 2-7 days prior to
hepatectomy for the conventional liver functional test
as a routine test. To define the accurate segmentation
of the liver for anatomical hepatic resections, 0.075 mg/
10 ml of ICG was administrated into the targeted por-
tal vein of the estimated resected area. We often
applied 0.075 mg/10 ml of ICG was administrated into
the bile duct to detect the biliary fistula at the transect-
ed planes. Fluorescence of ICG was precisely detected
by the photodynamic eye infrared-camera.
Results: Detectable liver lesions were 123 nodules dur-
ing hepatectomy. Sensitvity of diagnosis for primary
or metastatic liver tumors was high as 96% and, how-
ever, diagnostic accuracy was lower in the benign
tumor as a hemangioma (Video). The newly detected
liver lesions were observed in 25 lesions in hepatocellu-
lar carcinomas (HCC), in which 3 nodules were histo-
logically diagnosed as HCC. In advanced stage HCC
with portal vein thrombosis, extension of tumor
thrombi was remarkablly detected via portal trunk by
ICG-PDE system (Video), which was quite useful to
remove tumor thrombi. In case of the anatomical hep-
atectomy, marking of ICG-PDE was more significantly
visible in comarison with the conventional dye injec-
tion method (Video). This diagnosctic tool was also
useful to detect the burden of the caudate lobe. Tiny
biliary fistula was sensitively detected by ICG-PDE
system in five cases.
Conclusions: The novel fluoresence-navigation surgery
using ICG-PDE system is a powerful diagnostic tool
during hepatectomy to improve surgical results and
curavility of resections in patients with liver malig-
nancies.
BO09-05
A CLINICOPATHOLOGICAL AND
PROGNOSTIC STUDY OF 3 RARE
PATHOLOGICAL SUBTYPE 78 CASES
OF HEPATOCELLULAR CARCINOMA
Zhiyu LI, Xinyu Bi, Ling Yang, Hong Zhao, Jianjun
Zhao, Zheng Huang, Yefan Zhang and Jianqiang Cai
Cancer Hospital of Chinese Academy of Medical
Science, China
Introduction: To investigate the clinicopathological fea-
tures and prognosis of 3 rare cellular morphological
types of hepatocellular carcinoma(HCC),improving
diagnosis and management of HCC.
Method: A retrospective clinical analysis of 78 rare
pathological subtype HCC cases diagnosed by postop-
erative pathological examination during October 2005
to June 2013. All clinical data were analyzed by statisti-
cal software.
Results: A total 78 cases included clear cell carcinoma
(CCC, n = 43); Giant cell carcinoma (GCC, n = 19);
Sarcomatoid carcinoma (SC, n = 16), The median age
was 57 years. The histologic grade of CCC group is
best among them, 97.7%(42/43) cases were classified as
well or moderately differentiated, 84.2%(16/19) cases of
GCC were classified as poor differentiated; 87.5%(14/
16) cases of SC group were classified as poor differenti-
ated and the rest(12.5%, 2/16)were classified as undif-
ferentiated ; There exist statistically significant
differences (p < 0.01). We found 1 transverse colon
invasion case in GCC group, furthermore, two hilar
lymph nodes metastasis cases and two directly invasion
adjacent organ cases were found in SC group. The sur-
vival analysis revealed that median survival time and
the 1-, 3-, 5-year survival rates for these three groups
were CCC(45 months, 92%, 65%, 45%) > GCC
(13 months, 55%, 30%, 0%)>SC(8 months, 31%, 0%,
0%) respectively, there are statistically significant dif-
ferences (p < 0.01) between each two groups. The histo-
logic grade of tumor cell and the TNM staging were
two independent unfavorable prognostic factors.
Conclusions: Clear cell carcinoma is a rare low degree
malignancy pathological subtype of HCC and may
achieve a relatively optimistic prognosis; However, the
giant cell carcinoma, especially sarcomatoid carcinoma
are two rare high degree malignancy pathological
subtypes of HCC with highly aggressive and poor
prognosis.
BO09-06
OUTCOMES OF UNRESECTABLE
SOLITARY HEPATOCELLULAR
CARCINOMAS SIZED 5 TO 8 CM
TREATED BY RADIOFREQUENCY
ABLATION VERSUS TRANSARTERIAL
CHEMOEMBOLIZATION
Wing Chiu Dai, Tan To Cheung, Kenneth SH Chok,
Albert CY Chan, Simon HY Tsang, See Ching Chan,
Sheung Tat Fan, Chung Mau Lo and Ronnie TP Poon
The University of Hong Kong, Hong Kong, China
Introduction: To compare the efficacy of radiofrequen-
cy ablation (RFA) versus transarterial chemoemboliza-
tion (TACE) in treating large (5–8 cm) unresectable
solitary hepatocellular carcinomas (HCCs).
Method: Retrospective study of a prospectively col-
lected data based on 2750 HCC patients managed at
the Department of Surgery, The University of Hong
Kong between 2003 and 2011 was performed. Among
41 patients who had large unresectable solitary HCCs,
15 patients received RFA and 26 patients received
TACE. The primary endpoint was overall survival and
the secondary endpoints were tumor response, time to
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disease progression, and treatment-related morbidity
and mortality.
Results: The complication rate was 33% in the RFA
group and 19.2% in the TACE group (p = 0.525). In
the RFA group, the complete ablation rate was 80%
and local recurrence rate 6.7%, and the median dis-
ease-free survival was 13 (2.8–38) months. In the
TACE group, there was no complete response whereas
the partial response rate was 15.4%, and the median
time to disease progression was 8 (1–68) months. The
RFA group had a median survival duration of
39.8 months and that in the TACE group was
19.75 months (p = 0.257). The 1-, 2- and 5-year sur-
vival rates were 93.3%, 86.2% and 20.9% respectively
in the RFA group and 73.1%, 40.6% and 18.3%
respectively in the TACE group.
Conclusions: RFA resulted in better initial tumor con-
trol and a higher short-term survival rate, but the two
treatment modalities brought about similar long-term
survival.
BO10-01
HEAD MASSES IN CHRONIC
PANCREATITIS: WHICH FACTORS
INDICATE MALIGNANCY?
KP Manjuraj, Hariharan Ramesh, Mahesh
Subramaniayer, Divakar Jain and Ambady Venugopal
Lakeshore Hospital and Research Center, India
Background: Mass lesions in head of pancreas in the
setting of chronic pancreatitis present a diagnostic and
therapeutic challenge. The present study aims at ana-
lyzing the data of patients with chronic pancreatitis
and head masses to determine preoperative risk factors
for malignancy, to construct a regression equation and
a probability model to identify a cut-off which provides
an acceptable sensitivity and specificity and validate
this prospectively.
Method: The data of patients with chronic pancreatitis
with head masses was retrospectively analyzed. The
patients in the primary analysis group was divided in
two subgroups- malignant on histology and benign on
histology with follow up >3 years. A regression equa-
tion was constructed and it was validated prospectively
in the validation group.
Results: 145 patients were included in the study of
which 105 were included for primary analysis and 40
patients for validation group. Of the primary analysis
group, 52 had histologically proven malignancy and 53
had benign mass. On univariate analysis, gender, age,
symptom duration, weight loss, median bilirubin levels
and median CA 19-9 levels, were found to be statisti-
cally significant. However, on multivariate analysis, bil-
irubin levels, CA 19-9 and weight loss were found to be
statistically significant. A regression equation was con-
structed using the formula: Z = Coefficient (4.2641)
+ (serum bilirubin 9 0.3254) + (CA 19.9 9 0.002545)
+ (wt loss 9 3.3707). Probability = 1/1 + Expz. This
formula was validated in the validation group.
Conclusions: Elevated bilirubin levels, CA 19-9 levels
and weight loss have a strong association with cancer.
A regression score can be calculated. Using a probabil-
ity score of 0.5, malignancy can be predicted with a
sensitivity of 76 and a specificity of 84%. If probability
score is less than 0.2, cancer can be excluded. If proba-
bility score is more than 0.8, cancer is highly likely
(specificity of 99%).
BO10-02
TREATMENT OF PRIMARY AND
METASTATIC SOLID-
PSEUDOPAPILLARY TUMORS
Viacheslav Egorov, Roman Petrov2, Helena Dubova4,
Alexander Schegolev4, Konstantin Pavlov4 and
Melekhina Olga3
Sechenov First State Medical University, Ostroumov
14th City Hospita, Moscowl, Russia; 2Ostroumov 14th
City Hospital, Russia; 3Vishnevsky Institute of Surgery,
Russia; 4Kulakov Federal Research Center of Obstetrics,
Gynecology and Perinatology, Moscow, Russia, Russia
Introduction: Pancreatic solid-pseudopapillary tumor
(SPT) is a rare entity with positive prognosis and
uncertain malignant potential.
Method: The clinical, demographic, imaging, and path-
ologic findings of 23 patients operated for SPT (2005–
2012) were analyzed. Positive immunohistochemical
staining for vimentin, nuclear b-cathenin and e-cadher-
in, a -1-antitrypsin and a -1-antichemotrypsin with neg-
ative reaction for sinaptophisin and chromogranin A
were the diagnostic signs.
Results: The mean age was 37,4 (15–70) years, 22 were
female. The duration of follow-up after the first tumor
detection varied from 0.5 to 17 years. The main symp-
toms were nausea, vomiting and vague abdominal pain.
Tumor markers were normal in all cases. On B-US, CT
and MRI tumor were solid in seven cases. Tumors with
the mean diameter of 7.2 cm (3–15 cm) were located at
the head (12), body (10), and tail (1) of the pancreas.
Surgical procedures included pancreaticoduodenectomy
(12), distal (including combined and extended) pancrea-
tectomy (8) and segmental resection (3). One (4.75%)
had had at presentation and 2(9.5%) patients devel-
oped liver and retroperitoneal metastases in 14 and
60 months after the initial operation, which required
staged hepatectomies, removal of tumor nodules and
repeated arterial liver chemoembolisation. All patients
except one are alive.
Conclusions: In spite of strong believe in low grade
malignant potential of SPT 14% of patient developed
distal metastases. Aggressive surgery for initial and
metastatic SPTs prolongs survival even in disseminated
tumors. In the absence of metastases and tumor inva-
sion in adjacent structures pathohistology is not able to
distinguish a benign SPT from a malignant one.
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BO10-03
AUTOMATED PANCREATIC CYST
SCREENING USING NATURAL
LANGUAGE PROCESSING: A NEW
TOOL IN PANCREATIC CANCER
EARLY DETECTION
Alexandra M Roch, Saeed Mehrabi2, Anand
Krishnan2, Heidi Schmidt, Joseph Kesterson, Chris
Beesley, Paul R Dexter, William M Tierney, Mathew
Palakal2 and C. Max Schmidt
Indiana University School of Medicine, Indianapolis IN,
U.S.A.; 2Indiana University, Indianapolis IN, U.S.A.
Introduction: As many as 3% of CT-scans detect pan-
creatic cysts. Because pancreatic cysts are incidental,
ubiquitous, and poorly understood, follow-up is often
not performed. This is concerning since pancreatic cysts
may have significant malignant potential, and their
identification represents a ‘window of opportunity’ for
early detection of pancreatic cancer. The purpose of
this study was to implement an automated Natural
Language Processing (NLP)-based pancreatic cyst iden-
tification system.
Method: A multidisciplinary team including informati-
cians, hospital administrators, pancreatologists and
pancreatic surgeons was assembled. NLP-based identifi-
cation algorithms were developed based on key words
and acronyms commonly used by physicians to describe
pancreatic cysts. The algorithms were then pro-
grammed for automated search of electronic medical
records (EMR). A pilot study was conducted prospec-
tively in a single institution using EMR of monthly dis-
charged patients. Physicians with expertise in
pancreatic disease retrospectively validated the data,
resulting in an assessment of the system performance.
Results: From March to July 2013, 406,188 reports
belonging to 35,309 consecutive patients were analyzed.
The mean number of patients reported with a pancre-
atic cyst was 90 month (range 80–98). One false nega-
tive was detected and the mean number of false
positives was 2 month, resulting in a sensitivity and
specificity of 99.8% and 97.8% respectively. Of 453
patients recruited in 5 months, 66 (14.6%) harbored a
cyst with malignant potential (i.e. mucinous cyst),
among which 41 (62.1%) were new discovery or never-
followed lesions.
Conclusions: NLP is an effective tool to automatically
identify patients with pancreatic cysts based on EMR.
This inexpensive and highly accurate system can help
capture patients ‘at-risk’ for pancreatic cancer in a reg-
istry and allow for optimal education of both health-
care providers and patients on screening resources
available. Being an adaptable template, this program
may ultimately lead to a more organized national ini-
tiative for pancreatic cancer early detection.
BO10-04
LONG-TERM PROSPECTIVE COHORT
STUDY OF PATIENTS UNDERGOING
PANCREATECTOMY FOR
INTRADUCTAL PAPILLARY
MUCINOUS NEOPLASM OF THE
PANCREAS: IMPLICATIONS FOR
POSTOPERATIVE SURVEILLANCE
Mee Joo Kang, Jin-Young Jang, Kyoung Bun Lee, Ye
Rim Chang, Wooil Kwon, Woohyun Jung and Sun-
Whe Kim
Seoul National University College of Medicine, Korea
Introduction: Little is known about the postoperative
natural history of IPMN, especially about long-term
follow-up results in patients with benign or noninvasive
IPMN. The purpose of this study was to evaluate long-
term follow-up results after surgical treatment of intra-
ductal papillary mucinous neoplasm (IPMN) in order
to optimize postoperative surveillance strategies.
Method: Long-term follow-up was monitored in a pro-
spective cohort of 403 consecutive patients who under-
went surgical treatment for IPMN at Seoul National
University Hospital. Of these, 37 patients with ductal
adenocarcinoma associated IPMN was excluded from
analysis.
Results: Of the 366 patients, 82 had low-, 171 had
intermediate-, and 45 had high-grade dysplasia, and 68
had IPMN with associated invasive carcinoma. During
a median follow-up of 44.4 months, the overall recur-
rence rate was 10.7%. Pathologic grade of dysplasia
was associated with recurrence rate (p < 0.001). IPMN
involving main duct had higher rate of recurrence
(p = 0.021). Of the 298 patients with benign or nonin-
vasive IPMN, 16 (5.4%) had recurrences including dis-
tant metastasis. Multivariate analysis revealed that
degree of dysplasia was the most important predictor
of recurrence (p < 0.001). The overall 5-year disease
free survival rate (DFS) was 78.9%, and was signifi-
cantly lower in patients with high- than low- or inter-
mediate-grade dysplasia (p = 0.045).
Conclusions: Pancreatic IPMNs recur in 10.7% of
patients. Recurrence is correlated with degree of dys-
plasia, and 5.4% of patients with benign or noninvasive
IPMN have recurrences including distant metastasis.
Thorough postoperative surveillance is needed not only
for patients with invasive IPMN but also those with
benign or noninvasive IPMN, especially for patients
with high grade dysplasia.
BO10-05
OBSERVATIONAL COHORT ANALYSIS
OF THE INCIDENCE OF
EXTRAPANCREATIC NEOPLASMS AND
PANCREATIC CANCER IN PATIENTS
WITH BRANCH-DUCT INTRADUCTAL
PAPILLARY MUCINOUS NEOPLASIA
Giuseppe Malleo, Alex Borin, Federico Accordini,
Giovanni Marchegiani, Tiziana Marchese, Giovanni
Butturini, Claudio Bassi and Roberto Salvia
Unit of Surgery B, The Pancreas Institute, Italy
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Introduction: The relationship between intraductal pap-
illary mucinous neoplasms (IPMN), extra-pancreatic
and pancreatic carcinogenesis is controversial. The pri-
mary objective of this observation cohort analysis was
to assess the incidence of extra-pancreatic neoplasms
(EPN) and pancreatic ductal adenocarcinoma (PDAC)
in patients with branch-duct IPMN who were managed
conservatively.
Method: Patients with well-documented branch duct
IPMN on cross-sectional imaging (first observation on
January 2000), and devoid of malignancy concern were
enrolled in a surveillance protocol. Patients with a per-
sonal history of an EPN, with a synchronous tumor, or
with a follow-up <12 months were excluded from the
analysis. The incidence of EPN and of PDAC during
follow-up was compared with the Italian tumor regis-
try. In particular, the number of expected cases was
calculated, and the standardized incidence ratio (SIR)
with 95% CI was obtained. Risk function for the devel-
opment of EPN and PDAC was also plotted.
Results: The study cohort consisted of 437 patients
(median follow-up of 49 months). Thirty-four new neo-
plasms were observed, with a median time-to-diagnosis
of 38 months. Cumulate incidence of EPN was 7.3%,
the SIR was 1.78 (95% CI 1.23–2.48). The incidence
was significantly greater for gastric, esophageal, lung
and prostate cancer in males, and for colorectal cancer,
breast cancer and melanoma in females. The risk of
developing an EPN increased over time (5 years = 8%).
Eight patients developed a PDAC (cumulate incidence
1.8%). The median time-to-diagnosis was 29 months,
the SIR was 10.7 (95% CI 3.15–31.31) in males and
12.2 (95% CI 3.93–28.46) in females. The risk of devel-
oping a PDAC increased over time (5 years = 2%).
Conclusions: As compared with the control population,
patients with branch duct IPMN managed conserva-
tively harbor an increased incidence of EPN and
PDAC during follow-up. However, the 5-year risk of
PDAC (2%) equals postoperative mortality for major
pancreatic resections at high-volume insitutions.
BO10-06
VALIDATION OF THE SENDAI
CONSENSUS GUIDELINES FOR
BRANCH-DUCT INTRADUCTAL
PAPILLARY MUCINOUS NEOPLASMS:
A SYSTEMATIC REVIEW
Brian Goh, Damien Tan, Alexander Chung and
London Ooi
Singapore General Hospital, Singapore
Introduction: The SCG was formulated in 2006 to
guide management of IPMN. The main area of contro-
versy is the criteria for selection of BD-IPMN for
resection. Although these guidelines have gained wide-
spread acceptance, there is limited data to date sup-
porting its use.This systematic review is performed to
validate the Sendai Consensus Guidelines (SCG) for
branch-duct intraductal papillary mucinous neoplasm
(BD-IPMN).
Method: Studies evaluating the clinical utility of the
SCG in surgically resected neoplasms were identified.
BD-IPMNs which met criteria for resection were
termed SCG+ve and those for surveillance were termed
SCG-ve.
Results: Eleven studies were included of which 8 were
suitable for pooled analysis. There were 651 surgically-
resected BD-IPMNs of which 24% were malignant. 473
BD-IPMNs were classified as SCG +ve and 178 were
SCG ve. The overall PPV of SCG +ve neoplasms was
29% and the NPV of SCG-ve neopalsms was 90%.
There were 18 reported malignant (11 invasive) BD-IP-
MNs in the SCG-ve group of which 17 (including all
11 invasive) were from a single study.
Conclusions: The SCG for BD-IPMN needs to be
revised. The PPV of these guidelines in predicting a
malignant BD-IPMN is low but more worryingly,
malignant BD-IPMNs may be missed based on these
guidelines.
BO11-01
ROLE OF ENDOSCOPIC
ULTRASONOGRAPHY IN THE
ASSESSMENT OF 16B1 LYMPHNODE
IN GALLBLADDER CANCER
MN Saravanan, Raja Kalayarasan, Amit Javed,
Pramod Garg2 and Anil Agarwal
GB Pant Hospital and MAM College, India; 2All India
Institute of Medical Sciences, India
Introduction: Involvement of the 16b1 (interaortocaval)
lymphnode (LN) in gallbladder cancer(GBC) is consid-
ered to represent metastatic disease.. IAC nodes are dif-
ficult to target percutaneously, especially when small.
Routine frozen-section histopathological examination
(HPE) of the 16b1 LN is advocated at laparotomy
before proceeding for radical cholecystectomy. Endo-
scopic Ultrasonography(EUS) is a good modality to
visualise the interaortocaval region. We prospectively
evaluated EUS in assessing 16b1 lymphnode and
thereby avoid laparotomy in cases positive on HPE.
Method: Prospective analysis from January2012 to
July2013 of patients of GBC with IAC nodes reported
on on US/CT,but not amenable for image guided
FNAC. EUS was performed in all patients to look for
IAC lymphnodes and perform FNAC of nodes
detected. EUS outcome was correlated with clinical,
imaging, surgical and histopathological findings.
Results: Of the nineteen patients who underwent EUS ,
no IAC node was identifiable in 5 patients. Of the
remaining 14,13 underwent EUS FNA of IAC node
successfully. Of these, 11 were positive for malignancy
and laparoscopy/laparotomy was avoided. Of the 2
IAC FNA negative, one proceeded to definitive surgery
while in the other, peritoneal deposits were detected on
staging Laparoscopy(SL).
Of the 5patients with no LN on EUS, 4 proceeded for
definitive surgery after SL and intraoperative IAC node
sampling with frozen section; while in one patient, SL
precluded surgery in view of discontiguous liver depos-
its. During the definitive surgery in the 4 patients, in-
traoperative frozen section of subcentimetric IAC node
was negative for malignancy. EUS corroborated well in
© 2014 The Authors
HPB © 2014 Americas Hepato-Pancreato-Biliary Association HPB 2014, 16 (Suppl. 2), 76–127
100 Best Oral
16 (84.21%) patients (2 not evaluated) and avoided a
non-therapeutic laparotomy in 57.9% patients.
Conclusions: Endoscopic Ultasonography is an extre-
mely useful modality to assess involvement of the 16b1
(interaortocaval) lymph node in gallbladder cancer and
thereby avoid non therapeutic laparotomy in significant
proportion of patients.
BO11-02
INCIDENTAL GALLBLADDER CANCER
DIAGNOSED AFTER
CHOLECYSTECTOMY – A
MULTICENTER STUDY
Seigo Hiratani, Ryusei Matsuyama, Koichi Taniguchi,
Ryutaro Mori, Kazunori Nojiri, Takafumi Kumamoto,
Kazuhisa Takeda, Kuniya Tanaka and Itaru Endo
Yokohama City University, Japan
Introduction: Cancer of the gallbladder is often discov-
ered incidentally during or after cholecystectomy and it
is called incidental gallbladder cancer (IGBC). The
aims of this study are to clarify the clinicopathological
factors of IGBC patients and the effectiveness of a rad-
ical second operation in the treatment of IGBC retro-
spectively.
Method: Cholecystectomy was performed on 6,775
patients during the recent 10-year period at 12 institu-
tions belonging to Yokohama Clinical Oncology Group
(YCOG). We conducted a questionnaire survey regard-
ing IBGC cases. Data on clinicopathological factors,
operative details, TNM tumor stage, and outcome were
collected and analyzed.
Results: Of all these patients, 70 (1.03%) were histo-
pathologically diagnosed as having a IGBC. The tumor
stages were: pT1a (19), pT1b (5), pT2 (35), and pT3
(11). Twenty four (34.2%) patients underwent re-resec-
tion.The most common complete procedure (58% of
re-resected cases) was gallbladder bed resection with
lymphadenectomy. Bile duct resection was performed
in 11 (46% of re-resected cases) patients. No patient
underwent re-resection in pT1a and pT1b patients. The
3-year and 5-year cumulative survival rate were 100%
and 100% in the pT1a and pT1b patients, 62.8% and
51.6% in the pT2 patients and 9.1% and 0% in the
pT3 patients respectively. Re-resection significantly
increased survival in patients with pT2 disease
(p = 0.038). Multivariate analysis revealed that pT3
stage and bile leakage were an independent prognostic
factor of disease-specific survival. Range of hepatec-
tomy and additional bile duct resection in re-resection
did not influenced on disease-specific survival.
Conclusions: Re-resection for advanced IGBC have a
clear therapeutic effect in pT2 patients especially. There
is currently a modification in the surgical procedure of
IGBC, with gallbladder resection and lymph node dis-
section without bile duct resection.
BO11-03
ANALYSIS OF SURVIVAL AND
RECURRENCE PATTERNS AFTER
CURATIVE RESECTION IN T2
GALLBLADDER CANCER ACCORDING
TO THE TUMOR LOCATION (LIVER
SIDE VS SEROSA SIDE)
Woohyun Jung, Jin-Young Jang, Mee Joo Kang,
Wooil Kwon, Ye Rim Chang and Sun-Whe Kim
Seoul National University College of Medicine, Korea
Introduction: Extended cholecystectomy (EC) is gener-
ally recommended for T2 gallbladder (GB) cancer.
However, lymphatic and venous drainage may be dif-
ferent according to anatomic area of GB cancer. Espe-
cially there is rare evidence to support liver bed
resection is needed for serosa side GB cancer over T2.
The aim of this study is to clarify the role of EC in T2
GB cancer according to tumor location.
Method: Clinicopathologic features, extents of resec-
tion, survival rates, and recurrence patterns of 102
pathologically confirmed T2 GB cancer patients were
retrospectively investigated.
Results: The mean age was 64.9 years, 58.8% were
female and 23 patients underwent simple cholecystec-
tomy (SC) and 79 underwent EC. The 5-year disease
free survival rate (5DFS) of resected T2 GB cancer
patients was 74.4%. SC showed significantly poorer
survival rate than EC (5DFS, 55.1% vs. 79.5%;
p = 0.012). LN metastasis was also associated with
poor outcome (5DFS, 56.5% vs. 87.4%; p < 0.001). In
multivariate analysis, SC (95% CI, 1.074–9.868;
p = 0.037), and LN metastasis (95% CI, 1.497–10.560;
p = 0.006) were independent risk factors of poor sur-
vival.
The clinicopathologic features (including resection
extents and LN metastasis) according to tumor location
were not different. The survival rates were not associ-
ated with tumor location (5DFS, 76.7% (liver side) vs.
69.2% (serosa side); p = 0.697). SC group in serosa side
tumor showed particularly lower survival than EC
group (5DFS, 22.2% vs. 79.5%; p = 0.001). The recur-
rence rate according to tumor location was not differ-
ent but SC group in serosa side tumor showed higher
recurrence rate (57.1% vs. 17.4%; p = 0.060).
Conclusions: LN metastasis and SC group showed sig-
nificantly poorer survival rate in T2 GB cancer. The
location of tumor was not associated with survival and
recurrence rate. But, SC for serosa side tumor showed
significantly lower survival and higher recurrence ten-
dency. In conclusion, EC is recommended for T2 GB
cancer patients regardless of tumor location.
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BO11-04
VALIDATION OF THE 2012/2013
UPDATED KOREAN PRACTICAL
GUIDELINES FOR SURGICAL
TREATMENT OF THE GALLBLADDER
CANCER BY USING SINGLE-CENTER
EXPERIENCE OF 500 CASES
Gil Chun Park, Shin Hwang, Ki-Hun Kim, Youngjoo
Lee, Chulsoo Ahn, Deokbog Moon, Kwangmin Park
and Sung-Gyu Lee
Asan Medical Center, Ulsan University, Korea
Introduction: Surgical treatment of the gallbladder can-
cers has not been reliably standardized yet due to
diverse oncologic features, thus the Korean practical
guidelines are updated in year 2012/2013. Since they
were prepared with extensive literature review, it is
worthy of validating them with clinical data of large-
volume single-center experience.
Method: The draft concepts of Korean practical guide-
lines for surgical treatment of the gallbladder cancer
were validated by analyzing the profiles of 500 gallblad-
der cancer patients undergone surgical resection in
Asan Medical Center. Their medial records were
reviewed retrospectively according to the guideline sug-
gestions.
Results: Median patient age was 63 years and the
upper quartile was 70 years. R0 resection was achieved
in 73%. During postoperative follow-up, 21% of
patients were lost at a median follow-up period of
21 months. For pT1aNx lesions, the 5-year survival
rate (5-YSR) was 91%. For pT1bNx lesions, 5-YSR
was around 70%, which was not different in both open
and laparoscopic cholecystectomy groups, but that of
extended cholecystectomy group was 78%, which impli-
cating the potential benefit of re-do resection. For
pT2N0 lesions, 5-YSR was 62% after R0 resection,
showing no survival difference depending on concur-
rent resection of the extrahepatic bile duct. For stage 3
lesions, 5-YSR was 32% after R0 resection and 11%
after R1 resection. For stage 4 lesions, 5-YSR was 26%
after R0 resection and 0% after R1 resection.
Conclusions: Considering that a considerable propor-
tion of very old-aged patients showed a lower compli-
ance on long-term follow-up as well as a higher
incidence of cancer-unrelated death in such age group,
the overall survival outcome should be adjusted espe-
cially in patients with T1 and T2 lesions. The main
pathways of lymph node metastasis and prognostic sig-
nificance of lymphovascular and neural invasion should
be taken into account prudently during individualized
planning for surgical treatment.
BO11-05
IS LOCAL RESECTION ADEQUATE
FOR T1 STAGE AMPULLARY CANCER?
John Miura, John Miura, Thejus Jayakrishnan, Fabian
Johnston, Susan Tsai, Kathleen Christians, Clark
Gamblin and Kiran Turaga
Medical College of Wisconsin, U.S.A.
Introduction: Concerns for morbidity of a pancreatico-
duodenectomy (PD) has led to practitioners adopting
endoscopic resection only or ampullectomy without
lymphadenectomy in the treatment of early stage
ampullary tumors. We hypothesized that survival for
patients undergoing local resection of ampullary
tumors was inferior to those undergoing PD.
Method: All patients with ampullary cancer reported in
the Surveillance, Epidemiology, and End Results data-
base between 2004 and 2010 were collected. Demo-
graphic features, distribution of histological types,
adjuvant radiation and 5-year survival rates according
to nodal disease and histologic type were compared.
Results: There were 1916 cases of ampullary cancer
and 421 (22%) had T1 disease. Among the patients
with T1 disease, 217 (51%) received no surgery (endo-
scopic treatment or biopsy only), 21 (5%) underwent
ampullectomy alone, 20 (5%) underwent ampullectomy
with regional lymphadenectomy, and 163 (39%) under-
went radical resection (PD). For patients with complete
nodal staging (PD), 23% had metastatic disease in the
nodes. Grade was significantly associated with node
positivity with 10% positivity in well differentiated
(n = 61), 12% in moderately (n = 163), and 27% in
poorly differentiated tumors (n = 85, p = 0.007). Node
positivity was significantly associated with a worse sur-
vival (HR 2.2 (95% CI 1.3–3.8, p = 0.003) in multivari-
ate models after adjusting for radiation and
demographic characteristics. Survival was improved
with either an ampullectomy with regional lymphaden-
ectomy (HR 0.16 (95% CI 0.08–0.03, p < 0.001) or a
PD (HR 0.26 (95% CI 0.15–0.44, p < 0.001)).
Conclusions: Patients with early stage ampullary cancer
have a high risk for nodal metastases especially if they
are higher grade lesions. Nodal clearance with a regio-
nal lymphadenectomy or a PD is essential to ensuring
long term survival for these patients.
BO11-06
10-YEAR EXPERIENCE OF SURGICAL
RESECTION WITH AMPULLA OF
VATER MALIGNANCY IN A SINGLE
INSTITUTION : SURGICAL AND
ONCOLOGIC RESULTS
Myung Jae Jung, Chang Moo Kang, Kyung Sik Kim,
Ho Kyung Whang, Sunghoon Choi, Jin sub Choi and
Woo Jung Lee
Severance Hospital, Yonsei University, Korea
Introduction: Ampulla of vater cancer is known to
show relatively good prognosis than other peri-ampul-
lary malignancies. We performed surgical resection
more than twenty patients with ampulla of vater cancer
annually. We evaluated our surgical and oncologic out-
comes for 10-years consequetive.
Method: All patients who underwent surgical resection
for ampulla of vater malignancy at Yonsei University
Severance Hospital between Jan 2003 and Dec 2012
were studied. Medical records were retrospectively
reviewed and all patients were classified as staging by
7th AJCC classification system.
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Surgical and oncologic results were evaluated including
perioperative morbidity, mortality and overall 5-year
survivals.
Results: Between January 2003 and December 2012,
199 patients underwent surgical resection with ampulla
of vater cancer. The mean age of the patients was
60.0 + 10.3 years, with 57% being male and 43 female.
PPPD was performed in 90.1%, conventional Whipple
in 4.3%, and transduodenal ampullectomy in 5.6%.
Pathologic staging was identified as stage IA 13%,
stage IB 16.3%, stage IIA 18.7%, Stage IIB 20.5%,
Stage III 23.5%, and stage IV 2.3%.
The overall 5-year survival for all patients was 57%,
and 5YRS by each stage were 93% in stage I, 82% in
stage II, 37% in stage III and 5% in stage IV disease.
Conclusions: Ampulla of vater cancer showed relative
good oncologic outcome with low significant complica-
tions in our experience. Furthermore In selective cases,
transduodenal ampullectomy can be safe treatment
option for early lesions. Further study is needed for
make a treatment guidelines of ampulla of vater malig-
nancy.
BO12-01
MULTIDISCIPLINARY TREATMENT
FOR UNRESECTABLE PANCREATIC
CANCER
Kanji Katayama1, Makoto Murakami2, Mitsuhiro
Morikawa2, Kenji Koneri2, Yasuo Hirono2, Takanori
Goi2, Atsushi Iida2 and Akio Yamaguchi2
1University of Fukui, Japan; 2University of Fukui, Japan
Introduction: Most cases of pancreatic cancer have
reached advanced stage when first diagnosed so most
of them are unresectable. Since 1988, we have per-
formed multidisciplinary treatment (MDT) including an
operation, intra-operative irradiation (IOR), RF-
Hyperthermia (RF-HT), and chemotherapy for such
cases.
Method: Of all 251 cases of invasive ductal pancreatic
cancer, Curative resection was performed on 73
patients (Cur Group) and 19 of locally advanced were
resected but was non-curative resections (Non-C
group). Of all unresectable cases, 39 with only locally
advanced underwent MDT (MDT Group). If unresec-
table, IOR and by-pass operations were performed.
The tumor was located at just below abdominal wall,
improving the heating efficacy and the safety of extra-
corporeal radiation. Two weeks after, extra-corporeal
irradiation and then RF-HT with Thermotron RF-8
followed with CDDP and MMC iv. RF-HT was car-
ried out once a week and carried out for 3 to 4 ses-
sions.
Results: Heating over 1000 W by Thermotron RF-8,
and monitoring the tumor temperature are important
to heat successfully. The tumor of 25 patients of MDT
group diminished. Pain was relieved in 27 of 30. The
MST of MDT group was 19.8 mo. and the longest 96
mo. MST of the Cur. Group and the Non-C. group
were 20.8 and 13.2 mo. The quality of life of groups
after treatment, that of MDT group surpassed that of
the Non-C. group.
Conclusions: By MDT, we could control the local dis-
ease and prolonged the survival of patients with locally
unresectable pancreatic cancer.
BO12-02
ORAL S-1 WITH CONCURRENT
RADIOTHERAPY VERSUS S-1 ALONE
IN PATIENTS WITH LOCALLY
UNRESECTABLE PANCREATIC
CANCER
Hiroyuki SHINCHI1, Sonshin Takao2, Kosei
Maemura1, Yuko Mataki1, Hiroshi Kurahara1,
Kiyokazu Hiwatashi1, Satoshi Ino1, Masahiko
Sakoda1, Shinichi Ueno1 and Shoji Natsugoe1
1Kagoshima University Faculty of Medicine, Japan;
2Kagoshima University, Japan
Introduction: S-1 is a new oral fluoropyrimidine anti-
cancer agent shown to be effective for pancreatic can-
cer. In a previous phase I and phase II trial, we have
confirmed the efficacy and safety of S-1 combined with
radiotherapy in patients with locally advanced and un-
resectable pancreatic cancer (Br J Cancer 2007; JHBP
Sciences 2012). This randomized phase III trial was
conducted to evaluate the survival benefit of S-1 com-
bined with radiotherapy compared to S-1 alone.
Method: Eligible patients had locally advanced and un-
resectable pancreatic cancer without distant metastases,
an ECOG performance status of 0–1, and no prior
anticancer therapy. Patients were randomized to receive
S-1 combined with radiotherapy versus S-1 alone. S-1
was given orally at a dose of 80 mg/m2/day twice daily
on days 1 to 21 in both groups. Radiotherapy was
delivered in fractions of 1.25 Gy twice daily, 5 days per
week for 4 weeks (total dose: 50 Gy in 40 fractions). In
both groups, S-1 was administered for 14 days followed
by a 14-day rest period as maintenance therapy. The
primary endpoint was overall survival.
Results: A total of 40 patients were enrolled. Twenty
patients received S-1 combined with radiotherapy, and
20 patients received S-1 alone. There was no treatment-
related death or grade 4 toxicity in the both groups.
Median overall survival of 19.7 months in the S-1 with
radiotherapy group was better than 14.9 months in the
S-1 alone group (p = 0.073). Survival rates at 1 and
2 years were 79% and 32% in the S-1 with radiother-
apy group and 67% and 10% in the S-1 alone group,
respectively.
Conclusions: Combination therapy with S-1 and radia-
tion is considered a promising, well-tolerated regimen
that can be recommended as a more effective treatment
compared to S-1 alone for locally advanced pancreatic
cancer.
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BO12-03
LONG-TERM SURVIVAL AND
PREVENTION OF LIVER METASTASES
AFTER RESECTION FOR NON-
PANCREATIC PERIAMPULLARY
CANCER FOLLOWED BY ADJUVANT
INTRA-ARTERIAL CHEMOTHERAPY
Joris Erdmann, Marjolein Morak, Hugo
Duivevoorden2, Herman Dekken van3, Geert
Kazemier4, Niels Kok and Casper Eijck van
ErasmusMC, Netherlands; 2Statistician, Netherlands;
3ErasmusMC, Netherlands; 4VUMC, Netherlands
Introduction: In pursuit of improvement of survival
after surgery for pancreatic and non-pancreatic periam-
pullary cancer, several randomized trials have been
conducted offering adjuvant chemotherapy with or
without concomitant radiotherapy. This has led to the
consensus that for pancreatic cancer gemcitabine based
chemotherapy is of benefit. For non-pancreatic periam-
pullary cancers no proven adjuvant therapy is currently
available. Aim of this study was to compare the effect
on suvival of adjuvant intra-arterial chemotherapy with
concomitant radiotherapy (CAI/RT) to surgery alone
in a randomised controlled trial.
Method: After resecton 120 patients were were random-
ized into two groups: CAI/RT or surgery alone and
stratified for tumor origin (pancreatic or non-pancreatic
periampullary adenocarcinoma). We now present the
data after complete 5-year follow-up of all patients.
Results: Long-term survival (>60 months) was
observed in 19 patients. CAI/RT did not influence sur-
vival for pancreatic cancer (20 vs. 21 months p = 0.9),
For CAI/RT in non-pancreatic periampullary cancers,
median survival was 37 vs. 28 months and a doubling
of the number of long-term survivors from 5 to 10 was
seen. Interestingly, occurrence of livermetastases was
also reduced by CAI/RT, from 57% to 29% (p = 0.04).
Cox regression revealed a substantial effect of CAI/RT
on survival (hazard ratio 0.436, 95% CI: 0.231–0.825,
p = 0.01).The other independent factor was differentia-
tion grade: p < 0.01 (hazard ratio 2.548 (95% CI:
1.529–4.242).
Conclusion: This long term-analysis shows that for non-
pancreatic periampullary cancers median and long-term
survival is improved after CAI/RT, probably because of
the effective reduction of livermetastases. These results
advocate further investigation of this concept.
BO12-04
A COMPARISON OF SURGICAL
RESULTS FOLLOWING NEO-
ADJUVANT THERAPY IN PATIENTS
WITH PANCREATIC CANCER:
CHEMORADIATION VS.
CHEMOTHERAPY
Sohei Satoi, Tomohisa Yamamoto, Hiroaki
Yamamoto, Hideyoshi Toyokawa, Satoshi Hirooka, So
Yamaki, Hironori Ryota, Taku Michiura, Kentaro
Inoue and A-Hon Kwon
Kansai Medical Univeristy, Japan
Introduction: Our objective was to compare short-term
surgical results in pancreatic cancer patients who
underwent surgical resection after neo-adjuvant chemo-
radiation therapy (NACRT) or chemotherapy (NAC).
Method: The study population comprised 54 patients
with UICC T3/4 pancreatic cancer. All patients had
pathological evidence of pancreatic ductal adenocarci-
noma before starting chemotherapy. In the NACRT
group, 35 patients underwent S-1 80 mg/m2 administra-
tion concomitant with external radiation therapy of
50.4 Gy followed by pancreatectomy with nerve plexus
resection in all patients. In the NAC group, 19 patients
underwent Gemcitabine 1000 mg/m2+S-1 80 mg/m2 fol-
lowed by pancreatectomy with nerve plexus resection
as needed for curative resection.
Results: Neo-adjuvant therapy was completed in 97%
of NACRT and 84% of NAC patients, but Grade 3/4
adverse events (mostly hematologic) occurred signifi-
cantly less frequently in NACRT than in NAC (29%
vs. 68%, p = 0.009). Clinical response rates were 17%
in NACRT and 21% in NAC. Borderline resectable
status was found in 51% of NACRT and 53% of
NAC. Although portal vein resection was done in 54%
of NACRT and 53% of NAC, operative time was
longer in NACRT than in NAC (p = 0.008). There was
no significant difference in R0 resection rate between
the two groups (91% vs. 79%), but the rate of negative
lymph node metastasis was significantly higher in
NACRT than in NAC (49% vs. 16%, p = 0.021). A
significantly higher rate of Evans grade≥IIB was found
in NACRT relative to NAC (29% vs. 0%, p = 0.010).
However, high rates of intractable diarrhea and ascites
in NACRT were observed, resulting in significantly less
relative dose intensity of adjuvant chemotherapy.
Conclusions: Both regimens are feasible and safe.
NACRT was superior in local control, but development
of postoperative diarrhea and ascites may inhibit com-
pletion of adjuvant chemotherapy.
BO12-05
SURVIVAL OUTCOME OF
NEOADJUVANT CHEMORADIATION
THERAPY FOLLOWED BY
PANCREATECTOMY IN LEFT-SIDED
PANCREATIC CANCER
Ho Kyoung Hwang, Sung Hwan Lee, Sung Hoon
Choi, Chang Moo Kang and Woo Jung Lee
Yonsei University College of Medicine, Korea
Introduction: Neoadjuvant chemoradiation therapy
(Neo-CRTx) could give survival benefit in above bor-
derline resectable pancreatic cancer patients. In this
study, we focused on left-sided pancreatic cancer to
analyze survival outcome of patients who underwent
curative distal pancreatectomy with splenectomy(DPS)
after Neo-CRTx.
Method: From July 1992 to October. 2012, 83 patients
who underwent DPS for left-sided pancreatic adenocar-
cinoma were enrolled. 65 patients underwent DPS with-
out Neo-CRTx (Neo-CRTx(-) group) and 18 patients
underwent DPS after Neo-CRTx (Neo-CRTx(+) group).
Clinicopathologic features and survival outcomes were
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evaluated with retrospective analysis between two
groups.
Results: Fourty-eight patients were male and 35 were
female with a mean age of 61.5  9.4 years. Open pro-
cedure was done in 69 patients(83.1%) and minimally
invasive(laparoscopic or Robotis) DPS was done in 14
patients(16.9%). Preoperative resectabilities based on
image studies were different between two groups
(resectable : Borderline : Locally advanced = 89.2%:
6.2%:4.6% in Neo-CRT(-) group, vs. 50%:22.2%:27.8
% in Neo-CRTx(+) group, p = 0.001). Curative resec-
tion (R0) rate was 90.8% in Neo-CRTx(-) group and
83.3% in Neo-CRTx(+) group (p = 0.668). Combined
vascular resection (0 vs. 11.1%, p = 0.045) and organ
resection (20% vs. 50%, p = 0.011) were more fre-
quently done in Neo-CRTx(+) group. Other clinico-
pathologic parameters including TNM stage,
lymphovascular invasion, perineural invasion, tumor
size, CA19-9, histologic grade, operation time, and
operative methods were similar between two groups. In
Neo-CRTx(+) group, two patients(11.1%) were reveled
complete tumor remission in pathologic reports. Over-
all survival (Neo-CRTx(-) vs. Neo-CRTx(+), median
survival time(months): 25.0  4.8 vs. 22  4.3,
p = 0.559) and disease free survival were not different
in two groups (10.0  1.6 vs. 6  2.1, p = 0.334).
Conclusions: Even preoperative image studies showed
borderline or locally advanced stage in left-sided pan-
creatic cancer patients, Neo-CRTx can give chances to
take R0 resection and similar survival outcomes com-
pared with resectable stage.
BO12-06
PROGNOSTIC FACTORS AFTER
SURGICAL RESECTION OF
PANCREATIC DUCTAL
ADENOCARCINOMA
Ki Byung Song1, Song Cheol Kim1, Young Soo
Chung2, Young-Joo Lee1, Kwang-Min Park1, Jae
Hoon Lee1, Jeong Su Nam1, Jong Hee Yoon1, Dong
Joo Lee1 and Jung Woo Lee1
1Asan Medical Center, Ulsan University, Korea; 2Busan
National University Hospital, Korea
Introduction: The prognosis of pancreatic ductal adeno-
carcinoma (PDAC) remains very poor. We performed
large scale retrospective analysis to assess the factors
associated with favorable prognosis of PDAC.
Method: Between January, 2000 and December, 2011,
a total of 1000 patients with PDAC underwent pancre-
atic resection with curative intent at Asan Medical Cen-
ter. The characteristics of patients and tumor and
surgery-related factors were analyzed to evaluate prog-
nostic factors.
Results: One thousand patients who had a pancreatic
resection and a pathologic diagnosis of PDAC were
analyzed. Median survival time was 19 months. Overall
1-year, 2-year, 3-year and 5-year survival rate were
68.3%, 39.3%, 28.0% and 21.5%, respectively. Age
over 70, total pancreatectomy, presence of symptoms,
CA19-9 > 37 U/ml, Albumin < 3.3 g/dl, portal vein
resection, tumor size > 2 cm, poor tumor differentia-
tion, positive lymph node, lymphovascular invasion,
perineural invasion and no adjuvant therapy were inde-
pendently associated with survival differences in a mul-
tivariate Cox proportional hazards model.
Conclusions: Favorable prognostic factors of PDAC
after resection are the patients with good peri-operative
performance status, early stages of PDAC, and adju-
vant therapy.
BO13-01
POSTOPERATIVE ADVERSE
OUTCOMES IN PATIENTS WITH LIVER
CIRRHOSIS RECEIVING NON-HEPATIC
SURGERY: A NATIONWIDE
POPULATION-BASED STUDY
Chien-Chang Liao1, Ta-Liang Chen1 and Chao-Shun
Lin2
1Taipei Medical University, Taiwan; 2Department of
Anesthesiology, Taiwan
Introduction: The global feature of postoperative out-
comes in cirrhotic patients was unavailable. We aimed
to evaluate the influence of liver cirrhosis and associ-
ated clinical scenarios on postoperative outcomes after
non-hepatic surgery.
Method: We used insurance claims data to identify
patients with preoperative liver cirrhosis who under-
went non-hepatic surgery between 2004 and 2007. For
cirrhotic cases, non-cirrhotic controls matched by age,
sex, types of surgery and anesthesia were randomly
selected. The adjusted odds ratios (ORs) and 95% con-
fidence intervals (CIs) of postoperative adverse events
associated with liver cirrhosis were calculated in the
multivariate logistic regressions.
Results: In 24,282 surgical patients with liver cirrhosis
and 97,128 non-cirrhosis controls, liver cirrhosis was
associated with 30-day postoperative mortality
(OR = 1.88; 95% CI: 1.63–2.16), acute renal failure
(OR = 1.52; 95% CI: 1.34–1.74), septicemia
(OR = 1.42; 95% CI: 1.33–1.51), and intensive care
unit stay (OR = 1.39; 95% CI: 1.33–1.45) after non-
hepatic surgery. Patients with cirrhosis-related clinical
indicators facing increased 30-day postoperative mor-
tality included those with viral hepatitis (OR = 2.87;
95% CI: 1.55–5.30), alcohol dependence syndrome
(OR = 3.74; 95% CI: 2.64–5.31), jaundice (OR = 5.47;
95% CI: 3.77–7.93), ascites (OR = 5.85; 95% CI: 4.62–
7.41), gastrointestinal hemorrhage (OR = 3.01; 95%
CI: 2.33–3.90), and hepatic coma (OR = 5.11; 95% CI:
3.79–6.87).
Conclusions: Patients with liver cirrhosis undergoing
non-hepatic surgery had increased postoperative mor-
tality and complications, particularly cirrhotic patients
with cirrhosis-related clinical indicators. Preoperative
optimization to correct cirrhosis-related risk factors is
important in improving postoperative outcomes in cir-
rhotic patients.
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BO13-02
MORTALITY AND RELATED RISK
FACTORS OF 4460 LIVER RESECTIONS
IN SWEDEN BETWEEN 2002-2011 - A
POPULATION-BASED STUDY
Stefan GILG, Cecilia Str€omberg and Bengt Isaksson
Karolinska University Hospital, Sweden
Introduction: In Sweden (population 9 million), the
accessibility of population-based data gives the unique
opportunity to study the operative outcome in the field
of liver surgery. Between 2002 and 2011 the number of
performed liver resections has more than tripled, from
227 to 720 annually. The aim of this study was to
investigate the mortality and related risk factors for
liver resections in a population based setting.
Method: In a retrospective register study (years 2002–
2011) all patients who underwent liver resection in Swe-
den were identified using the Swedish Hospital Dis-
charge Registry, National Cancer Registry and
Registry of Causes of Death. Survival analysis was per-
formed for liver resections categorized in minor, major
and extended surgery as well as for different diagnosis
categories. Risk factors such as patient age, sex, resec-
tion type, diagnosis and co-morbidity were analyzed
with Cox regression.
Results: During the study period a total number of
4460 liver resections were performed (n = 4120
patients). The 90-day mortality was calculated with
3.1%; despite an increase of major procedures, opera-
tive mortality remained unchanged in the second five
years of the study period. The overall survival for all
diagnosis was 45% and 38% for a five and 10-year sur-
vival, respectively. As significant, independent risk fac-
tors for increased mortality, patient age, co-morbidity
(Charlson-score), male gender, diagnosis intra- / extra-
hepatic cholangiocarcinoma, gallbladder and extent of
the liver resection were identified. 374 patients under-
went re-resection (78.1% with diagnosis ‘metastasis’).
The mortality risk for those patients decreased by >50
% (OR 0.419; 95% CI 0.329–0.534).
Conclusions: Our results show that today liver resection
can be performed with a low overall mortality-risk. Re-
resection of the liver should be performed if applicable,
especially in patients with liver metastasis.
BO13-03
MAJOR HEPATIC RESECTIONS IN THE
ELDERLY: A CASE-MATCHED STUDY
Daniel Azoulay, Rony Eshkenazy2, Gerard Pascal,
Riccardo Memeo, Rene Adam3 and Arie ariche2
Henri Mondor Hospital - Creteil France, France; 2West
galilee hospital-nahariya, Israel; 3Paul Brousse Hospital
- Villejuif, France
Introduction: Liver resection remains the gold standard
in the treatment of liver metastases from colorectal can-
cer (CRLM). Major hepatectomy in elderly patients is
still a challenge.We compared the outcome of major
hepatic resections between young and elderly patients
analyzing a prospective data base in a case-controlled
study.
Method: From 1974 to 2013, 2392 patients underwent
liver resections for colorectal liver metastases in Wes-
tern Galilee Hospital (Israel), Hopital Henri Mondor
(France) and Hopital Paul Brousse (France). Of this,
1156 patients underwent major hepatectomy (≥3 seg-
ments). Among them, 728 patients met the inclusion
criteria (patients that did not receive chemotherapy and
those without anatomical resections were excluded).
Two groups were analysed: old group patients (OG)
aged ≥70 and young group patients (YG) aged
<70 years old.
Results: The OG included 182 patients, of which 69
(38%) female, and the YG included 546, of which 231
(42%) female (p = 0.29). When matching OG with YG
the following criteria were considered: type of surgical
resection (p > 0.999), number of resected segments
(p > 0.999), size of maximal diameter nodule
(p = 0.849) and number of nodules (p = 0.715).
Before resection, portal vein embolisation was realized
in 26 patients (14%) of OG vs. 100 patients (18%) of
YG. Intraoperative blood transfusion was necessary in
53 patients (29%) of OG vs. 191 (35%) in YG
(p = 0.146). Global morbidity was 34% in the OG vs.
31% in the YG (p = 0.583). According to Dindo-Cla-
vien’s classification, severe complications grade 3–4 rate
was 26% vs. 16% (p = 0.04) and mortality was 4.4%
vs. 1.4% (p = 0.01) in OG and YG respectively. The
mean hospitalization stay was 13.9 vs. 15.5 days in OG
and YG respectively (p = 0.06).
Conclusions: Significantly higher mortality and severe
morbidity after major hepatectomies in old patients
needs a rigorous selection for surgery in this popula-
tion.
BO13-04
ASSESSMENT OF THERAPEUTIC
OUTCOME AFTER CURATIVE
RESECTION OF EXTREMELY ELDERLY
PATIENTS WITH HEPATO-BILIARY-
PANCREATIC MALIGNANCY
Nobuhiro Saito, Hiroaki Shiba, Yasuro Futagawa,
Tomonori Iida, Kenei Furukawa, Yuki Fujiwara,
Koichiro Haruki, Ryota Iwase, Yoshihiro Shirai and
Katsuhiko Yanaga
Jikei University School of Medicine, Japan
Introduction: For the aging society, assessment of ther-
apeutic outcome after curative resection of extremely
elderly patients with hepato-biliary-pancreatic malig-
nancy is important.
Method: The study included 25 patients more than 80-
year-old, who underwent elective pancreatic or hepatic
resection for hepato-biliary-pancreatic malignancy
between 2005 and 2012 at Jikei University Hospital.
We retrospectively investigated the therapeutic outcome
including postoperative complications and hospital
stay.
Results: Eleven patients (80 to 86 years) received elec-
tive pancreatic resection consisting of pancreaticduo-
denectomy in 8 and distal pancreatectomy in 3
patients. Postoperative complications occurred in 3
patients including chylous ascites in 1, bile leakage in 1
and rupture of pseudoaneurysm related to pancreatic
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leakage in 1 patient. All patients made satisfactory
recoveries, and discharged on postoperative day 15 to
47 (median 25). Fourteen patients (80 to 90 years)
received elective hepatic resection including right lobec-
tomy in 3, central bisegmentectomy in 1, subsegmentec-
tomy in 3, lateral segmentectomy in 4 and partial
resection in 3 patients. Postoperative complications
occurred in 2 patients including bile leakage in 1 and
hepatic failure in 1 patient. All patients made satisfac-
tory recoveries, and discharged at postoperative day 9
to 62 (median 14.5).
Conclusions: Pancreatic or hepatic resections are possi-
ble for extremely elderly patients provided that the
patients’ general physical condition in good and under
appropriate perioperative management.
BO13-05
SURGICAL RESECTION VERSUS
INTRAOPERATIVE THERMAL
ABLATION IN SINGLE SMALL
HEPATOCELLULAR CARCINOMA:
LONG-TERM SURVIVAL ANALYSIS
Florin Botea, Simona Dima, Vlad Brasoveanu, Mihnea
Ioan Ionescu, Razvan Grigorie and Irinel Popescu
Fundeni Clinical Institute, Bucharest, Romania
Introduction: Nowadays, thermal ablation (TA) com-
petes with liver resection (LR) and liver transplantation
(LT) as treatment of choice for small HCC. The aim of
this study was to compare the long-term outcome of
liver resection (LR) vs. intraoperative thermal ablation
(TA) in the treatment of single small (≤3 cm) hepato-
cellular carcinoma (HCC) on liver cirrhosis.
Method: Eighty-eight patients (male/female ratio 62/26;
median age 61, ranging 44–78), treated for single small
HCC with LR (n = 49 pts) or intraoperative TA
(n = 39 pts) with curative intent, were retrospectively
analyzed. All patients had Child-Pugh A (69 pts, 78%)
or B (19 pts, 22%) liver cirrhosis. Univariate and multi-
variate analyses were performed. Statistical significance
was set at p = 0.05. The study was approved by our
Institutional review board.
Results: The local recurrence rate after LR and intra-
operative TA was 8.1% (4/49) and 15.3% (6/39),
respectively (p = 0.328). There were no significant dif-
ferences between the two groups in terms of overall
survival (OS) and recurrence free survival (RFS): the
1-, 3- and 5-year OS rates after LR and intraoperative
TA were 85%, 63%, 31% and 83%, 55%, 24%,
respectively (p = 0.757), while the corresponding RFS
rates were 82%, 51%, 29% and 77%, 52%, 22%,
respectively (0.573). At the multivariate analysis of the
prognostic factors affecting the OS and the RFS,
recurrence within 1 year (p = 0.014; HR = 3.9;
CI = 1.3–11.9), and HBV infection (p = 0.017;
HR = 2.50; CI = 1.1–5.3), respectively were proved
significant.
Conclusions: In single small HCC, intraoperative TA
and LR seem to have the same outcome in terms of OS
and RFS, therefore intraoperative TA could be the
treatment of choice for this type of HCC.
BO13-06
A NOMOGRAM PREDICTING LUNG
METASTASIS OF HEPATOCELLULAR
CARCINOMA FOLLOWING LIVER
RESECTION
Jun Li1, Yang Liu1, Zhen-Lin Yan1, Xu-Yin Wan1,
Yong Xia1, Kui Wang1, Jin-Feng Liu2, Meng-Chao
Wu1 and Feng Shen1
1Eastern Hepatobiliary Surgery Hospital, Second
Military Medical University, Shanghai, China; 2First
Affiliated Hospital, Fujian Medical University, Fuzhou,
China
Introduction: Lung metastasis (LM) following curative
hepatectomy for hepatocellular carcinoma (HCC) is
indicative of a poor prognosis. This study aimed to
develop a nomogram to identify patients at high risks
of LM.
Method: A primary cohort of patients who underwent
curative liver resection for HCC at the Eastern Hepa-
tobiliary Surgery Hospital from 2002 to 2010 were pro-
spectively studied. A nomogram predicting LM was
constructed based on independent risk factors of LM.
The predictive performance was evaluated by the con-
cordance index (c-index) and calibration curve, and
clinical consequence was analyzed with decision curve
analysis (DCA). During the study period, a validation
cohort was included at the First Affiliated Hospital of
Fujian Medical University.
Results: Postoperative LMs were detected in 106 of
620 and 45 of 218 patients, respectively, in the primary
and validation cohorts. Factors included in the nomo-
gram were microvascular invasion, serum alpha-feto-
protein, tumor size, tumor number, encapsulation and
intratumoral CD34 staining. The nomogram had a c-
index of 0.75 and 0.82 for the two cohorts for predict-
ing LM, respectively. The calibration curve fitted well.
In 428 patients who were within the Milan criteria (318
and 110 patients in the two cohorts, respectively), the
nomogram also showed a good c-index of 0.78 for pre-
diction. In the two cohorts, the DCA demonstrated
positive net benefits or net reduction in intervention by
the nomogram, within the threshold probabilities of
PM greater than 10%.
Conclusions: The nomogram was accurate and useful
in predicting LM following curative hepatectomy for
HCC.
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BO14-01
SPONTANEOUS RUPTURE OF
HEPATOCELLULAR CARCINOMA: A
FRENCH MUTLI-CENTER EXPERIENCE
Lilian Schwarz1, Yves PatriceLe Treut3, Fabrice
Muscari2, Eric Savier4, Emmanuel Boleslawski5, Ahmet
Ayav6, Pablo Ortega Deballon7, Francois Lacaine8 and
Michel Scotte1
1Rouen University Hospital, France; 2Toulouse
University Hospital - Rangueil Hospital, France;
3Marseille University Hospital - La Conception, France;
4La Pitie Salpetriere Hospital, France; 5Lille University
Hospital, France; 6Nancy University Hospital - Ho^pital
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Introduction: Although spontaneous rupture as the first
manifestation of hepatocellular carcinoma(HCC) has
been reported with an incidence of 15% in Eastern
countries, it appeared to be rare in Western countries
(3%). The reported mortality rate of this life-threaten-
ing complication was about 50%. The aim of this study
was to report the French multi-center’s experience in
the management of ruptured HCC.
Method: This retrospective study included 140 patients
who presented with spontaneous ruptured HCC
between May 2000 and May 2012 in 13 French teach-
ing hospitals. Data on clinical features, treatment strat-
egies, and prognosis were collected.
Results: There were 119(85%) men and the median age
was 67(34–91) years. 113(81%) patients presented with
risk factors of liver disease. Pathological evidence of
cirrhosis was found in 37% of operated patients.
Tumors were unique in 60% of cases, with a mean size
of 65(20–250) mm and subcapsular in 78% of cases.
The median alpha-foeto-protein level was 21(2–
317500) ng/ml. Abdominal pain (86%) and anemia
(65%) were the most frequent symptoms at presenta-
tion. 51(71.4%) patients presented with hemodynamic
instability, associated with organ dysfunction (pulmo-
nary and/or renal). Bleeding control was performed
using transarterial embolization or surgery in 77(55%)
and 34(24%) patients, respectively. The post-ruptured
morbidity and mortality rates were 38% and 21%. The
main prognostic factors were organ dysfunction at ini-
tial presentation (p = 0.01), and bleeding recurrence
(p < 0.001). Definitive treatment was provided by emer-
gency and staged hepatectomy in 27(19%) and in 50
(36%) patients. Overall survival rates at 1-, 3-, and 5-
years were 52%, 17% and 7% while disease-free sur-
vival rates were 36%, 13% and 3%.
Conclusions: This study constitutes the largest Euro-
pean cohort ever reported. It confirms that ruptured
HCC is characterized by a poor prognosis even in non-
cirrhotic patients. Considering the two main prognosis
factors of post-rupture mortality, optimization of med-
ico-surgical management at initial presentation is still
the key-point to further improve survival.
BO14-02
DOES SPONTANEOUS TUMOR
RUPTURE ALWAYS HAS AN ADVERSE
PROGNOSTIC IMPACT ON PATIENTS
WITH RESECTABLE
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Introduction: Spontaneous tumor rupture (STR) is a
life-threatening complication of hepatocellular carci-
noma (HCC) with high mortality. Previous study
showed that 20% patients with STR could eventually
receive hepatectomy after initial haemostasis and attain
long-term survival. Nonetheless, the prognostic impact
of STR on the prognosis of these patients in relation to
non-ruptured resectable HCC is still not known.
Method: From 1989 to 2010, a total of 1338 patients
received hepatectomy and 84 patients had STR before
resection (Group I). Their clinicopatholgical data and
survival outcomes were compared with patients who
had resections of non-ruptured HCC (Group II).
p ≤ 0.05 was regarded as significant.
Results: There was no significant difference in preoper-
ative liver function and ICG value. Group I had signifi-
cantly larger tumor size (10 cm vs. 5.5 cm), higher
incidence of multiple tumors (38.1% vs. 27.3%) and
microvascular invasion (61.9% vs. 46.5%). The inci-
dence of major vascular invasion was not significantly
different between both groups (10.7% vs. 8.1%). When
Group I was stratified according to 7th AJCC/TNM
classification, after excluding STR as an element from
staging, the 3- and 5-year disease-free survival (DFS)
rates for T1 were 41.8% and 31.4% in Group I; 61.9%
and 51.2% in Group II (p = 0.023); for T2 were 15.4%
and 7.7% in Group I, and 32.0% and 24.8% in Group
II(p = 0.007); for T3 were 14.7% and 9.8% in Group I,
and 16.6% and 13.8% in Group II (P = 0.626). Fur-
thermore, the DFS in Group I were significantly wors-
ened than Group II when tumor size 5-10 cm (5-year
DFS: 6.3% vs. 29.3%, P = 0.053) but not when tumor
size ≤5 cm (5-year DFS: 31.3% vs. 41.2%, p = 0.224)
or >10 cm (5-year DFS 10.4% vs. 15.4%, p = 0.259).
Conclusions: STR only has an adverse prognostic
impact on early staged or medium-sized tumors. Re-
defining the significance of STR in future AJCC/TNM
staging is indicated.
BO14-03
THE MANAGEMENT OF SOLITARY
HEPATOCELLULAR CARCINOMA
Andrew Healey, Megan Anderson, Anya Adair and
Steve Wigmore
Royal Infirmary of Edinburgh, United Kingdom
Introduction: In the UK, treatment of hepatocellular
carcinoma incorporates recommendations for trans-
plant assessment. Donor shortage and priority based
on severity of liver disease means that patients with
HCC and preserved function may be disadvantaged.
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Alternative treatments for these patients include resec-
tion and radiofrequency ablation (RFA).
This study compares outcome for patients in our insti-
tution with a solitary HCC (sHCC) listed for transplan-
tation to those undergoing resection/RFA.
Method: All patients referred to the Scottish Liver
Transplant Unit between 2010 and 2013 for assessment,
with sHCC lesions were reviewed. Data was retrieved
from the national transplant database. Inclusion crite-
ria were radiological diagnosis of solitary lesion. Exclu-
sion criteria were the presence of metastatic or
multifocal disease and previous liver transplant. Paired
T-test was used to compare listed vs not listed cohorts.
Results: 72 patients were included. 75% were male,
and mean age was 58 yrs.
68% patients were listed for transplant. Mean MELD
was 19 and blood groups (%breakdown) O:A:B:AB
were 51:36:13:0 respectively. Unlisted patients (32%)
were considered for alternative treatment mean MELD
15 and blood groups O:A:B:AB 50:42:4:4. 25% under-
went liver resections (all R0) and 43% RFA treatment,
(30% and 0% morbidity respectively).
Of those listed, 83% had successful transplants, (45%
morbidity). 4% of patients progressed outwith criteria
and 6% died on the waiting list.
Overall and disease-free survival was not significantly
different between those managed with transplant vs.
those with RFA/resection (p > 0.05).
Conclusions: With increasing numbers of patients on the
transplant waiting list and the shortage of organ donors,
the use of transplantation in the management of sHCC
needs careful scrutiny. Should we be moving towards a
model of salvage transplantation for those with a sHCC
and preserved synthetic function? Our data supports
both RFA and resection in patients with preserved liver
function who might otherwise be disadvantaged.
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ROLE OF THE TRANSARTERIAL
CHEMOEMBOLIZATION PRIOR TO
LAPAROSCOPIC RESECTION FOR
HEPATOCELLULAR CARCINOMA
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Introduction: Transarterial chemoembolization (TACE)
has been used in intermediate stage HCC to increase
resecability. It is not clear if it could increase survival and
reduce the recurrence rate. We performed a preoperative
TACE in all patients with HCC in which we had sched-
uled a laparoscopic resection with the aim to reduce sur-
gical bleeding. We analyze factors related with our main
objective and furthermore we analyze tumour related
factors, local recurrence, and survival at 1, 3 and 5 years.
Method: We have performed 146 laparoscopic liver
resection and 24 of them were for HCC: 17 patients
with Child A cirrhosis (tumour size was 3 cm;range
1.6–6) and 7 with healthy liver (tumor size was 7 cm;
range 3–12). A TACE was performed prior to surgery
in all patients diagnosed with HCC. A CT scan three
weeks after TACE assessed the abscence of vasculariza-
tion on the embolized segments and then the following
operations were carried out: 17 pure laparoscopy , 6
hand-assisted laparoscopy, 1 SILS.
Results: No patient required transfusion, Pringle
manoeuvre was used in three patients (12.5%), blood loss
was170 ml (0–500), operative time was 145 min (50–240),
hospital stay was 4.4 days (range 2–12). Morbidity was
4.1%, mortality was 0%. We obtained free tumour mar-
gin in all nodules: two cases <0.5 cm, nine cases between
0.5–1 cm and 13 cases >de 1 cm; The tumour necrosis
was 100% in 14 nodules, >90% in 8 nodules and between
70–80% in two nodules. With a follow-up of 38 months
there wasn’t local recurrence and overall survival at 1, 3
and 5 years was 100%, 87% and 87% respectively.
Conclusions: The isquemic effect of TACE seem to be
usefull to facilitate the laparoscopic surgery reducing
the intraoperative bleeding and its related complica-
tions and it could be reduce the recurrence on the
resection’s margin.
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Introduction: Patients with hepatocellular carcinoma
(HCC) who underwent hepatectomy often developed an
intrahepatic recurrence, even though it was a curative
one. The relationship between surgery-induced liver
damage and the recurrence of HCC has not been
described. This study evaluated whether posthepatecto-
my liver failure, as defined by the International Study
Group of Liver Surgery, affected the recurrence of HCC.
Method: We performed a retrospective cohort study of
488 patients with HCC who underwent hepatectomy
between 2004 and 2012 at Kyoto University Hospital.
Early posthepatectomy liver failure (EPLF) was defined
as liver failure occurring between postoperative days 5
and 10. The patients were divided into an EPLF group
and a non-EPLF group. Disease-free survival (DFS)
was compared between these groups. The influences of
host-related, surgery-related, and tumor-related factors
on patient outcomes were evaluated using multivariate
analyses.
Results: The EPLF group and the non-EPLF group con-
tained 153 and 335 patients, respectively. The probability
of DFS was significantly increased in the non-EPLF
group (median: 574 days) compared to the EPLF group
(median: 348 days). {hazard ratio (HR) [95% confidence
interval (CI)]: 1.61 (1.29–2.00)} The multivariate analysis
revealed that EPLF was an independent factor for DFS
[HR (95%CI): 1.44 (1.13–1.82)], besides the factors previ-
ously described including fibrosis [1.32 (1.04–1.67)], stage
[1.85 (1.34–2.51)], tumor differentiation [1.46 (1.12–1.89)]
and des-c-carboxyprothrombin (DCP) [1.40 (1.11–1.76)].
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Conclusions: EPLF was associated with postoperative
HCC recurrence. The prevention of EPLF might
improve the prognosis of patients with HCC.
BO14-06
PARTIAL HEPATECTOMY VERSUS
TRANSCATHETER ARTERIAL
CHEMOEMBOLIZATION FOR
RESECTABLE MULTIPLE
HEPATOCELLULAR CARCINOMA
BEYOND MILAN CRITERIA: A RCT
Lei Yin1, Wei-ping Zhou1, Ai-jun Li1, Wan Yee Lau2,
Ze-ya Pan1, Eric C.H. Lai2 and Meng-chao Wu1
1Eastern Hepatobiliary Surgery Hospital, China; 2The
Chinese University of Hong Kong, Prince of Wales
Hospital, Hong Kong, China
Introduction: Partial hepatectomy (PH) is an effective
treatment for large but resectable hepatocellular carci-
noma (HCC). However, its role in the treatment of
resectable multiple hepatocellular carcinoma (RMHCC)
outside of Milan Criteria is not clear. The aim of this
randomized comparative trial (RCT) is to compare PH
with transcatheter arterial chemoembolization (TACE)
for patients with RMHCC.
Method: This RCT was conducted on 180 patients with
RMHCC outside of Milan Criteria (tumor number
2 ≤ N ≤ 5 with diameter of biggest tumor ≥5 cm) who
were treated in our centre from November 2008 to Sep-
tember 2010. The patients were randomly assigned to
the PH group and the TACE group. The primary out-
come measure was overall survival (OS) from the date
of treatment. A multivariate Cox proportional hazards
regression analysis was performed to assess the prog-
nostic risk factors associated with OS.
Results: The 1-, 2- and 3- year OS rates were 76.1%,
63.5% and 51.5%, respectively, for the PH group com-
pared with 51.8%, 34.0% and 18.7% respectively, for
the TACE group(log-rank test, v2 = 3.755,
p < 0.001).Multivariate Cox proportional hazards
regression analysis revealed the type of treatment (haz-
ard ratio, 2.359; 95% CI, 1.610 to 3.456, p < 0.001)
and serum alpha-fetoprotein level (hazard ratio, 1.567;
95% CI, 1.085 to 2.263, p = 0.017) were significant
independent risk factors associated with OS.
Conclusions: The OS for patients with RMHCC out-
side of Milan Criteria (tumor number 2 ≤ N ≤ 5 with
diameter of biggest tumor ≥5 cm) was superior after
PH than TACE.
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IMPACT OF ANTIVIRAL THERAPY ON
POST-HEPATECTOMY RECURRENCE
AND SURVIVAL IN PATIENTS WITH
HBV-RELATED HCC
Charing Chong, Grace Wong, Vincent Wong, HC Yip,
Anthony Fong, Sunny Cheung, John Wong, KF Lee,
Henry Chan and Paul Lai
Prince of Wales Hospital, Hong Kong, China
Introduction: To evaluate the effect of antiviral therapy
on post-hepatectomy recurrence and survival in
patients with HBV-related HCC.
Method: This was a prospective-retrospective study on
patients with HBV-related HCC who underwent hepa-
tectomy in from January 1999 to March 2012. Antiviral
therapy will be started if patient has a high viral load.
Patients in the prospective cohort, who were treatment-
na€ıve and outside the traditional criteria for antiviral
therapy will be interviewed by a hepatologist for coun-
seling on the use of antiviral therapy. Antiviral therapy
will be started if significant liver fibrosis or upon
patients’ preference. Data on patient and tumour char-
acteristics, tumor recurrence, treatment for recurrence
and survival were compared between antiviral and no
antiviral groups.
Results: A total of 393 (244 antiviral group vs. 149 no
antiviral group) patients were recruited. Patient’s demo-
graphics, tumor staging and baseline liver function
before hepatectomy were comparable between antiviral
and no antiviral groups, except a higher proportion of
patients with cirrhosis in the antiviral group. With a
mean follow-up time of 44.9 months (S.D.
36.7 months), patients in antiviral group had a better
5-year disease-free survival (44.6% vs. 37.1%, p =
0.037) and overall survival (69.2% vs. 54.6%,
p = 0.002). Use of antiviral therapy is associated with
better liver function reserve at the time of recurrence in
terms of higher serum albumin level (p = 0.009) and
lower serum ALP level (p = 0.003). Furthermore, a
greater proportion of patients could receive curative
treatment for recurrence. (43.4% vs. 21.3%, p = 0.012).
Conclusions: Antiviral therapy improves the disease-
free and overall survivals in patients with HBV-HCC
undergoing hepatectomy by means of reducing the
recurrence, and preserving the liver function and
renders them amendable to curative treatment upon
recurrence. It should be considered for patients with
HBV-HCC before or after curative resection.
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RECURRENT HEPATOCELLULAR
CARCINOMA WITHIN UCSF CRITERIA:
STRATEGY FOR MANAGEMENT AND
PROGNOSTIC FACTORS FOR RE-
RECURRENCE
Mahmoud Mohamed Abdelwahab Ali1, Chih-Chi
Wang2, Shih-Ho Wang2, Chih-Che Lin2, Yueh-Wei
Liu2, Chee-Chien Yong2, Ting-Lung Lin2 and Chao-
Long Chen2
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Introduction: Management of intrahepatic recurrence
(IHR) remains the main challenge after hepatocellular
carcinoma (HCC) resection. However, there are no def-
inite criteria for management of IHR. In this study, we
analyzed the outcome of 4 modalities used for manage-
ment of IHR within University of California San Fran-
cisco (UCSF) criteria.
Method: All cases that underwent curative primary
resection (PR) for HCC from 2003 to 2010 were fol-
lowed up and cases with IHR within UCSF criteria
were included in the study. Patients were managed by
© 2014 The Authors
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using 4 modalities; salvage liver transplantation (SLT),
re-resection (RR), local ablation (LA) and transarterial
embolisation (TAE). Histopathological features of PR
and features of recurrent HCC were analyzed to find
out the prognostic factors for re-recurrence.
Results: The study group was 217 patients, managed as
follows; SLT (n = 25), RR (n = 31), LA (n = 74) and
TAE (n = 87). On multivariate analysis, 3 variables
adversely affected disease-free survival (DFS); cirrhosis
and microvascular invasion in PR and serum alpha
fetoprotein >200 ng/ml at the time of recurrence. In
absence of those 3 factors, there was no significant dif-
ference in DFS among the 4 groups. However, in the
presence of at least one factor, except for high serum
AFP, SLT showed significantly longer DFS.
Conclusions: Having the lowest potential for re-
recurrence, SLT should be reserved to patients with
IHR within UCSF criteria with cirrhosis and/or micro-
vascular invasion in the PR. Re-resection can be used
in absence of the 3 prognostic factors for re-recurrence.
BO15-03
INFLUENCE OF RESECTION MARGIN
ON CLINICAL OUTCOMES IN
RESECTABLE HEPATOCELLULAR
CARCINOMA
Jung Woo Lee, Young Joo Lee, Kwang Min Park,
Song Cheol Kim, Jae Hoon Lee and Ki Byung Song
Asan Medical Center, Ulsan University, Korea
Introduction: The effect of Surgical resection margin in
hepatocellular carcinoma remain controversial. The
objective of this study is to examine the effect of surgi-
cal margin status on postoperative recurrence and long
term outcomes in resectable hepatocellular carcinoma.
Method: A retrospective study was conducted on 1098
patients who underwent hepatectomy at division of he-
patobiliary and pancreatic surgery, Asan Medical Cen-
ter, Seoul, Korea, for hepatocellular carcinoma
between December 1999 and December 2009. They
were divided into 5 group with surgical margin histo-
logical positive(group A, n = 50), surgical margin nega-
tive by less than 1 mm(group B, n = 182), 1–5 mm
(group C, n = 228), 6–10 mm(group D, n = 194), wider
than 10 mm(group E, n = 326).
Results: After excluding group A, there was no signifi-
cance difference in disease free survival(DFS)e and
overall survival(OS) among the 4 groups on log rank
test. The 5 group patient’s 1-,3-, and 5-year recurrence
free survival was A: 28%-16%-16%, B: 53%-37%
33%, C: 53%-37%-33%, D: 63%-45%-37%, E; 56%
42%-36%. The 5 group patient’s 1-,3-, and 5-year overall
survival rate was A: 44%-36%-24%, B: 82%-67%
56%, C: 83%-67%-61%, D: 87%-73%-64%, E; 88%
70%-61%. Margin positive group in comparison with
group B-E has poor prognostic factors(tumor size,
tumor multiplicity, vascular invasion, and UICC stage).
So, in multivariate analysis, group A is not associated
with DFS and OS.
Conclusions: The width of the resection margin did not
influence the recurrence rate and overall survival. Also,
type of intrahepatic recurrence did not differ between
group A to E. Only a postitive histologic margin was
associated with a high recurrence rate and low overall
survival time. However, in multivariate analysis, there
was no difference.
BO15-04
OUTCOMES OF LIVER RESECTION
FOR HEPATOCELLULAR CARCINOMA
WITH OBSTRUCTIVE JAUNDICE
Tiffany C L Wong, TT Cheung, KS Chok, AC Chan,
W Sharr, SH Tsang, WC Dai, SC Chan, RT Poon and
CM Lo
The University of Hong Kong, Hong Kong, China
Introduction: Obstructive jaundice (OJ) is an uncommon
presentation in hepatocellular carcinoma (HCC). It is
controversial whether OJ implies a poorer prognosis and
few reports on long-term survival were published.
Method: This was a retrospective study conducted in a
university centre in Hong Kong. Surgical outcomes and
survival of 38 HCC patients presented with OJ and
underwent liver resection were analyzed and compared
to 228 matched non-OJ HCC patients.
Results: Baseline demographics were similar in terms
of age, sex, hepatitis B status and presence of co-mor-
bid diseases. Patients in OJ group had a significantly
higher preoperative bilirubin (18 vs. 11 mg/dl,
p < 0.001), lower albumin (37.5 vs. 40 g/l, p = 0.001)
and more patients were of Child’s B (42.1 vs. 3.1%,
p < 0.001). Other parameters including INR (1.1 vs. 1,
p = 0.186), indocyanine green retention at 15 minutes
(13 vs. 11.3, p = 0.267) and alpha fetoprotein (63 vs.
175 ng/ml, p = 0.75) were the same.
Majority of patients (34/38, 89.5%) with OJ required
preoperative intervention to alleviate jaundice.
Thirty-three patients (86.8%) and 167 (73.2%) in OJ and
control group underwent major hepatectomy (p = 0.07)
respectively. More patients in OJ group required hepati-
cojejunostomy (12/38 vs. 4/228, p < 0.001) and portal
vein resection (4/38 vs. 3/228, p = 0.007). Operative time
was longer in OJ group (488.5 vs. 400 minutes,
p = 0.002), more blood loss (1.33 vs. 0.9 l, p = 0.019) and
had more complications (50 vs. 31.1%, p = 0.023) but
hospital mortality was the same (2.6 vs. 3.9%, p = 0.844).
The 5-year overall and disease free survival were simi-
lar; 37.4% vs. 33.7% and 20.5% vs. 20.8% in OJ and
control group respectively. Prognosis was poorer in
those with larger tumor, presence of microvascular per-
meation, higher prothrombin time and more blood loss
while OJ itself would not confer an inferior survival.
Conclusions: Liver resection should be offered when-
ever possible and survival after liver resection is not
jeopardized in OJ patients.
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BO15-05
PREOPERATIVE TOTAL
CHOLESTEROL IS ASSOCIATED WITH
POSTOPERATIVE OUTCOMES AFTER
PARTIAL HEPATECTOMY IN
PATIENTS WITH CHRONIC HEPATITIS
RELATED HEPATOCELLULAR
CARCINOMA
Qi Wang, Bixiang Zhang, Zhiwei Zhang, Zhiyong
Huang and Xiaoping Chen
Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology, China
Background: Total cholesterol (TC) can reflect the
degree of liver damage in patients with chronic hepati-
tis B or C, its role in evaluating liver functional reserve
and predicting postoperative complications is still
unknown.
Method: The prospectively collected data of 996 con-
secutive patients with chronic hepatitis B or C receiving
partial hepatectomy for hepatocellular carcinoma in a
tertiary institution were retrospectively reviewed. The
relationship between preoperative TC and post-opera-
tive liver insufficiency, morbidity and mortality were
analyzed.
Results: TC showed significant correlation with postop-
erative complications on receiver operating characteris-
tic curves, with area under the curve of 0.81
(p < 0.001), 0.79 (p < 0.001) and 0.85 (p < 0.001) for
postoperative liver insufficiency, morbidity and mortal-
ity, respectively. Using the calculated cutoff at
2.80 mmol/L, Patients with low TC had worse preoper-
ative liver functional reserve and suffered from higher
post-operative complications when compared with
patients with normal TC (≥ 2.8 mmol/l). Further analy-
sis revealed low preoperative TC was more powerful in
predicting poor postoperative outcomes than Child-
Pugh’s classification, indocyanine green (ICG) retention
test and Mayo End-Stage Liver Disease (MELD) score.
It was an independent risk factor for post-operative
morbidity (OR, 4.87; p < 0.001) and mortality (OR,
14.60; p < 0.001).
Conclusions: In patients with chronic virus B or C hep-
atitis receiving partial hepatectomy, a low TC
(<2.8 mmol/l) predicted poor post-operative outcomes.
It was better than Child-Pugh’s classification, ICG and
MELD score in the prediction of postoperative compli-
cations, and was useful in the preoperative evaluation
of liver functional reserve.
BO15-06
TREATMENT RESPONSE OF
HEPATOCELLULAR CARCINOMA BY
ETIOLOGY OF LIVER DISEASE
David Iannitti1, Jun Lee1, Ryan Swan1, David
Sindram1, John Martinie1, Mark Russo2 and
Ramanathan M. Seshadri1
1Carolinas Medical Center, U.S.A.; 2Carolinas
HealthCare System, U.S.A.
Introduction: In the US, HCC is usually associated
with Cirrhosis from either Alcohol; hepatitis C (HCV)
or Nonalcoholic Fatty Liver Disease (NAFLD). Ther-
apy while waiting for transplant includes transarterial
chemoembolization (TACE), microwave ablation
(MWA), radioembolization using Yttrium 90 and so-
rafenib. Our aim was to determine if there is an associ-
ation between etiology of cirrhosis and treatment
response to MWA and TACE for HCC.
Method: Retrospective analysis was performed from
our patient. 332 patients were reviewed of which 118 of
them were found to have HCC. 71 patients developed
HCC from HCV and 21 patients from NAFLD. The
first CT/MRI after treatment was reviewed and data
were organized using the RECIST (response evaluation
criteria in solid tumors) criteria between the 2 groups.
The final analysis was based on level of response;
1 year mortality, type of treatment and demographic
data between the 2 groups.
Results: The most common modality of treatment was
TACE in the HCV/HCC group (65%) and NAFLD/
HCC group (76%), followed by ablation (35%) and
(24%). Complete response (CR) in HCV/HCC and
NAFLD/HCC were 45% and 52%, p = 0.55. CR and
partial response (PR) in HCV/HCC and NAFLD/HCC
were 77% and 90%, p = 0.22. Mean age in the HCV/
HCC group and NAFLD/HCC group were 57 and 66,
p < 0.0001. The proportion of patients with AFP
>200 ng/ml was higher in the NAFLD than HCV
group (37.5% vs. 20.8%).
Conclusions: NAFLD patients with HCC had higher
response rates to locoregional therapy but our sample
size may have been too small to demonstrate statistical
significance. The HCV group was younger compared to
the NAFLD group and the NAFLD group was more
likely to have higher AFP. Further study is warranted
because these findings may have implications of when
to initiate screening and utilize AFP based upon etiol-
ogy of liver disease.
BO16-01
COMPARING OUTCOMES OF
LAPAROSCOPIC
THORACOABDOMINAL VS CLASSICAL
APPROACHES FOR RESECTIONS OF
POSTERIOR LIVER SEGMENTS (VII
AND VIII)
Bavahuna Manoharan, Joel Lewin, Kat Black, David
Cavallucci, Richard Bryant and Nicholas O’Rourke
Royal Brisbane Hospital, Queensland, Australia
Introduction: Laparoscopic resection of lesions in the
dome of the liver are difficult due to limited access
beneath the ribcage. A new laparoscopic thoracoab-
dominal technique has evolved using intercostal trocars
either beneath the diaphragm, through the diaphragm,
or through the pleural cavity. This paper compares the
indications and outcomes of this novel technique to
those of the traditional laparoscopic or open
approaches to posterior segment (VII and VIII) lesions.
Method: Patients who underwent posterior liver resec-
tions utilising thoracoabdominal, laparoscopic and
open approaches were identified in a prospective HPB
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database. Data collected includes patient demographics,
pathology and surgical procedure and statistics, compli-
cations, hospital stay details and Pre- and Post-Op Bas-
ingstoke Predictive Index and Clinical Risk Score.
Results: 61 patients (58% male) with segments VII
and/or VIII underwent resections between 2000-2013.
There were 28 Open, 22 Laparoscopic (3 conversions to
open), 3 Hybrid and 8 using the thoracoabdominal
approach. 82% of all lesions were colorectal adenocar-
cinoma metastasis and 10% were Hepatocellular carci-
nomas. Mean blood loss (192  101 ml) and mean
length of hospital stay (3.1  3 days) in the thoracoab-
dominal group was significantly less compared to all
other groups (p < 0.005). Operative time was reduced
with the transcostal technique (109  41mins) com-
pared to both open surgery (198  90mins) and lapro-
scopic (199  106 mins) technique times. The mean
size of lesions was significantly smaller (p < 0.005) in
the thoracoabdominal group (20  11.5 mm) compared
to open (56  43 mm) and laparoscopic (36  26 mm)
groups, however there were no significant difference in
tumour resection margins.
Conclusions: Transcostal access, either through or
above the diaphragm, offers a safe and effective way to
manage previously difficult to access tumours when
attempting minimally invasive liver surgery. We have
shown in some cases that this technique is not indi-
cated, with preference for an open technique, however
this is due to clinical and surgical complexity.
BO16-02
GLISSONIAN APPROACH FOR
LAPAROSCOPIC LIVER RESECTION
Marcel Autran Machado, Fabio Ferrari Makdissi and
Rodrigo Canada Surjan
Sirio Libanes Hospital, Brazil
Introduction: Glissonian approach was established by
Galperin et al., Takasaki et al., and Launois et al.
Based on small incisions in specific anatomical land-
marks, we described a straight forward control of Glis-
sonian pedicles without hilar or parenchymal dissection
for both open and laparoscopic liver resections. The
purpose of this study is to demonstrate detailed techni-
cal description for Glissonian approach for laparo-
scopic anatomical liver resection and assess the
feasibility and immediate results. To the best of our
knowledge this is the largest series of laparoscopic liver
resection using Glissonian approach in the English lit-
erature.
Method: The patients consisted of 147 consecutive indi-
viduals who underwent laparoscopic liver resection
from April 2007 to April 2013. Individual data was
prospectively recorded in our database. Among them,
we reviewed all patients with laparoscopic anatomical
liver resection using intrahepatic Glissonian technique.
Technique of laparoscopic intrahepatic Glissonian
approach was reported by the authors. Nonanatomic,
wedge resections and anatomic resections with hilar dis-
section were excluded from the study.
Results: Among the 147patients, laparoscopicGlissonian
approach was used in 94 patients (64%): 30 hemihepatec-
tomies, 10 mono-segmentectomies, 48 bi-segmentecto-
mies, 3 mesohepatectomies and 3 trisectionectomies were
performed. There were 44 men and 50 women with mean
age of 53.9 years (17–85 years). The diagnosis was meta-
static liver disease (n = 41), primary liver malignancy
(n = 26), intrahepatic lithiasis (6), and benign lesions
(n = 21). Glissonian access was possible in all patients but
one, using described anatomical landmarks.Median oper-
ative time consumed to achieve complete control of pedi-
cles was 6 minutes (1–21 minutes) and mean operation
timevaried according typeofoperation.Blood transfusion
was required in 15 patients. Median hospital stay was
5 days (1–22 days).
Conclusions: Laparoscopic Glissonian approach is fea-
sible and it is a useful technique for a rapid and safe
control of the main and segmental liver pedicles, facili-
tating anatomical liver resections.
BO16-03
LAPAROSCOPIC LIVER RESECTION
USING THE RUBBER BAND:
TECHNIQUE AND OUTCOMES OF 100
CONSECUTIVE CASES
Sung Hoon Choi, Gi Hong Choi, Dae Hoon Han and
Jin Sub Choi
Yonsei University College of Medicine, Korea
Introduction: Although laparoscopic liver resection is
increasingly performed worldwide, surgeons still face
technical challenge according to multiple different pro-
cedures by tumor locations. The purpose of this study
was to present our rubber band technique focusing
mainly on perioperative and early postoperative out-
comes.
Method: A series of 100 consecutive patients who
underwent laparoscopic liver resection using the pure
rubber band technique between August 2008 and June
2013 was analyzed retrospectively in terms of demo-
graphics, operation type, and in-hospital outcomes. All
the study patients were applied rubber band retraction
method at both resection edges to keep the resection
plane horizontal with laparoscope view.
Results: Overall, 36% of the patients had underlying
liver cirrhosis. There were 4 conversions. Types of
operation included 86% of minor hepatectomy [wedge
resection (60%), segmentectomy (12%), and left lateral
sectionectomy (14%)] and 14% of major hepatectomy
[left hepatectomy (12%), and right hepatectomy (2%)].
When 56 favorable location tumors (II, III, IVb, V and
VI) were compared with the remaining 30 unfavorable
location tumors (I, Iva, VII and VIII) among the minor
hepatectomy, the former group required a shorter oper-
ation time [185 (60–395) minutes vs. 248 (92–655),
p = 0.002] and showed a lesser amount of blood loss
150 (10–550) vs. 263 (10–1000) ml, p = 0.017). How-
ever, open conversion rate (2% vs. 1%, p = 1.0), post-
operative complication rate (7% vs. 3%, p = 1.0), and
hospital stay (6.7 days vs. 6.8 days, p = 0.946) were not
different between the two groups. When the operative
time was analyzed using the moving average method,
operative time for left lateral sectionectomy and left
hepatectomy were stabilized at 9 and 6 cases, respec-
tively. There was no postoperative mortality.
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Conclusions: Rubber band technique in laparoscopic
liver resection provides useful and safe laparoscopic
hepatectomy including unfavorably located tumors or
major hepatectomy, and allows reasonable learning
curve applying a constant surgical principle.
BO16-04
PORTAL VEIN ARTERIALIZATION: A
SALVAGE PROCEDURE FOR A
TOTALLY DE-ARTERIALIZED LIVER
Daniel Azoulay1, Pranshant Bhangui2, Chady
Salloum2, Gerard Pascal2 and Denis Castaing2
1Henri Mondor Hospital - Creteil France, France; 2Paul
Brousse Hospital - Villejuif, France
Introduction: Portal vein arterialization (PVA) has been
used as a salvage inflow technique when hepatic artery
(HA) reconstruction is impossible in liver transplantation
(LT) or in hepatobiliary and pancreatic (HPB) surgery.
Method: We evaluated our results following PVA in 16
consecutive patients and performed a systematic review
of published studies.
Results: We performed PVA either as an emergency
procedure after LT (n = 7) and after liver resection
(n = 1) for hepatic artery thrombosis (HAT) or in elec-
tive situations during curative resections for HPB can-
cers invading HA (n = 8).
After a mean follow up of 13 months (range 1–
60 months), 10 patients (62.5%) are alive with normal
liver function (1 re-transplanted). Of the 6 postopera-
tive deaths, 2 each were due to haemorrhagic shock
and multiorgan failure, 1 due to liver ischaemia and 1
due to unknown cause. Three patients had major portal
hypertension (PHT) related bleeding, one underwent
successful PVA embolization, while two died. Four
patients had early shunt thrombosis, 2 underwent a sec-
ond PVA. Literature review (total 52 patients including
our 16 patients) revealed a perioperative mortality of
19% (10/52), significant PHT in 27% (14/52), shunt
thrombosis in 23% (12/52) and need for PVA emboli-
zation in 29% (15/52). Thirty-one patients (60%) were
alive at the end of respective study periods.
Conclusions: PVA results in acceptable survival, consid-
ering the spontaneous outcome in patients with a com-
pletely de-arterialized liver. In LT, PVA could be
recommended as a lifesaving salvage procedure or bridge
to re-transplantation. For advanced HPB cancers, it
could expand the possibility of curative resection. Strict
monitoring and management of subsequent PHT is vital.
BO16-05
SYSTEMATIC LIMITED RIGHT
HEPATECTOMY ACCORDING TO THE
ANTERIOR FISSURE OF THE RIGHT
LIVER FOR HEPATOCELLULAR
CARCINOMA
Bong-Wan Kim, Hee Jung Wang, Yong-Keun Park
and Weiguang Xu
Ajou University School of Medicine, Korea
Introduction: Right hepatectomy (RH) has been per-
formed for the hepatocelluar carcinoma (HCC) when
the HCC(s) is/are in contact with right hepatic vein
(RHV) and/or located across the right portal fissure.
The limited right hepatectomy (LRH) along the ante-
rior fissure of the right liver could be an alternative
systematic resection for the HCC patients with limited
liver function. In this study, we evaluate the surgical
and oncological safety of LRH along the anterior fis-
sure of the right liver.
Method: Between 2006 and 2012, among 351 patients
with HCC consecutively received partial hepatectomy
at our hospital, 37 patients were performed curative
resection of the HCC in the right liver and enrolled in
this study. Twenty-one received RH (RH group,
n = 21) and 16 received LRH (LRH group, n = 16).
Median follow-up was 36 months (range 6–87 mo.)
Results: Preoperative patients characteristic of all
patients in this series were not different between two
groups such as age, gender, preoperative TACE, HBV
antigenemia, CTP score, platelet count, and ICG-R15
(p > 0.05). Pathological characteristics of the HCCs,
such as tumor size, number, presence of micro- and
macro-vascular invasion, histologic differentiation, sur-
gical margin, and TNM stag, were not different
between two groups (p > 0.05). All the patients in this
study recovered from the hepatectomy, however, the
postoperative day 3 serum bilirubin level was different
(2.25  0.83 in RH vs. 1.57  0.48 in LRH,
p = 0.006). Recurrence of HCC occurred 15 patients
(11 in RH group vs. 4 in LHR group, p = 0.089). 3-
and 5- year survival rates were 83% and 66% in RH
group and 100% and 67% in LRH group.
Conclusions: We could conclude that the LRH for the
HCC may have benefit in restoration of the liver func-
tion after resection of the right liver without oncologi-
cal disadvantages compare to the RH.
BO16-06
IN SITU HYPOTHERMIC PERFUSION
WITH RETROGRADE OUTFLOW
DURING RIGHT HEMIHEPATECTOMY:
FIRST CLINICAL EXPERIENCES
Megan Reiniers1, RowanVan Golen1, Michal Heger1,
Roelof Bennink2 and ThomasVan Gulik1
1Department of Surgery, Academic Medical Center,
University of Amsterdam, Amsterdam, Netherlands;
2Department of Nuclear Medicine, Academic Medical
Center, University of Amsterdam, Amsterdam,
Netherlands
Introduction: To assess outcomes of selective in situ
hypothermic perfusion with retrograde outflow (IHP-
R) during right hemihepatectomy.
Method: After right liver mobilization, the right branch
of the portal vein (RPV) and the right hepatic artery
(RHA) were clamped and cut. Following RHA cannu-
lation, the portal triad was clamped, the right hepatic
vein was closed and cut, and the middle/left hepatic
veins were clamped to exclude the liver from the circu-
lation. The left hemiliver was perfused through the
RHA using cold Ringer’s lactate solution (target liver
temperature of 28°C), allowing retrograde outflow via
the cut end of the RPV until parenchymal transection
was completed. Seven patients underwent IHP-R. Lab-
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oratory parameters (AST, ALT, total bilirubin, PT),
transfusion requirements, complications, ICU stay,
functional liver regeneration (assessed preoperatively
and at postoperative day (POD) 3 by hepatobiliary
scintigraphy with SPECT), and hospital stay of this
group were compared to a historic cohort of 13 patients.
Results: The median/range IHP-R times were 45/25–
55 min while the target temperature of 28°C was
reached in 6 patients. There were no statistical differ-
ences regarding age, gender, diagnosis, ASA score,
resection type, ischemia time, laboratory parameters,
ICU stay, and complications between both groups.
Median/range transfusion requirements (units) and
hospitalization (days) were significantly lower in the
IHP-R group (2/0–5 vs. 5/0–33 units, p = 0.019, and
11.5/6–25 versus 17/11–79 days, p = 0.029). There was
significant functional liver regeneration within the IHP-
R group on POD-3 compared to preoperatively calcu-
lated values (p = 0.0312). Moreover, functional liver
regeneration was significantly higher in the IHP-R
group on POD-3 compared to the historic cohort on
POD-1 (p < 0.001) and similar to the historic cohort
on POD-90 (p = 0.437), suggesting early and possibly
improved functional liver regeneration following IHP-R.
Conclusions: IHP-R allows easy and safe cold liver per-
fusion that could improve clinical outcomes following
right hemihepatectomy.
BO17-01
134 ROBOT-ASSISTED
PANCREATECTOMIES
Mario Antonio Belluomini, NelideDe Lio, Stefano
Signori, Francesca Costa, Vittorio Grazio Perrone,
Fabio Vistoli, Emanuele Federico Kauffmann, Niccolo
Napoli and Ugo Boggi
University of Pisa, Pisa, Italy
Introduction: Laparoscopy has revolutionized abdomi-
nal surgery becoming the standard approach for many
operations. The da Vinci surgical system overcomes
most of the inherent technical limitations of laparos-
copy. We test whether the robotic approach can
improve the outcome of pancreatic resections, which
often require challenging dissection and complex diges-
tive reconstructions.
Method: 134 consecutive robotic pancreatic resections
were performed between 10/2008 and 07/2013. There
were 48 males and 84 females (62.6%), with a mean
age of 57.8 yrs (range 21-80) and a mean BMI of 24.4
Kg/m2. 52 patients underwent pancreaticoduodenecto-
my (PD) (39%), 60 distal pancreatectomy (DP)
(44.5%), 9 total pancreatectomy (TP) (7%), 10 tumor
enucleation (7.5%) and 3 central pancreatectomy (2%).
Results: No patient was converted to laparoscopy or
open surgery. Overall mean operative time (OT) was
425 minutes (150-960), PD-OT 560, DP-OT 319, TP-
OT 606. Seven patients underwent to vascular resection
en-bloc (six superior mesenteric vein resections and one
celiac trunk resection): a jump graft was used in five
cases, a patch in one case and a direct suture in one.
Mean number of intraoperative blood transfusion was
2. Mean hospital-stay was 15.8 days. Post-operative
morbidity was 55.2%, post-operative mortality 1.49%.
Pancreatic fistula occurred in 35% of the patients.
Final pathology disclosed 43 malignancies. The mean
number of lymph nodes examined was 26.5.
Conclusions: In selected patients robot-assisted pancre-
atic resections can be safely performed. The dexterity
and magnification of robotic system also allow to face
by the mininvasive approach selected locally advanced
pancreatic malignancy with vascular involvement. Fur-
ther studies are needed before any final conclusion can
be draw.
BO17-02
LESSONS LEARNED FROM EN-BLOC
RESECTION AND RECONSTRUCTION
OF 384 VASCULAR SEGMENTS IN 311
PATIENTS DURING
PANCREATECTOMY
Mario Antonio Belluomini, NelideDe Lio, Francesca
Costa, Andrea Gennai, Niccolo Napoli, Dario
Tartaglia, Fabio Vistoli, Stefano Signori, Franco
Mosca and Ugo Boggi
University of Pisa, Pisa, Italy, Italy
Introduction: Up to 30 % of pancreatic tumors are
denied resection because of suspected vascular infiltra-
tion. Whether or not this condition has negative prog-
nostic implications has been fiercely debated. It is now
clear that venous involvement is a weak prognosticator,
while the debate continues for arteries. Recent avail-
ability of effective neoadjuvant regimens further com-
pounds the discussion. We herein present one of the
world largest experiences including all types of pancrea-
tectomy plus vascular resection (PPVR).
Method: Data from 311 patients undergoing PPVR,
between 10/1986 and 08/2013, were reviewed and ana-
lyzed.
Results: There were 171 males and 140 females, with a
mean age of 64.2 years. Chief complaints, in the 223
symptomatic patients, were jaundice (56%) and pain
(41%). Mean serum Ca19. level was 742.1 U/L. One
hundred and seventy-nine patients underwent pancreati-
coduodenectomy, 95 total pancreatectomy, and 37 distal
pancreatectomy. An isolated vein segment was resected
in 236 patients (76%), and an isolated arterial segment
in 27 (9%). Combined artero-venous resection was car-
ried out in 48 patients (15%). Overall 384 vessels were
resected: the superior mesenteric/portal vein in 276
patients, the superior mesenteric artery was in 27, the
celiac trunk in 24, and the hepatic artery in 32. Recon-
struction was required in 295 patients and employed dif-
ferent techniques. Perioperative morbidity was 56% with
a mortality of 5%. Final pathology demonstrated pan-
creatic ductal adenocarcinoma in 222 patients and actual
infiltration of vessels in 56.5%. Mean overall survival
was 28.4 months, being longer for isolated vein resection
(32.1 months) than for isolated arterial (14.7 months) or
combined artero-venous (15.1 months) resection. Sur-
vival of patients receiving medical therapy was signifi-
cantly longer, for all resection types.
Conclusions: The decision whether or not to pursue
PPVR relies solely on oncological considerations. Our
experience shows that PPVR can be carried out with
acceptable morbidity and mortality rates.
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BO17-03
RELIABLE TECHNIQUES TO ACHIEVE
NEGATIVE SURGICAL MARGIN IN
DISTAL PANCREATECTOMY WITH EN
BLOC CELIAC AXIS RESECTION (DP-
CAR) FOR ADVANCED PANCREATIC
BODY CANCER
Satoshi Hirano, Keisuke Okamura, Takahiro
Tsuchikawa, Joe Matsumoto, Toru Nakamura, Yuma
Ebihara, Yo Kurashima and Toshiaki Shichinohe
Hokkaido University Graduate School of Medicine,
Japan
Introduction: Recently, several authors have reported
relative high rate of pathological residual tumor follow-
ing DP-CAR (R1 or R2 resection). Reliable techniques
of DP-CAR to achieve negative pathological margin
has yet to be established.
Method: DP-CAR was carefully performed in 79
patients in Hokkaido University Hospital from 1998 to
July 2013. To achieve R0 resection, we have built a sys-
tematic procedure of DP-CAR which was consisted of
right and left dorsal, ventral, and medial approaches.
In the dorsal approach, bottoms of the celiac axis (CA)
and superior mesenteric artery (SMA) were exposed in
bilateral side with exposing the crus of the each side of
the diaphragm. In this approach, bilateral para-aortic
nodes and ganglions, and retroperitoneal fat tissue
including the left adrenal gland and left perirenal fat
were dissected completely. The plexus of the SMA was
divided at its dorsal side and removed from the bottom
toward the distal side 4 or 5 cm in length. In the ven-
tral approach, transection of the pancreas after dividing
of the common hepatic artery was performed. In the
medial approach, the plexus of the SMA was divided
at its dorsal side continued to the division line made
previously at the bottom of the SMA. The dissection of
the plexuses went across the SMA to the right side and
continued toward the bottom of the SMA along with
the uncinate process of the pancreas. The CA was
divided after complete dissection of the SMA plexus.
Results: R0 resection could be done in 70 (89%)
patients. Among the 9 patients, the pathological resid-
ual tumor was revealed in the stump of the pancreatic
parenchyma or main pancreatic duct in 5, in dissection
plane of retroperitoneal dissection in 2, of the SMA
plexus in 2.
Conclusions: Triple approaches in DP-CAR seemed to
be beneficial for surgeons to achieve R0 resection.
BO17-04
NO-TOUCH ISOLATION SURGICAL
TECHNIQUE REDUCES
DISSEMINATION OF CIRCULATING
TUMOR CELLS IN PATIENTS WITH
PANCREATIC CANCER
Tamara Gall, Jimmy Jacob, Adam Frampton,
Jonathan Krell, Charis Kyriakides, Leandro
Castellano, Justin Stebbing and Long Jiao
Hammersmith Hospital, United Kingdom
Introduction: Circulating tumor cells (CTCs) dissemi-
nate from the primary tumor and travel through the
bloodstream and lymphatics. The detection and/or
increase in the number of CTCs during a patients’ clini-
cal course may be a harbinger of forthcoming overt
metastasis. We aimed to examine the impact of two dif-
ferent surgical techniques, standard pancreatico-
duodenectomy (ST-PD) and ’no-touch’ isolation
pancreaticoduodenectomy (NT-PD) on tumor behav-
iour and outcome in patients with pancreatic cancer by
using CTCs as biomarkers.
Method: In this pilot study, patients were randomized
to either ST-PD (n = 6) or NT-PD (n = 6). Intraopera-
tively, blood samples were taken from the portal vein
(PV) for measurement of CTCs before and immediately
after removal of the tumor.
Results: An increase in CTCs was seen in 83% of
patients in ST-PD, but none in NT-PD (p = .003).
Median overall survival (OS) was 13.0 and 16.7 months
respectively (p = .328); there was no difference in dis-
ease-free survival (DFS; p = .421).
Conclusions: NT-PD siginificantly reduced the number
of CTCs in the PV with no benefit in survival outcomes
compared to ST-PD, although more extensive studies
are required.
BO17-05
OUTCOMES FOLLOWING NON-
PYLORUS PRESERVING
PANCREATICODUODENECTOMY
WITH AND WITHOUT ADDITION OF A
BRAUN ENTEROENTEROSTOMY: A
RANDOMIZED CONTROL STUDY
Venkatarami Reddy Vutukuru, Sriram Parthasarathy
and Chakrapani Uppala
Surgical Gastroenterology, SVIMS, India
Introduction: Pancreaticoduodenectomy is the proce-
dure of choice for tumors of the head of the pancreas
and periampullary region. Despite improvements in
operative mortality rates, a high incidence of morbidity
still remains. Few studies have shown decrease in mor-
bidity with the addition of Braun enteroenterostomy.
Our aim was to determine any possible benefits in the
postoperative outcome with addition of Braun ente-
roenterostomy to the standard reconstruction after
non-pylorus preserving pancreaticoduodenectomy.
Method: All patients who underwent pancreaticoduo-
denectomy from February 2011 to July 2013 were
included. They were randomized to undergo either
Standard reconstruction with or without addition of
Braun enteroenterostomy. Outcomes of patients who
underwent standard reconstruction were compared with
patients in whom Braun enteroenterostomy was added
to standard reconstruction and the results were ana-
lyzed. Post-operative complications were predefined.
p value of <0.05 was considered significant.
Results: 52 patients were included in the study. They
were divided into 2 groups. Group A included 28
patients who underwent standard reconstruction and
Group B had 24 patients who underwent reconstruc-
tion with addition of Braun enteroenterostomy. The
demographic profile, tumor characteristics, and bio-
© 2014 The Authors
HPB © 2014 Americas Hepato-Pancreato-Biliary Association HPB 2014, 16 (Suppl. 2), 76–127
116 Best Oral
chemical profile were similar in two groups. Mean
operating time was not significantly increased in group
B. Intraoperative blood loss and requirement for trans-
fusion were similar in two groups. The incidence of
pancreatic fistula did not differ significantly in two
groups (7/28, 25% in group A vs. 4/24, 16.6% in group
B; p = 0.42). The Incidence of Delayed Gastric Empty-
ing (DGE) was not statistically different in 2 groups
(10/28, 35.7% in group A vs. 6/24, 25%; p = 0.77).
Infection rates were similar in both groups. Mean hos-
pital stay was similar in two gropus (11.2 in group A
vs. 10.7 days in group B; p = 0.68).
Conclusions: The outcomes of patients after pancreati-
coduodenectomy were not altered by addition of Braun
enteroenterostomy.
BO17-06
PURE LAPAROSCOPIC
PANCREATODUODENECTOMY:
INTEREST ACCESS OF THE SUPERIOR
MESENTERIC ARTEY IN THE FIRST
Juan Santiago Azagra, Martine Goergen and Luca
Arru
Centre Hospitalier de Luxembourg, Luxembourg
Introduction: The aim of this paper is to propose our
technique, Pure Laparoscopic PancreatoDuodenectomy
(PLPD) with the initial approach of the superior mes-
enteric artery (SMA), as an interesting alternative to
perform a pancreatoduodenectomy (PD) for cancer,
defining the feasibility and exposing the short outcomes
at 3rd postoperative month (POM).
Method: A series of 12 selected patients, 7 female and
5 male, reporting a mean BMI of 26 Kg/m2 (range: 23–
30) and a mean age of 62 (range: 55–78) who under-
went elective PLPD with an initial approach of the
SMA. In order to evaluate formally the feasibility of
the PLPD, the two preoperative conditions were: -
exclusion of suspected patients of vascular resection by
a preoperative helicoidally multi-slices CT scan –
‘intention to treat by PLPD’ The technique which is
performed is described, and the iconography is
included. The outcomes include: operative time, conver-
sion, transfusions, fistula, reinterventions and incisional
hernia (IH) or trocar metastasis at 3rd POM.
Results: The mean operative time was 340 minutes
(range: 300 – 540) No per-operative complications were
observed. No conversions to laparotomy neither blood
transfusion was necessary. The mean postoperative hos-
pital stay was 18 days (range 8 – 42) Mortality is 0.
There were three major complications at 3rd POM: 2
grade A pancreatic fistula (Clavien II) and one biliary
fistula. All of them healed without reoperation. No
patient required another surgery at 3rd POM follow-
up.
Conclusions: The PLPD with the initial approach of
the SMA it’s feasible, safe and reproducible in selected
patients.
Key words: Pancreatoduodenectomy, pure laparoscopy,
feasibility, short outcomes.
BO18-01
CONTRIBUTION OF MODERN
APPROACHES TO PERMIT CURATIVE
HEPATIC RESECTION IN TREATMENT
OF PATIENTS WITH COLORECTAL
LIVER METASTASES
Nikolay Bagmet, Lilia Polishchuk, Marina Sekacheva,
Arkadii Bedzhanian and Oleg Skipenko
Petrovsky National Research Centre of Surgery RAMS,
Moscow, Russia
Introduction: Surgical resection is the treatment of
choice in patients (pts) with colorectal liver metastases
(CLM). The criteria for resection have broadened over
the past decade. Now there are two important ways to
increase resectability – surgical (two-stage liver surgery
 radio frequency ablation) and medical (conversion
therapy). The aim of the study was to estimate the con-
tribution of above mentioned modalities in treatment
of CLM.
Method: Between 2003 and 2013, 329 liver resections
were performed in patients (age 57.9  9.8) with CLM.
112 pts were initially unresectable due to unfavorable
location of CLMs or small future remnant liver vol-
ume. Following modalities were used in order to con-
vert to resection: only conversion therapy (n = 32; 38%
with addition of anti-EGFR and anti-VEGF) and two-
stage liver surgery (n = 80; 56% received also conver-
sion chemotherapy).
Results: Two-stage liver surgery was completed in 58
(73%) pts. 20 (62%) pts became resectable after conver-
sion therapy. R0-R1 liver resection was done in 96%
patients. Complications occurred in 32% pts, mortality
was 1,2%. 5-year survival was 34% and not differs from
initially resectable group (35%, p < 0,05). In total, 24%
(n = 78) of all liver resections were performed in initially
unresectable pts after successful «aggressive» surgical
and medical conversion approaches.
Conclusions: Modern approaches to multimodal treat-
ment can notable increase resectability in patients with
initially unresectable CLM. About quarter of liver
resections with potentially curative intent in tertiary
surgical centre are now possible only thanks to conver-
sion strategy. Development of such approaches could
be one of the key directions in treatment of CLM for
the near future.
BO18-02
LONG-TERM SURVIVAL IN
LAPAROSCOPIC VS OPEN RESECTION
FOR COLORECTAL LIVER
METASTASES: THE BRISBANE
EXPERIENCE
Joel Lewin1, David Cavallucci2, Stephanie Huxley1,
Richard Bryant1, Ian Martin2, Leslie Nathanson1 and
Nicholas O’Rourke1
1Royal Brisbane Hospital, Australia; 2Wesley Hospital,
Australia
Introduction: Laparoscopic approach to liver resection
for malignancy remains controversial due to the lack of
evidence that long-term survival outcomes are
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equivalent to the more widely practiced open approach.
This paper compares long-term survival and outcomes
between patients operated on laparoscopically versus
open for colorectal liver metastases.
Method: Patients undergoing liver resection for colo-
rectal liver metastases by 6 surgeons in 3 institutions
between 1998 and 2013 were collected in a prospective
database. Follow up data were confirmed by chart
review. Patients were matched on a 1:1 basis using pro-
pensity scoring analysis, based on age, number of
lesions, maximum lesion size, pre- and post-Basingstoke
Predictive Index (BPI) scores and major hepatectomy
status.
Results: After matching by propensity score, laparo-
scopic and open groups were well matched. In the
intent to treat laparoscopic group, 141 procedures were
performed in 135 patients, with 5-year overall survival
of 61%, and 5-year disease-free survival of 34%. In the
open group, 152 procedures in 146 patients were analy-
sed, with a 5-year overall survival of 57% and 5-year
disease free survival 32%. Log-rank comparison
between laparoscopic and open groups in overall
(p = 0.67) and disease-free (p = 0.11) Kaplan-Meier
survival curves were not significant. Log-rank overall
survival comparison between patients who had laparo-
scopic and open major hepatectomies was also not sig-
nificant (p = 0.78).
Mean blood loss (MD 301 ml, p < 0.01) and operating
times (MD 48 min, p < 0.01) were significantly less for
the laparoscopic group. Hospital length of stay was sig-
nificantly less (p < 0.01) for the laparoscopic group
(5.7 days) than for the open group (8.8 days). No dif-
ference was determined between groups for mean mar-
gin distance or frequency of positive margin. Mean
follow-up was 30 months.
Conclusions: In the Brisbane experience, long term sur-
vival after laparoscopic liver resection for colorectal
liver metastases is equivalent to outcomes in open sur-
gery.
BO18-03
FIRST REPORT OF OUTCOMES OF 134
PATIENTS ON BEHALF OF THE
INTERNATIONAL ALPPS REGISTRY
GROUP
Erik Schadde1, Schnitzbauer Andreas3, Marcel Autran
Machado4, Ricardo Robles-Campos5, Olivier
Soubrane6, Roberto Hernandez-Alejandro7, Max
Malago8, De Santibanes Eduardo2 and Pierre-Alain
Clavien1
1University of Zurich Hospital, Switzerland; 2Italian
Hospital Buenoas Aires, Argentina; 3Johann Wolfgang
von Goethe University Frankfurt, Germany; 4Sirio
Libanes Hospital Sao Paolo, Brazil; 5Virgen de la
Arrixaca University Hospital Murcia, Spain; 6St.
Antoine Hospital, Paris, France; 7Western University
Medical Center London Ontario, Canada; 8Royal Free
Hospital, University College London, London, UK,
United Kingdom
Introduction: Associating Liver Partition and Portal
vein Ligation for Staged Hepatectomy (ALPPS) was
recently introduced to allow resection of primarily non-
resectable liver tumors with marginal future liver rem-
nants. The procedure was criticized due to its high
mortality in case series. We analyzed a world-wide reg-
istry to assess safety and outcomes of ALPPS.
Method: Data extraction was performed in August
2013. All patients with confirmed morbidity and mor-
tality data during hospital admission were included.
Primary endpoint was morbidity and mortality during
hospitalization. Secondary endpoints were volume
changes and risk factors for severe complications in
multivariate analysis.
Results: Between 10/2012 and 08/2013, 38 centers regis-
tered 190 patients. The primary endpoint was com-
pletely confirmed in 134 patients. Mean age was 60
( 11)years, 40% were female, 74% had metastatic dis-
ease. Mean operation duration of Stage1 was 5.4  2
and of stage2, 2.6  1 hours. Four cases were per-
formed laparoscopically. In 2% of patients stage2 was
not performed. 63 % of patients had non-healthy liver
(fibrosis, macrosteatosis>30% or chemotherapy associ-
ated injury). The sFLR increased by 88%( 53%) in a
mean of 11( 9)days and a risk factor for lack of vol-
ume increase was a starting sFLR<25%. Stage1 and 2
In-hospital mortality was 2.4% and 13.5%, respec-
tively. The rate of severe complications (Clavien-Din-
do > IIIB to IVB) after stage1 and 2 was 33% and
24%, respectively. 10% of patients developed liver fail-
ure and 18% postoperative bile leaks. Patients with
colorectal metastases have less severe complications
than other indications (22%vs. 38% resp., OR 2.2;
p = 0.05). Independent predictors for severe complica-
tions and mortality were sFLR< 25% (OR 4.0) and
non-healthy liver (OR5.5).
Conclusions: In this largest series of ALPPS patients
presented to date, the mortality is comparable to previ-
ously published reports. The best indication is colorec-
tal metastases and ALPPS should be performed with
caution in patients with non-healthy liver.
BO18-04
PREVENTION OF PERIHEPATIC
ADHESIONS IN TWO-STAGE
HEPATECTOMY (TSH) FOR
METASTASES FROM COLORECTAL
CANCER (MCRC) : FINAL RESULTS OF
A RANDOMIZED MULTICENTER
PHASE II TRIAL (SEPRA-C2T, NCT
01262417)
Michel Rivoire, Aurelien Dupre1, Emmanuel Buc2,
Frederic Marchal3, Ahmet Ayav4, Guillaume Passot9,
Jean Robert Delpero7, Francois Quenet5, Serge Evrard6
and Sylvie Chabaud8
1Leon Berard Cancer Center, France; 2D’Estaing
University Hospital, France; 3Alexis Vautrin Cancer
Center, France; 4Nancy University Hosipital, France;
5Val d’Aurelle Cancer Center, France; 6Bergonie
Institute, France; 7Paoli Calmettes Institute, France;
8Leon Berard Cancer Center, France; 9Lyon-Sud
University Hospital, France
Introduction: TSH offers the possibility of long-term
survival to selected patients whose liver metastases
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cannot be removed in a single procedure. However, the
2nd operation is made more difficult by perihepatic
adhesions. SEPRA-C2T is a prospective, randomized,
multicenter, controlled phase-II trial designed to assess
feasibility and efficacy of using bioresorbable hyal-
uronic acid/carboxymethylcellulose (HA-membrane) to
prevent perihepatic adhesions in TSH.
Method: 54 candidates for TSH were randomized (3:1
ratio) at the end of the 1st procedure to implantation
of HA-membranes (n = 41) or standard management
(n = 13). Thirty patients from the membrane group
and 11 well-matched controls underwent the planned
2nd hepatectomy. Primary endpoint was the time to
achieve complete liver mobilization at the 2nd hepatec-
tomy. Secondary endpoints were extent and severity of
perihepatic adhesions, perioperative complication rates
and long-term survival. Analysis was by intention to
treat.
Results: Positioning of the HA-membranes was feasible
in all but one patient and did not increase complications.
At 2nd hepatectomy, patients in the HA-membrane
group required 33% less time than controls to achieve
complete liver mobilization (median: 50 vs. 75 minutes;
primary endpoint). The risk of extensive adhesions was
reduced in the HA-membrane group (31% had grade
3–4 adhesions vs. 55% in controls), as was adhesion
severity (17% thick and hypervascular adhesions vs.
46%). The proportion of patients with complications at
2nd hepatectomy was higher in the control group (55%
vs. 23% in the HA membrane group, p = 0.07). At
median follow-up of 45 months, 4-year overall and
progression free survival were respectively 62% and
17%, without difference between groups (intent-to-treat
analysis).
Conclusions: SEPRA-C2T is the first prospective ran-
domized study to demonstrate encouraging evidence of
long-term survival of TSH for mCRC. In this setting,
HA-membranes effectively reduced perihepatic adhe-
sions and complications at 2nd hepatectomy, with no
adverse effects on long-term survival. Thus, HA-mem-
brane is a safe and effective tool for use in liver surgery.
BO18-05
THE EVOLVING ROLE OF HEPATIC
RESECTION FOR METASTATIC
UROLOGIC MALIGNANCIES
John Hamner, Hans Schoellhammer, Joseph Kim and
Gangandeep Singh
City of Hope National Medical Center, U.S.A.
Introduction: While hepatic resection for metastatic
colorectal and neuroendocrine cancers has established
benefits, controversy remains whether resection for
other histologies metastatic to the liver is warranted.
Our objective was to review our institutional experience
with hepatic resection for rare metastatic genitourinary
tumors.
Method: We performed a single institution review of a
consecutive series of patients who underwent hepatic
resection for metastatic genitourinary tumors between
the years of 2000–2013. Patient charts were analyzed
for pathologic data and perioperative outcomes includ-
ing short and long-term morbidity and mortality.
Results: We identified 11 patients who underwent
hepatic resection for diagnosis of metastatic urologic
malignancy (renal cell carcinoma, n = 5; prostate can-
cer, n = 2; bladder cancer, n = 2; ureteral carcinoma,
n = 1; and germ cell tumor, n = 1). All patients were
male with a mean age of 63.5 years. Hepatectomy
included wedge resection (n = 7), hepatic lobectomy
(right, n = 1 and left, n = 2), and left lateral sectionec-
tomy (n = 1). All patients had an R0 resection. The
mean estimated blood loss was 855 ml (range 50-2400)
with higher loss occurring when liver resection was
combined with resection of the primary tumor (mean,
2200 ml). Two patients had a total of 3 major compli-
cations including wound infection, atrial fibrillation,
and exacerbation of gout. Mean length of stay was
6.5 days and there was no 90-day mortality. During the
follow up period, 3 patients have died of recurrent dis-
ease at an average of 11.2 months from resection to
death; and the remaining patients are still alive during
a mean follow up of 28.5 months.
Conclusions: Hepatic resection for metastatic genitouri-
nary tumors is safe with low morbidity and mortality
in appropriately selected patients. Liver resection for
isolated hepatic disease should be considered for this
rare metastatic disease to the liver.
BO18-06
LIVER RESECTION FOR
NEUROENDOCRINE LIVER
METASTASES GIVES EXCELLENT
LONG-TERM SURVIVAL BUT HIGH
RECURRENCE RATE. ANALYSIS ON 115
RESECTIONS
Fadhel Samlir Fteriche, Safi Dokmak, Beatrice
Aussilhou, Alain Sauvanet, Olivia Hentic, Philippe
Ruszniewski and Jacques Belghiti
Beaujon Hospital, France
Introduction: Evaluate the results of liver resection for
neuro-endocrine liver metastases (NELM) in a tertiary
centre with long-term follow-up.
Method: Between 2000–2009, among 2012 liver resec-
tions, 115 (6%) were for NELM in 70 patients, includ-
ing 36 women, with a mean age of 54 years (17–76).
The origin of the primary was pancreatic (51%), small
bowel (33%), indeterminate (9%) and rare location
(7%) and it was functional in 20%. NELM were bilo-
bar (66%), metachronous (24%), >3 lesions (60%) and
underwent major resection in 69%, preceded by hyper-
trophy procedure in 34 (48%) patients. Combined
resection was necessary in (39; 56%) including 2 steps
resection (28; 40%), ablation (10; 7%) and repeated
hepatectomy (17; 15%). Mortality and major morbidity
were observed in 1 (1.4%) and 17 (24%) patients,
respectively. The mean hospital stay was 12 (3–72).
Results: The mean number and size were of 8.4 (1–31)
and 2 cm (0.3–21), respectively. NELM were well dif-
ferentiated in 83%, MIB ≥ 10% in 20%, positive
lymph node (LN) of the primary in 16 (23%) and R0
in 58 (83%). After a mean follow up period of
43 months (0–149), 4 were lost of follow up and 13
died within a delay of 54 months (0–20) including 12
diseases related. Recurrence was observed in 54 (77%)
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within 19 months (2–97) mainly in the liver (52%). The
median survival was 69 (0–150) and the mean overall
and disease free survival at 5 and 10 years was 88%,
63%, 26% and 15%, respectively. In multivariate
analysis, prognostic factors for OS were (MIB >10%,
LN and R0) and for recurrence were differentiation
and LN.
Conclusions: Resection of NELM give an excellent
long term survival but the recurrence still very high jus-
tifying in some subgroup of patients at higher risk of
recurrence, other therapeutic alternatives including liver
transplantation.
BO19-01
REDUCING READMISSIONS
FOLLOWING PANCREATECTOMY:
COORDINATION OF THE CARE
CONTIUUM
Henry Pitt, Eugene Ceppa2, Attila Nakeeb2, C. Max
Schmidt2, Nicholas Zyromski2, Michael House2, Alisha
George-Minkner3, Elizabeth Brand3, Denise Weidert3
and Keith Lillemoe4
Temple University School of Medicine, U.S.A.; 2Indiana
University School of Medicine, U.S.A.; 3Indiana
University Health, U.S.A.; 4Massachusetts General
Hospital, U.S.A.
Introduction: Recent analyses of major gastrointestinal
operations document that postoperative complications
are a key driver of readmissions. However, successful
efforts to reduce readmissions require coordination of
the care continuum. This analysis documents a series of
steps that were implemented to reduce complications
and readmissions following pancreatectomy.
Method: From July, 2007 through June, 2012, the 30-
day, all-cause readmissions rates for patients undergo-
ing proximal, distal and total pancreatectomy were
measured. Length of stay and mortality indices were
risk-adjusted. In 2008, a multifactorial effort was
undertaken which resulted in fewer surgical site infec-
tions. In 2010, a team of surgeons, nurses, advanced
providers, pharmacists, social workers and care manag-
ers was formed. Discharges with home care were
increased from 20 to 50%, and relationships with post-
acute care facilities were strengthened. In 2011, ‘Project
RED’ (ReEngineering Discharges) was adopted and
employed a ‘discharge coach’ to assure that patients
had proper instructions as well as follow-up care. Sta-
tistical analysis included control charts and Fischer’s
Exact tests.
Results: Over five years, 1,147 patients underwent
proximal (69%) distal (26%) or total pancreatectomy
(5%). The mortality index (observed/expected rate) was
0.73 and did not vary over time. The length of stay
(LOS) index (observed/expected days) and 30-day all-
cause readmission rates were:
Conclusions: All-cause readmissions following pancrea-
tectomy can be reduced without altering length of stay.
Efforts to reduce complications and create a team to
coordinate inpatient and outpatient care are required
to reduce readmissions.
BO19-02
ASSOCIATION OF PREOPERATIVE
BILIARY DRAINAGE RELATED
COMPLICATIONS WITH
POSTOPERATIVE COMPLICATIONS
AFTER
PANCREATICODUODENECTOMY
Manabu Kawai, Masaji Tani, Seiko Hirono, Ken-ichi
Okada, Motoki Miyazawa, Atsushi Shimizu, Yuji
Kitahata, Masaki Ueno, Shinya Hayami and Hiroki
Yamaue
Wakayama Medical University, Japan
Introduction: Routine preoperative biliary drainage for
jaundiced patients with pancreaticoduodenectomy (PD)
remains still controversial. One of the major problems
is that preoperative biliary drainage may lead to biliary
drainage related complications such as cholangitis or
pancreatitis. The aim of this study was to clarify how
biliary drainage related complications affect postopera-
tive complications after PD and to evaluate the appro-
priate approach for preoperative biliary drainage after
PD by comparing internal and external biliary drain-
age.
Method: One hundred twenty-seven patients (60 exter-
nal drainage and 67 internal drainage) required biliary
drainage before PD were retrospectively reviewed. Per-
cutaneous transhepatic biliary drainage (PTBD) and
endoscopic nasobiliary drainage (ENBD) were per-
formed as external drainage, and endoscopic retrograde
biliary drainage (ERBD) was performed as internal
drainage. Severe complications was defined as a condi-
tion that was grade III or more based on the Clavien
classification.
Results: Cholangitis due to biliary drainage occurred in
16 patients (12.6%). In 10 of 16 patients (62.5%) with
cholangitis, stent occlusion resulting in stent replace-
ment occurred. Preoperative cholangitis in internal
drainage group (22.4%) occurred significantly more
often than in external drainage group (1.7%;
p < 0.001). The incidence of severe complications
(grade III or more) was significantly higher in patients
with preoperative cholangitis (62.5%) than in those
without it (25.2%; p = 0.002). By univariate analysis, 4
2007–
08
2008–
09
2009–
10
2010–
11
2011–
12
Patients 192 241 224 228 262
LOS Index 1.09 1.04 1.00 1.10 1.01
Readmissions
(%)
23.1 19.1 15.4 17.1 11.5*
*p < 0.05 vs. 2007–11.
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factors were extracted as being useful for discriminating
between patients with and without severe complications
after PD: internal drainage (p = 0.021), preoperative
cholangitis (p = 0.002), soft pancreas (p = 0.001), and
other disease except pancreatic cancer (p = 0.001) were
identified. A multivariate logistic regression analysis
revealed that preoperative cholangitis (odds ratio 4.61,
95% confidence interval 1.3–16.5; p = 0.019) was the
significant risk factor for morbidity after PD.
Conclusions: Preoperative cholangitis during biliary
drainage significantly increases the incidence of severe
complications after PD.
BO19-03
INTERIM ANALYSIS OF PROSPECTIVE
RANDOMIZED CONTROLLED STUDY
COMPARING CLINICAL EARLY
OUTCOME INCLUDING PANCREATIC
FISTULA BETWEEN EXTERNAL AND
INTERNAL PANCREATIC DRAINAGE IN
PANCREATICODUODENECTOMY
Ye Rim CHANG, Jin-Young Jang, Wooil Kwon, Mee
Joo Kang, Dong-Wook Choi2, Seong-Ho Choi2, Jin-
Seok Heo2, Seung-Eun Lee3 and Sang Jae Park4
Seoul National University College of Medicine, Korea;
2Samsung Medical Center, Sungkyunkwan University,
Korea; 3Chung-Ang University School of Medicine,
Korea; 4National Cancer Center, Korea
Introduction: Internal and external stenting are two
widely used pancreatic drainage method after pancrea-
ticoduodenectomy. A multicenter prospective random-
ized trial is underway to compare the two methods. We
aim to report an interim analysis of short-term results.
Method: The trial began in 2009 and is in progress
with target of 466 enrollments. An interim analysis on
short-term complications was conducted with 258
patients. Demographics, operation and pancreas related
data, pancreatic fistula (PF) rates, and other complica-
tion rates were investigated.
Results: The differences in age, sex, and diagnosis dis-
tribution were not observed between external group
(EG) and internal group (IG). Operation type, opera-
tion duration, estimated blood loss, transfusion require-
ment, and hospital-duration were all similar. Pancreas
texture and pancreatic duct size were similar. P-tube
caliber was similarly distributed and the ratio of fibrin
glue application to pancreaticojejunostomy was without
difference. Given this similar background, the compli-
cation rate was 60.4% for EG and 60.5% for IG
(p = 0.986). The PF rates were 49.3% and 43.0% for
EG and IG (p = 0.312). Grade A PF occurred in
29.2% of EG and 25.4% of IG. Excluding PF grade A
from complication, the complication and PF rates were
lowered to 38.4% and 20.1% for EG, and 39.5% and
17.5% for IG. These figures were also similar between
the groups (p = 0.746, 0.598). Other complication rates
were not different with 31.3% and 35.1% for EG and
IG (p = 0.515).
Conclusions: Similar population of external drainage
and internal drainage showed comparable results in
terms of short-term complication rate, especially in
respect to PF rate and grade. This may hint that both
methods are feasible. However, this is only an interim
analysis and the final results remain to be seen which
will include short and long-term results on complica-
tions, pancreatic function, and residual pancreas vol-
ume change (Final result will be presented at the
congress.).
BO19-04
HIGH INTRAOPERATIVE FLUID
VOLUME ADMINISTRATION IS
ASSOCIATED WITH AN INCREASED
INCIDENCE OF PANCREATIC
FISTULAS AFTER
PANCREATICODUODENECTOMY
Xinbo Wang, Sizhen Wang, Hongshan Dai, Jianming
Han and Jieshou Li
Jinling Hospital, China
Introduction: Fluid therapy may be one of the most
controversial topics in perioperative management. The
dangers and consequences of inappropriate fluid and
electrolyte management have been highlighted previ-
ously. Despite improvements in the perioperative care
of patients and patient selection for surgery, pancreati-
coduodenectomy for cancer continues to have one of
the highest postoperative mortality rates among elective
surgical procedures. However, data concerning the
influence of perioperative fluid administration on com-
plications after pancreaticodudenectomy are sparse.
Method: A group of 147 patients underwent pancreati-
codudenectomy for benign or malignant pathology of
the pancreas or of the periampullary region between
2005 and 2009. Clinical data, perioperative fluid admin-
istration, overall morbidity in the hospital and long-
term outcomes were recorded.
Results: A total of 147 patients underwent pancreatico-
duodenectomy for benign or malignant pathology of
the pancreas or of the periampullary region. We cate-
gorized the patients into 2 groups according to intraop-
erative fluid volume administration: a low fluid volume
group (LFVG, <8.2 mL/kg/h, n = 90) group and a high
fluid volume group (HFVG, ≥8.2 mL/kg/h, n = 57). In
terms of colloid administration, the high fluid volume
group received significantly more colloid both during
the intraoperative period and 0–12 h after surgery
(p < .001 and p < .007, respectively). Pancreatic fistula
rates were significantly greater in the high fluid volume
group (p = 0.035). However, the long-term survival rate
was not different between the 2 groups.
Conclusions: High intraoperative fluid volume adminis-
tration is associated with an increased incidence of pan-
creatic fistulas after pancreaticoduodenectomy.
However, intraoperative fluid volume was not associ-
ated with improvement in the long-term survival rate.
Adequate intraoperative and postoperative fluid admin-
istration management can considerably reduce the rate
of postoperative complications after pancreaticoduo-
denectomy.
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BO19-05
QUALITY OF LIFE AND DIABETIC
MANAGEMENT AFTER TOTAL
PANCREATECTOMY: A CASE
MATCHED ANALYSIS
Keith Roberts, Georgina Blanco, Ravi
Marudanayagam, Roberts Sutcliffe, John Isaac, Paolo
Muiesan, Simon Bramhall and Darius Mirza
University Hospitals Birmingham NHS Trust, United
Kingdom
Introduction: Total pancreatectomy (TP) is associated
with significant morbidity and mortality. The severity
of post-operative diabetes is unclear; the existence of
’brittle diabetes’ not supported in simple observational
studies. This study sought to identify quality of life
(QoL) and diabetes specific outcomes after TP.
Method: Patients who underwent TP over 24 years
were identified. Alive patients were matched (age, sex
and duration of diabetes) with non-surgical insulin
dependent diabetics. General QoL was assessed using
the QLQ C30 + Pan26 tools, diabetes specific outcomes
using the Problem Areas In Diabetes Scale (PAIDS)
tool and an assessment of specific diabetic complica-
tions/outcomes.
Results: 112 patients underwent TP; 87 had died (none
due to diabetic complications), 2 lost to follow up and
33 alive. 28 patients returned questionnaires (84.5%).
The median follow up was 8.7 years. Physical status,
working ability, cognitive functioning, social function-
ing, fatigue, nausea, insomnia, pancreas specific pain,
dietary restriction, bloating, bad tasting food, flatu-
lence, weakness, dry mouth were all significantly worse
amongst the TP cohort (QLQ C30 and PAN26). How-
ever, when diabetes specific outcomes were compared
only concern over hypoglycaemic attacks was worse
amongst the TP cohort as assessed by the PAIDS tool.
There was no significant difference with respect to the
remaining 19 PAIDS outcomes. The median HbA1c
was comparable (74.5 vs. 65.0, control vs. TP respec-
tively, p = 0.299) as were diabetic complications such
as hypoglycaemic attacks and organ dysfunction.
Conclusions: TP is associated with impaired general
QoL measures compared to non-surgical diabetic
patients. Importantly, however, there was almost no
significant difference in diabetic outcomes as assessed
by a diabetes specific questionnaire or of diabetic con-
trol. This study does not support the existence of ’brit-
tle diabetes’ after TP.
BO19-06
SURGICAL MANAGEMENT OF
COMPLICATIONS OF PANCREATIC
ENDOTHERAPY
Mukund Joshi, Shaila Jadhav, Ranjana Bhadbhade2
and Sudhir Dube
B. J. Medical College, India; 2Joshi Clinic, India
Introduction: Endoscopic pancreatic stenting is quite
commonly practiced in cases of chronic Pancreatitis.
Often it is followed by Pancreatic lithotripsy for easier
extraction. We have presented our experience of 23
cases in which surgical exploration was required after
pancreatic endotherapy. We have emphasized the prob-
lems and care that needs to be taken during surgery.
Method: We selected cases of chronic pancreatitis who
had undergone pancreatic endotherapy, who presented
with abdominal pain, sepsis or Jaundice. 11/14 cases
had undergone pancreatic stenting alone, 9/14 had
undergone stenting with Lithotripsy, 3/14 had under-
gone ERCP where stenting had failed. All patients
underwent CT scan evaluation, biochemical work up
and were started on IV antibiotics 24/48 hours prior to
surgery. All cases underwent Laparotomy. Identifica-
tion of pancreatic duct was found to be difficult sec-
ondary to ‘Edematous Fibrotic pancreas’. In majority
of cases stones were seen around the stent and 10/20
stents were all blocked. All patients underwent PJ after
successful removal of stent.
Results: There was no mortality. Average blood loss
was 350 cc requiring Blood transfusions. Average time
was 4.30 hrs and average patient stay was 14 days.
Overall post-operative recovery appeared delayed as
compared to Pancreatico-jejunostomies done without
pre-operative pancreatic endotherapy.
Conclusions: Surgical exploration of pancreas becomes
difficult due to edematous pancreas which spreads to
nearby tissues making the dissection difficult. Secondly
increased vascularity needs careful hemostasis. Stent
can never be palpable on the surface of pancreas due
to edematous pancreas. One needs to be extremely gen-
tle while performing pancreatic anastomosis as sutures
can give way secondary to pancreatic tissue edema.
Stents need careful pulling as it can lead to severe
bleeding and duodenal injury. Pancreatic endotherapy
is not without complications. Lithotripsy does not nec-
essarily lead to duct clearance. Careful dissection is pri-
ority. Adequate blood transfusions need to be reserved.
BO20-01
ASSOCIATION BETWEEN ATP
BINDING CASSETTES TRANSPORTER
POLYMORPHISMS AND
SUSCEPTIBILITY TO GALLSTONE IN
IRANIAN PATIENTS
Seyed Reza Mohebbi, Saman Milanizadeh, Amir
Hooshang Mohammad Alizadeh, Pedram Azimzadeh,
Mahsa Khanyaghma, Hanieh Mirtalebi and
Mohammad Reza Zali
Gastroenterology and Liver Diseases Research Center,
Shahid Beheshti University of Medical Sciences, Iran
Introduction: Gallstone disease (GSD) is a common
and complex disease that can be caused by multiple
environmental influences, genetic factors and their
interactions. Aberrant cholesterol trafficking and accu-
mulation is the molecular basis for many diseases, such
as GSD. Recently, several ATP-binding cassette (ABC)
transporters, such as ABCA5 and ABCG8 have been
shown to play possible roles in the susceptibility to
gallstone. The aim of this study was to explore the
association of single nucleotide polymorphisms of
human ABCA5 and ABCG8 genes with gallstone dis-
ease in Iranian population.
Method: A total of 200 patients with gallstone and 251
healthy controls were included in the case-control study
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for risk prediction. Using Polymerase chain reaction-
restriction fragment length polymorphism (PCR-RFLP)
method, single nucleotide polymorphisms in ABCG5
gene (rs6720173), ABCG8 (rs11887534) and (rs4148217)
were genotyped. For confirmation, 10% of samples ran-
domly selected and subjected for direct sequencing.
Results: Heterozygote variant of rs11887534 intervened
in gallstone by decreasing the risk of susceptibility in
males (p ≤ 0.001; OR = 0.125; CI 95% = 0.048–0.325).
In contrast C/C genotype associated with female gall-
stone susceptibility (p ≤ 0.001; OR = 5.555 CI
95% = 1.975–10.632).
Conclusions: Our results suggest that polymorphism in
ABCG8 rs11887534 may have a significant effect on
GBC susceptibility in a gender specific manner in Ira-
nian population. Additional studies on a larger popula-
tion are needed to confirm our findings.
BO20-02
ABSORBABLE BIOPROSTHESIS FOR
THE TREATMENT OF BILE DUCT
INJURY IN AN EXPERIMENTAL
MODEL
Alvaro R. Jaime-Limon1, Min Jeong Kim Koh1,
Manuel A. Garcıa-Pineda1, Fernando Rojas-Mendoza3,
Cesar Montalvo-Arenas4, Jorge Albores-Saavedra5,
Benjamın Leon-Mancilla1, Jesus Tapia-Jurado1, Carlos
Gutierrez-Banda2 and Eduardo E. Montalvo-Jave6
1School of Medicine, Universidad Nacional Autonoma de
Mexico UNAM, National Autonomous University of
Mexico, Mexico; 2Hospital General de Mexico, Mexico;
3Medica Sur Clinic Foundation, Mexico; 4School of
Medicine, Universidad Nacional Autonoma de Mexico
UNAM, National Autonomous University of Mexico,
Mexico; 5Instituto Nacional de Ciencias Medicas y
Nutricion ‘Salvador Zubiran’; Medica Sur Clinic
Foundation, Mexico; 6School of Medicine, Universidad
Nacional Autonoma de Mexico UNAM, National
Autonomous University of Mexico; Hospital General de
Mexico, Mexico
Introduction: Biodegradable stent implants are an alter-
native replacement of the bile duct due to benign steno-
sis, bile duct injury or cancer. We employed an
acellular bone based bioprosthesis (10% water, 65%
collagen and 25% hydroxyapatite) as an alternate treat-
ment for biliary injury.
Method: Eight 15 kg Landrace pigs underwent an ini-
tial laparotomy in which 3 cm of the common bile duct
was excised. An end to end anastomosis (bile duct-
prosthesis-bile duct), with the liquid collagen coated
and hydrogen peroxide gas plasma sterilized biopros-
thesis, was performed. Every pair of pigs underwent a
follow-up during 1, 6, 12 and 18 months respectively,
with liver function serum test, cholangiography, chol-
angioresonance, cholangioscopic procedure with Spy-
glass, followed by cytokeratin (CK-7 and CK-19)
immunohistochemistry, and finally H-E staining for
microscopic evaluation.
Results: No intraoperative mortality or infectious com-
plications were observed during the follow-up. All
gained weight and showed no evidence of acolia or
jaundice. Blood chemistry did not reveal increases in
hepatobiliary enzymes preoperatively or at 7, 30, 60, 90
or 180 days. Cholangioresonance showed adequate per-
meability and no stenosis, however, moderate dilatation
of extra and intrahepatic ducts were found in an 18-
month follow-up model. Cholangioscopy procedure
with Spyglass showed the bioprosthesis insertion in
place, without stenosis. Sacrificed by anesthetic over-
dose, the models underwent an exploratory laparot-
omy, without finding evidence of necrosis, stricture or
bile leakage. Biopsies were obtained from the bifurca-
tion of the bile duct up to the second portion of the
duodenum including the graft site. Conventional
microscopy, at one month postimplantation, showed a
rich deposit of collagen fibers with persistent inflamma-
tory cellular infiltrate. In the third month the graft site
developed a columnar epithelium similar to the origi-
nal, as well as CK-7 and CK-19 positive epithelial cells.
Conclusions: This collagen based bioprosthesis has
potential for its application as a novel treatment for
biliary injury and stenosis.
BO20-03
REVIEW OF 500 CASES OF SINGLE
INCISION LAPAROSCOPIC
CHOLECYSTECTOMY
Jaehong Jeong, Jin Seok Heo, Dong Wook Choi,
Seong Ho Choi, Hyo Jun Park, Dong Hun Kim and
Hui Song Lee
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: There have been many reports regarding
single incision laparoscopic cholecystectomy (SILC)
published. However, most studies are case series with a
limited number of cases. We have reviewed the out-
come of 500 consecutive cases of SILC performed by a
single surgeon in our center.
Method: From April 2009 to October 2012, 1250
patients underwent laparoscopic cholecystectomy for
symptomatic gallbladder (GB) disease by a single sur-
geon. SILC was performed in 500 cases via a 2 cm
sized transumbilical port. SILC was chosen as the sur-
gical modality unless there is evidence of acute chole-
cystitis or GB empyema, the patient has a prior history
of upper abdominal surgery, has had endoscopic
sphincterotomy for cholelithiasis or bile duct sludge, or
has comorbidities with an ASA score of 3 or higher.
The clinicopathologic features and perioperative data
of patients were retrospectively reviewed.
Results: Mean age of patients was 42.7 years and mean
BMI was 23.6 kg/m2. There were 331 female patients
(66.2%). Mean operating time was 52 minutes (range
21 ~ 138 minutes). Mean hospital stay was 1.3 days
postoperatively. An additional 2 mm trocar was
inserted in the right anterior axillary line for retraction
of the GB in 55 patients. Five patients had a prior his-
tory of lower abdominal surgery. One case was con-
verted to open cholecystectomy for suspected Mirizzi
syndrome. No complications such as incisional hernias
have been observed in the patient population.
Conclusions: SILC is a safe and feasible procedure for
cholecystectomy and can be considered as the main sur-
gical strategy in a well selected patient population.
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BO20-04
RANDOMIZED CONTROL TRIAL OF
CONVENTIONAL LAPAROSCOPIC
VERSUS SINGLE INCISION
LAPAROSCOPIC CHOLECYSTECTOMY
Devendra Singh, Vaibhav Jaiswal, Abhinav Arun
Sonkar, Surender Kumar and Saumaya Singh
King George‘s Medical University, Lucknow, UP, India
Introduction: From big incision to minimally invasive
multiport classic laparoscopic cholecystectomy (CLC)
and now to single incision laparoscopic cholecystec-
tomy (SILC) surgery has travelled a long way. There
are proposed advantages and potential disadvantages
of SILC compared to the ’gold standard’ CLC. How-
ever, debate still exists whether SILC has anything
more to offer. We compared various parameters of
patient satisfaction, quality of life and short term surgi-
cal outcomes between CLC and SILC.
Method: RCT was conducted for duration of one year.
Patients were assigned into SILC and CLC groups.
Operative time, length of hospital stay, quality of life
(SF 36 questionnaire), patients overall and cosmetic
satisfaction and postoperative pain using 10-point
visual analogue scale (VAS) were assessed. The data
analysis was done using software SPSS version 20.0.
Results: A total of 36 patients (28 women and 8 men)
with mean age 39.88  11.99 years were allocated into
SILC (n = 18) and CLC (n = 18) groups. The mean
operative time for SILC was significantly longer than
CLC (66.33 vs. 46.50 minutes, p = 0.001). VAS
recorded higher pain in first 24 hours postoperatively
in SILC than CLC group (4.467 vs. 2.667, p = 0.06).
However, at the time of discharge patients in CLC had
greater pain than SILC group (0.22 vs. 0.133,
p > 0.99). No significant variability was seen in length
of hospital stay (SILC 3.60 vs. CLC 3.38 days,
p = 0.47). The QOL on first follow up visit showed sta-
tistically significant difference in two of the domain of
SF 36, namely vitality and bodily pain. Patients overall
and cosmetic satisfaction showed no superiority of
SILC over CLC
Conclusions: Although patient prefers SILC in wake of
cosmetic reasons, still it is a long way off from replac-
ing CLC. Larger operative time and lack of standardi-
zation makes SILC still an evolving procedure and
judicious patient selection is must for better outcome.
BO20-05
COST OF ROBOT VERSUS HUMAN
ASSISTANT IN LAPAROSCOPIC
CHOLECYSTECTOMY
Steve Morris2, Nishma Patel2, Kurinchi Gurusamy1
and Brian Davidson1
1University College London and Royal Free Hospital,
United Kingdom; 2University College London, United
Kingdom
Introduction: A recently-updated Cochrane systematic
review found that robot-assisted laparoscopic cholecys-
tectomy was safe but showed no significant advantages
over human-assisted laparoscopic cholecystectomy. We
investigated the cost of robot-assisted versus human-
assisted laparoscopic cholecystectomy from the perspec-
tive of the UK National Health Service.
Method: A model-based economic evaluation investi-
gating the cost of the surgical procedure accounting for
operating staff and assistant time, theatre time, cost of
laparoscopic system, cost of robotic system, surgical
instruments and length of hospital stay. Data were
obtained from published sources. Results were calcu-
lated for different types of robotic surgical system, ser-
vice life of robot and number of procedures per year.
Results: The cost of human-assisted laparoscopic cho-
lecystectomy was £2703 (2011–12 UK£). The cost of
using the robot assistant was £2877–£15,253, depending
on the type of robotic surgical system, the service life
of the robot (5–10 years) and the number of procedures
per year (50–500).
Conclusions: Robot-assisted laparoscopic cholecystec-
tomy is not cost-effective in the UK National Health
Service.
BO20-06
PROPOSAL AND RETROSPECTIVE
VALIDATION OF A SCORING SYSTEM
FOR THE PREDICTION AND
TREATMENT OF
CHOLEOCHOLITHIASIS
Samah Khayat1, Elfateh Abdeen1, Tasadooq Hussain3,
Mohamed Yassin4 and Bilal All-Jiffry2
1Al-Hada Military Hospital, Saudi Arabia; 2Taif
university, Saudi Arabia; 3Hull york medical school,
United Kingdom; 4Queen Elezabeth Hospital, King
Lynn, United Kingdom
Introduction: Endoscopic retrograde cholangiopancrea-
tography (ERCP) is the treatment for choledocholithia-
sis (CDL). Although recommended in patients with
confirmed CDL because of its morbidity and mortality.
On the other hand, MRCP is recommended for the
diagnosis of CDL, however, its cost is an issue if done
for all suspected patients. We aimed to evaluate a pre-
dictive scoring system for the presence and treatment
of CDL.
Method: 155 consecutive patients with symptomatic
gallstone, biliary pancreatitis, obstructive jaundice and/
or cholangitis were prospectively selected. All patients
had biochemical and ultrasound variables analyzed.
For the validation of the scoring system, scores were
analysed for the presence of CDL using a retrospective
cohort of 272 patients.
Results: From the testing group, variables such as
common bile duct diameter, ALK ≥ 200, abnormal bili-
rubin levels, ALT ≥ 220, age ≥ 50, and male gender,
were significant (p ≤ 0.05). A score in the range of 1-2
were considered as low risk and advised cholecystec-
tomy with an IOC. Patients with scores of 3-7 were
considered intermediate risk and investigated with
MRCP prior to cholecystectomy and patients with
scores ≥8 were considered high risk and underwent
ERCP. The model was tested on a second, validation
group of 272 patients using Fischer’s exact test. A total
of 96/272 (35%) patients were found to have scores ≥8
of which 92% had CDL. 86/272 (32%) patients had
scores 3-7 of which 40% had CDL. 27/272 (10%)
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patients had scores 1-2 of which 15% had CDL. 23%
(63/272) of patients scored zero and one patient was
found to have CDL (2%) (Incidental stone).
Conclusions: Our scoring system was found to accu-
rately predict the need for therapeutic ERCP. A score
of ≥8 strongly correlated with the presence of CDL in
the validation group. A prospective validation of our
predictive model in a larger patient series is now
required.
BO21-01
NUTRITIONAL RISK SCREENING (NRS
2002) AND SHORT-TERM OUTCOMES
AFTER LIVER RESECTION
Thomas Zacharias, Nelio FERREIRA, Pierre Barsotti
and Sebastian Dan
Ho^pital Emile Muller, France
Introduction: Undernutrition is a major source of mor-
bidity and mortality in surgery. We evaluated the abil-
ity of the Nutritional Risk Screening (NRS 2002) to
predict poor short-term outcomes after liver resection.
Method: Retrospective study of a prospective database
in a tertiary hospital. Primary endpoint was the 90-day
mortality. Secondary endpoints were overall and infec-
tious complications. Uni- and multivariate analysis of
risk factors for 90-day mortality in elective liver resec-
tion were performed.
Results: Two hundred liver resection were performed
between 9 November 2007 and 9 July 2013. The overall
90-day mortality was 7.0% (14/200) and 5.7% in elec-
tive surgery (11/191). The overall complication rate was
60.0%, and the infectious complication rate was
35.5%. In elective liver resection patients with a NRS
2002 Score of 2–3 had a 90-day mortality of 1.7%, with
a NRS 2002 Score of 4–5 mortality increased to 6.2 %,
and with a NRS 2002 Score of 6 a 90-day mortality of
41.6% was observed. Predictive factors in multivariate
analysis for 90-day mortality in elective liver resection
were: ASA score ≥ 3 [p = 0.035; odds ratio (OR): 4.08;
95% confidence interval (CI): 1.09–15.18] and Nutri-
tional Risk Screening 2002 (p = 0.0030; OR: 2.20; 95%
CI: 1.30–3.72).
Conclusions: In the present study Nutritional Risk
Screening (NRS 2002) was predictive of poor short-
term outcome after liver resection. Nutritional risk
should be reported in studies analyzing outcomes after
liver resection.
BO21-02
AGEING DOES NOT AFFECT HEPATIC
REGENERATION AFTER PORTAL VEIN
OCCLUSION: RESULTS OF CASE-
CONTROL STUDY
Nadia Russolillo1, Francesca Ratti2, Luca Vigano’1,
Alessandro Ferrero, Federica Cipriani2, Luca
Aldrighetti2 and Lorenzo Capussotti
1Mauriziano ‘Umberto I’ Hospital, Italy; 2Sant Raffaele
Hospital, Italy
Introduction: Portal Vein Occlusion (PVO) by emboli-
zation or ligation is routinely used to increase inade-
quate future liver remnant (FLR) in patients scheduled
for major or extended hepatectomy.
Several experimental studies showed a reduced liver
proliferative capacity and impaired liver regeneration in
aged animals following partial resection or chemically
induced injury. The impact of this impairment in clini-
cal setting is unclear. Aim of this study is to evaluate
the impact of the age on the hepatic regeneration after
PVO.
Method: 199 patients scheduled for PVO before sur-
gery between 01/2000 and 06/2013 were considered for
the study. 60 consecutive old patients (≥70 years) were
matched on a ratio of 1:1 with 60 patients aged
<70 years. Matching criteria were sex, diabetes, cirrho-
sis, pre-PVO chemotherapy, pre-PVO bevacizumab
administration and jaundice. The standardized FLR
volume was assessed by volumetric CT-scan. Liver
regeneration was assessed by volumetric increase
[(FLRpost% – FLRpre%) /FLRpre%].
Results: BMI, diagnosis, type of liver resection, median
number of chemotherapy cycles, liver function tests and
median value of FLR before PVO were similar in the
two groups. Post-PVO complications were higher in old
patients (15% vs. 3.3%, p = 0.026). Nevertheless, no
differences were encountered in terms of post-PVO
FLR and VI in the two groups. 10% of old patients
didn’t undergo liver surgery vs. 3.3% of younger group
(p = 0.057) mainly for disease progression. Mortality
(5.5% vs. 6.7%), overall and major morbidity (50% vs
40% and 18% vs 15% respectively) were similar. Nev-
ertheless liver failure rate was increased in older
patients (40% vs. 17%, p < 0.001) and this was mainly
related to Grade B and C liver failure (20% vs. 3.3%,
p = 0.012).
Conclusions: Liver regeneration after PVO is not
impaired by age. Nevertheless liver resection in elderly
patients is less often perform after PVO and carries
higher risk of postoperative severe liver failure.
BO21-03
ANATOMICAL STUDY OF
INTRAHEPATIC RAMIFICATION OF
MIDDLE HEPATIC VEINS USING
KOREAN CADAVERIC LIVERS
Sang In Bae1, Hee Chul Yu3, Zhe Wu Jin2, Jae Do
Yang1 and Baik Hwan Cho3
1Chonbuk National University Hospital, Korea;
2Yanbian University Medical College, China; 3Chonbuk
National University Medical School, Korea
Introduction: Tailoring transection of middle hepatic
vein(MHV) with interposition graft became a new stan-
dard in right-lobe living donor liver transplantation for
adult patients. We frequently encountered the discrep-
ancy between intersegmental border and hepatic vein.
In this study, we propose a new naming system to des-
ignate their intervening characteristics between sub-
and intersegments.
Method: Thirty-three livers removed from adult cadav-
ers were used in this study. Before anatomical dissec-
tion, hepatic venograms using 20% barium sulfates
were taken to demonstrate the MHV branches. Superfi-
cial dissection along the Cantlie line was deepened to
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MHV trunk to identify draining territory of its
branches. Thereafter left HV(LHV) territory was dis-
sected with same manner. The MHV branches of S4
are named as follows: inferior part is V4a, superior part
is V4b, between S4a and S4b is V4a-4b.
Results: 22 of 33 livers showed typical normal looking
MHV in form of a large trunk with medium sized sev-
eral branches. 11 livers revealed a wide variety of
MHV including a case of absent MHV trunk in the
midline of liver. There were 107 branches draining left
liver which include: V3, 3; V4b, 2; V4a-4b, 25; V4a, 77,
There were 151 branches draining right liver which
include: V6, 20; V8v-5, 30; V8v, 51; V8v-8d, 40; V8d,
10. There were 85 branches draining both right and left
liver: V4a-5, 32, V4b-8v, 19; V4a-8v, 34, Venous drain-
age pattern of S4 were MHV dominant (MHV
branches: LHV branches = 104:59). Pure V4b branches
were very rare (MHV: LHV = 2:4). V4a were most
common (MHV: LHV = 77:35). V4a-4b were less com-
mon (MHV: LHV = 25:20).
Conclusions: The proposed new naming system of V4
to designate their intervening characteristics is
described. This study should be helpful in identifying
the specific V4 vessels of the areas of the left medial
segment to be resected and to be preserved.
BO21-04
THE INHOMOGENEOUS
DISTRIBUTION OF LIVER FUNCTION –
POSSIBLE IMPACT ON THE
PREDICTION OF POSTOPERATIVE
REMNANT LIVER FUNCTION
Henrik Nilsson, Lennart Blomqvist and Eduard Jonas
Karolinska Institutet, Sweden
Introduction: Studies have shown that liver function is
inhomogeneously distributed in diseased livers, and this
uneven distribution of liver function cannot be compen-
sated for if a global liver function test is used for pre-
operative assessment of postoperative remnant liver
function. It has also been shown that dynamic Gd-
EOB-DTPA-enhanced MRI can be used to assess seg-
mental liver function, thus offering the possibility to
study this phenomenon.
Method: Ten patients with varying degrees of liver cir-
rhosis and ten normal volunteers were included. Using
dynamic Gd-EOB-DTPA enhanced MRI, segmental
contribution to total liver function and volume was cal-
culated. Remnant liver function predictions were com-
pared in a simulated left hemihepatectomy (segments 2,
3 and 4). For the simulation of the prediction based on
segmental functional MRI assessment, the actual func-
tion of the remnant liver segments was added. For
example, if resection implied removal of 45% of the
liver volume, the predicted remnant liver function using
global assessment was calculated as being 55 % of the
total liver function, whereas the measured function of
segments 1, 5, 6, 7, and 8 was added for the segmental
function-based prediction.
Results: Global liver function assessment overestimated
the remnant liver function in 9 out of 10 patients by as
much as 9.3% (median -3.5 (range 9.3–3.5)). In the
normal volunteers there was a slight underestimation of
remnant function in 9 out of 10 cases (median 1.07
(range 0.7–2.5)). If the actual value of the remnant
function as estimated by the segmental method is used
as reference, the miscalculation using the global assess-
ment was as much as 26%.
Conclusions: The study underlines the necessity of a
segmental liver function test able to compensate for the
non-homogeneous nature of liver function distribution
in patients with diseased liver parenchyma, if the
assessment of postoperative remnant liver function is to
be improved.
BO21-05
PREDICTION OF POST-
HEPATECTOMY COMPLICATIONS BY
TRANSIENT ELASTOGRAPHY
(FIBROSCAN) IN PATIENTS WITH
HEPATOCELLULAR CARCINOMA
Jeff SW Wong, Derek TL Tam, Tommy CF Lau, TP
Fong and SH Lam
United Christian Hospital, Hong Kong, China
Introduction: Liver cirrhosis associates with morbidity
after hepatectomy. Patients with hepatocellular carci-
noma (HCC) usually suffers from various degree of
liver cirrhosis. Transient elastography (TE) has shown
to be accurate in the assessment of liver cirrhosis.
Whether TE can predict the post-hepatectomy compli-
cations in HCC patients is still unclear.
Method: Study was carried out at the United Christian
Hospital in Hong Kong. From January 2012 to May
2013, total 38 patients with HCC were recruited for TE
assessment before hepatectomy. Bedside ultrasound
was routinely performed to assure the liver segment for
TE was tumour free. The peri-operative data were col-
lected and analyzed prospectively.
Results: The median age of patients was 66 (44–80)
and female to male ratio was 11:27. 34 (89%) patients
were hepatitis B carriers and 11(29%) patients had his-
tological cirrhosis. The median ASA score was 2 (1–3).
The median TE value was 10.2 kPa (3.6–31.6 kPa) and
the median ICG(R15) value was 10.2% (2.9–31.2%).
The percentage for major and laparoscopic hepatec-
tomy were 34% and 32% respectively. The mean oper-
ative time was 236  88 minutes. Median blood loss
was 115 ml (30–850 ml) and transfusion rate was 7.9%.
The median post operative stay was 8 days (3–36 days)
and there were no mortality. Complications occurred in
12 (31.6%) patients, including 7 liver related complica-
tions (3 pleural effusion, 2 ascites, 1 bile leakage, 1 pro-
long jaundice). Only TE but not ICG showed
significant correlation to liver related complications on
receiver operating characteristics curves with area under
curve 0.75, P = 0.04. Using the calculated cutoff at
11.8 kPa, TE had the sensitivity of 71.4%, specificity of
71% and accuracy of 71% in the predication of liver
related complications. TE also showed good correlation
to histological cirrhosis.
Conclusions: High TE (>11.8 kPa) was associated with
higher liver related complication for HCC patients.
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BO21-06
THE ASSESSMENT OF OPERATIVE
RISK AFTER LIVER SURGERY IN THE
MODERN ERA: RESULTS OF A
PROSPECTIVE STUDY
Luca Vigano1, Annalisa Garau1, Alessandro Ferrero1,
Nadia Russolillo1, Serena Langella1 and Lorenzo
Capussotti1
1Ospedale Mauriziano Umberto I, Italy
Introduction: Liver surgery has become safe with low
mortality rates, mainly thanks to accurate patient’s
selection. Nevertheless, severe morbidity rates did not
decrease (=15-25%). The present study aims to iden-
tify predictors of postoperative severe morbidity. They
could allow further outcomes improvement.
Method: Between January 2010 and December 2012,
361 consecutive patients undergoing liver resection at
the same institution were enrolled in a prospective
study. All patients had hepatic, renal, cardio-pulmon-
ary, immunological and metabolic status evaluation.
Predictors of severe morbidity (grade III-V) were ana-
lyzed.
Results: 136 (37.7%) patients had arterial hypertension,
56 (15.5%) diabetes, 20 (5.5%) COPD, 12 (3.3%) renal
dysfunction, and 8 (2.2%) coronary artery disease. 31
(8.6%) patients were cirrhotic. ASA score was III-IV in
134 (37.1%) patients. The commonest diagnoses were
colorectal metastasis (n=204), HCC (n=49) and cho-
langiocarcinoma (n=31). Major hepatectomy was
scheduled in 116 (32.1%) patients; 44 (12.2%) had
associated colorectal resection, 18 (5.0%) biliary resec-
tion and 4 (1.1%) vascular resection. Overall, 44
(12.2%) patients had severe morbidity, including 1
(0.3%, sepsis and MOF) operative death. At multivari-
ate analysis, predictors of severe morbidity were: WBC
count >10 103/microL (35.7% vs. 11.3%, OR=4.773,
p=0.002); bilirubin >2 mg/dL (50.0% vs. 10.0%,
OR=9.364, p=0.002); PT <70% (44.4% vs. 11.5%,
OR=4.714; p=0.046); creatinine >1.2 mg/dL (37.5%
vs. 11.6%, OR=6.635, p=0.019); major hepatectomy
(23.9% vs. 6.6%, OR=3.409, p=0.001). ASA score,
comorbidities, cirrhosis and associated resections did
not impact outcome. Severe morbidity risk was 4.5% if
0 risk factors, 17.3% if 1 and 53.6% if >1.
Conclusions: Thanks to actual patient selection, severe
postoperative complications are no more related to
ASA score, comorbidities and cirrhosis. The need for a
major hepatectomy, but not the association of extra-
hepatic resections, increases the operative risk. The
main determinants of severe complications are liver and
renal function, jaundice and leukocytosis. The correc-
tion of these parameters, whenever possible, could pre-
vent severe morbidity.
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